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Chapter 1 
Maintenance of the body Ca2+ balance is of vital importance for many physiological 
functions including intracellular signaling processes, neuronal excitability, muscle 
contraction and bone formation. The extracellular Ca2+ concentration ([Ca2+]e) is regulated 
by a homeostatic mechanism which tightly controls the concerted action of intestinal Ca2+ 
absorption, renal Ca2+ reabsorption and exchange of Ca2+ to and from bone 1, 2. 
Disturbances in Ca2+ (re)absorption may result in clinically relevant symptoms such as 
decreased bone mineral density (osteoporosis) when [Ca2+]e is persistently too low, or vice 
versa, to the formation of kidney stones when [Ca2+]e is too high. 
 
UNIQUE EPITHELIAL ION CHANNELS ESSENTIAL FOR BODY CA2+ HOMEOSTASIS 
 
Both in intestine and kidney, Ca2+ can (re-)enter the extracellular space (blood 
compartment) by passive paracellular as well as active transcellular Ca2+ transport 3, 4. 
Transcellular Ca2+ (re)absorption is initially tightly regulated by the influx of Ca2+ across 
the luminal membrane of the epithelial cell. Next, Ca2+ is sequestered by calbindin-D28K or 
-D9K to maintain low cytosolic Ca2+ concentrations. Subsequently, calbindin-bound Ca2+ 
diffuses to the basolateral side of the cell, where it is extruded into the bloodstream via 
Na+/Ca2+ exchanger (NCX1) and/or the plasma membrane Ca2+-ATPase (PMCA1b) 
(Figure 1). The influx of Ca2+ across the luminal membrane is mediated by specialized 
epithelial Ca2+ channels, i.e. Transient Receptor Potential Vanilloid-subtype 5 and/or 6 
(TRPV5 and TRPV6). The regulation of these channels is 
particularly important because it occurs down a steep 
concentration gradient of Ca2+ (indicated in Figure 1). In addition, 
TRPV5 or TRPV6 channel activity is uniquely characterized by 
selective Ca2+ currents (> 100 times over monovalent cations) that 
rapidly decrease, indicative of Ca2+-dependent feedback 
inactivation, and a specific (strong inwardly rectifying) ion 
current-voltage (I/V) profile 5-7. The latter is reflected by large 
currents at negative membrane potential and negligible currents at 
positive membrane potential 6. Based on these findings, TRPV5 
and TRPV6 are considered to be the gatekeepers of transcellular 
Ca2+ transport 2, 6, 8, 9.  
 
Luminal membrane:  
The membrane facing the 
interior or lumen of the 
gastro intestinal tract or 
nephron tubule 
 
Basolateral membrane:  
The membrane facing the 
basal (base) and lateral 
aspect of the cell that is 
in close contact with the 
bloodstream 
 
Membrane potential:  
Electrical potential 
difference (voltage) 
across a cell's plasma 
membrane
     TRPV5 and TRPV6 were originally cloned from rabbit kidney 
and rat intestine, respectively, and were subsequently identified in 
many additional species including fish, rabbit, mouse, rat and 
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Figure 1. Integrated model of active epithelial Ca2+ transport. Ca2+ enters the cell at the 
luminal membrane via the epithelial Ca2+ channel TRPV5 and/or TRPV6 and is sequestered 
by calbindin-D28K or –D9K. Next, bound Ca2+ diffuses to the basolateral cell surface where it 
is extruded into the blood compartment via the Na+/Ca2+ exchanger (NCX1) and/or plasma 
membrane Ca2+-ATPase (PMCA1b). Ca2+ influx occurs down a steep electrochemical 
gradient (luminal [Ca2+]e = 1 mM vs. [Ca2+]i = 100 nM).  
human 10, 11. TRPV5 and TRPV6 are about 730 amino acids, have a molecular mass of 
approximately 83 kDa, contain six transmembrane (TM) segments and large cytosolic NH2- 
and COOH-terminal domains. A short hydrophobic stretch between TM5 and TM6 was 
predicted to be the pore-forming region. The six-TM unit is one of four subunits presumed 
to surround the central pore in a tetrameric configuration 12 (see Figure 2). The NH2-
terminal domain contains six ankyrin repeats 13 that can mediate protein-protein 
interactions, and it is suggested that the first ankyrin repeat is 
critical for functional channel multimerization 14. The 
electrophysiological characteristics of TRPV5 and TRPV6 channel 
activity have been studied extensively. TRPV5 and TRPV6 do not 
require a stimulus or ligand to be activated, but are constitutively 
active at physiological membrane potentials and intracellular Ca2+ 
 
Ankyrin repeat:  
33 Amino acid sequence 
motif that couples 
membrane proteins to the 
cytoskeleton 
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Figure 2. The predicted topology of the TRPV5/6 monomer and architecture of the 
TRPV5/6 (hetero)tetrameric channel complex. (left panel) Schematic representation of 
TRPV5 and TRPV6 topology. Transmembrane segments are numbered, the pore region 
between segments 5 and 6 is depicted in grey, and ankyrin repeats in the N-terminal tail are 
indicated with A. (right panel) Top view of the TRPV5/6 (hetero)tetrameric channel. Four 
monomeric TRPV5/6 subunits form a tetrameric complex, of which each subunit faces the 
center of the channel with the pore-forming region. Modified after 1.  
concentrations [Ca2+]i. This is a unique property in relation to the other subfamily members 
5. Interestingly, TRPV5 and TRPV6 rapidly inactivate upon an increase of [Ca2+]i 15. 
Although many of the channel properties are similar between TRPV5 and TRPV6, there are 
a number of significant differences (see Figure 3). First, the rate of channel inactivation is 
different between the two channels. The initial inactivation is faster for TRPV6 than for 
TRPV5. A region between TM2 and TM3 (1st intracellular loop) was identified as a crucial 
domain in TRPV6 to generate this effect 15. Secondly, the recovery time from the Ca2+-
dependent inactivation is different. TRPV5 inactivates about three times slower than 
TRPV6 2. Importantly, this recovery effect seems to occur in a distinct fashion from Ca2+-
dependent inactivation 16. Third, TRPV6 permeates Ba2+ less efficient than TRPV5 (0.4 vs. 
0.9 IBa/ICa, respectively) 15 and requires higher doses of Cd2+ or ruthenium red to be blocked 
(4- and ~100-fold increase in IC50, respectively) 12, 17. The characteristic inward rectifying 
currents of TRPV5 and TRPV6 can also be blocked by Mg2+ in a voltage-dependent 
manner 18, 19 that is abrogated upon neutralization of a single negatively charged aspartic 
acid residue, within the pore region, which is crucial for high affinity Ca2+ binding – 
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Figure 3. Determinants of the fast component of inactivation of TRPV6. Functional 
differences between TRPV5 (dotted line) and TRPV6 (solid line) include (A) Ca2+-dependent 
inactivation, (B) Ba2+ selectivity, and (C) ruthenium red block. (D) The critical region 
responsible for the fast Ca2+-dependent inactivation of TRPV6. Alignment depicts the 
distinctive amino acids within this intracellular loop. Adapted and modified after 2. 
Asp(D)542 in TRPV5 and D541 in TRPV6. This suggests that the aspartic residues D542 
(TRPV5) and D541 (TRPV6) line the narrowest part of the pore. Consistent with this size-
mediated inhibition, the pore diameter of TRPV6 was recently estimated at 5.4 Å by 
permeation and cystein scanning experiments 20.  
  
     Detailed expression, (co)localization and functional studies 
suggested that TRPV5 comprises the epithelial Ca2+ channel 
predominantly involved in renal transcellular Ca2+ reabsorption 
from the pro-urine in distal convoluted tubules (DCT) and 
connecting tubules (CNT) 2, 8, 21 (see Figure 4), and to be essential 
for osteoclastic bone resorption 22. The physiological importance 
of TRPV5 was demonstrated by the generation of homozygous 
TRPV5 knock-out (-/-) mice, which suffer from severe 
hypercalciuria, polyuria, acidification of urine, and reduced bone 
thickness 23. Renal in vivo micropuncture experiments 
demonstrated a failure in Ca2+ reabsorption from the DCT/CNT 
 
Cystein scanning:  
Substituted cystein 
accessibility method 
(SCAM). Here: different 
amino acid residues in a 
region preceding D542 
for TRPV5 and D541 
for TRPV6 were 
replaced with cystein 
residues, and displayed a 
cyclic pattern of 
reactivity to cystein 
reacting agents 
indicative of a pore helix 
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segment, exactly where TRPV5 is localized 23. Furthermore, 
compensatory hyperabsorption of Ca2+ from the intestine was 
observed, which is most probably mediated by increased 1,25-
dihydroxy-vitamin D3 (the active form of vitamin D, hereafter 
referred to as 1,25(OH)2D3) levels observed in the serum of the 
knock-outs 23.  
     TRPV6 was postulated to mediate intestinal Ca2+ absorption 
from the diet, predominantly in the duodenum 2, 9, 24, 25 (see Figure 
4 for a schematic expression pattern). This is supported by the 
finding that TRPV6-/- mice display a 60 % decreased intestinal 
Ca2+ absorption 26. In addition, these knock-out mice have 
abnormal bone formation, slower weight gain compared to wild-type littermates, and are 
less fertile 26. Interestingly, however, 1,25(OH)2D3-responsive expression of TRPV6 in the 
kidney has also been demonstrated 27. Moreover, a functional role of TRPV6 for Ca2+ 
reabsorption in the kidney seems feasible since the TRPV6-/- mice also suffer from renal 
Ca2+ wasting 26, but the precise mechanism by which they do has not yet been defined.  
Homozygous knock-out 
mice:  
The targeted gene is 
rendered functionally 
inactive from both 
alleles in mice 
 
Renal micropuncture 
The process by which 
minute openings are 
created in nephron 
segments by piercing 
 
 
REGULATION OF TRPV5 AND TRPV6 
 
As gatekeepers of epithelial transcellular Ca2+ transport, the biological activity of TRPV5 
and TRPV6 is a highly coordinated and regulated process that can be modulated by 
systemic (hormonal), and local extra- and intracellular factors. In general, the control of 
TRPV5 and TRPV6 can be divided into four categories of regulatory mechanisms, as 
illustrated in Figure 5: (i) the transcriptional and translational levels of TRPV5 and TRPV6 
Figure 4. Schematic overview of the expression of the Ca2+ transport proteins in kidney (left 
panel) and small intestine (right panel). CCD, cortical collecting duct; OMCD/IMCD, outer/inner 
medullary collecting duct. Adapted and modified after 2. 
 14
General introduction 
are regulated by circulating calciotropic hormones; (ii) trafficking and recycling of TRPV5 
and TRPV6 into or out of the luminal membrane is essential to exert its biological activity; 
(iii) the activity of TRPV5 and TRPV6 at the plasma membrane is subject to Ca2+-and pH-
dependent regulatory mechanisms; (iv) modulation of channel activity at the plasma 
membrane by different TRPV5- and TRPV6-associated proteins. 
     The following paragraphs illustrate these different modes of TRPV5 and TRPV6 
channel regulation by introducing key players that are representative for the regulatory 
factors controlling channel activity. 
 
Systemic modulation of TRPV5 and TRPV6 expression 
 
The transcriptional and translational regulation of TRPV5 and TRPV6 gene expression is 
predominantly mediated by calciotropic hormones including PTH, 1,25(OH)2D3, and 
calcitonin. These hormones are secreted depending on the [Ca2+]e. In addition, the female 
sex hormone estrogen has been shown to affect expression and activity of the epithelial 
Ca2+ channels as well 1, 2. However, whether the male sex hormone androgen plays a role in 
active (renal) Ca2+ handling remains to be determined. Serum [Ca2+] is sensed by the 
extracellular Ca2+-sensing receptor (CaR) in the parathyroid that regulates secretion of PTH 
into the circulation. Upon low [Ca2+]e PTH is secreted and positively affects Ca2+ 
reabsorption by increasing expression of renal Ca2+ transport proteins (i.e. TRPV5, 
calbindin-D28K, NCX1, PMCA1b) in the DCT and CNT. This was demonstrated in 
parathyroidectomized rats that were treated with systemic PTH supplementation 28. 
Similarly, long-term treatment of primary rabbit CNT/cortical collecting duct (CCD) cells - 
an ex vivo cell model mimicking the PTH-depleted in vivo situation of the distal 
convolution - with PTH revealed increased expression of the Ca2+ transport proteins and 
increased transcellular Ca2+ transport 28. Elevation of serum PTH stimulates the production 
of 1,25(OH)2D3 and calcitonin that in turn increase Ca2+ absorption from the intestine, Ca2+ 
reabsorption in kidney, and release of Ca2+ from bone 2, 29. 1,25(OH)2D3 is a ligand for the 
vitamin D receptor (VDR) that forms heterodimers with the retinoid X receptor (RXR). 
After ligand binding, the 1,25(OH)2D3-VDR-RXR complex translocates to the nucleus and 
binds to vitamin D-responsive elements (VDREs) to stimulate promoter activity of several 
genes, including both calbindins, as well as the epithelial Ca2+ channels, leading to 
increased gene transcription 30-33. The fundamental importance of 1,25(OH)2D3 in 
regulation of the Ca2+ balance was demonstrated by a number of animal studies based upon 
dietary depletion of the steroid hormone, or by genetic ablation of its precursor enzyme 25-
 15
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Figure 5. Regulation of TRPV5 and TRPV6 can in principle occur at the level of (i) 
transcription and translation by calciotropic hormones, (ii) intracellular trafficking of 
channels to the plasma membrane, (iii) pH- and Ca2+-dependent mechanisms that regulate 
channel activity at the plasma membrane, and (iv) modulation of channel activity at the 
plasma membrane by associated proteins.  
hydroxyvitamin D3-1-α-hydroxylase. These perturbations caused hypocalcemia, 
hyperparathyroidism and abnormal bone formation 34-36, due to decreased expression of the 
renal and intestinal Ca2+ transport proteins. In these animals, the hypocalcemia could be 
normalized by 1,25(OH)2D3 supplementation. Interestingly, 1,25(OH)2D3 not only has a 
profound effect on expression of the Ca2+ transport proteins, but it has also been shown to 
regulate expression of proteins that are associated with different modes of TRPV5 and 
TRPV6 cellular regulation (as further emphasized in the next section). 
 
Local modulation of TRPV5 and TRPV6 activity 
 
In addition to the long-term systemic regulation of the Ca2+ balance by hormones, distinct 
regulatory mechanisms are involved in the fast and local fine-tuning of Ca2+ (re)absorption. 
Whereas assembly 14, trafficking and recycling 37-40 are essential prerequisites to deliver the 
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channels to the cell surface, perhaps more important are the activity (open probability; 
gating) and stability (abundance) of the channels present in their functional domain, the 
plasma membrane, because only these channels contribute to the entry of Ca2+. TRPV5 and 
TRPV6 activity and stability at the cell surface can be regulated by a number of different 
factors. 
     First, ionized Ca2+ modulates TRPV5 and TRPV6 expression and activity. Entry of Ca2+ 
induces a direct negative feedback inhibition of the channels at the cell surface 1, 2, and high 
dietary intake of Ca2+ decreases TRPV5 and TRPV6 expression 2. In addition, the local 
[Ca2+]e is also determined by local mechanical forces on the epithelial tissue (intestine or 
possible renal tubules) which can affect the volume of the interstitial space; i.e. a smaller 
space would increase the [Ca2+]e 41. Such local changes in [Ca2+]e are likely sensed by the 
CaR that is expressed along the nephron and contributes to different regulatory mechanisms 
controlling NaCl, Ca2+ and water transport 42, 43. However, the precise role of the CaR 
expressed in DCT/CNT, possibly affecting TRPV5 activity, remains elusive.  
     Second, the influx of Ca2+ is dependent on the extra- and intracellular pH. A rise in 
extracellular pH stimulates TRPV5 activity by increasing TRPV5 channel abundance in the 
plasma membrane 44. In contrast, acidic extracellular pH inhibits transcellular Ca2+ 
transport across primary rabbit CNT/CCD cells 45, and reduces TRPV5-mediated Ca2+ 
currents in vitro 46, 47. Similarly, intracellular acidification blocks Ca2+ influx through the 
channel 48. However, it remains to be established whether these effects are mediated via 
altered membrane expression of TRPV5. The sensitivity of TRPV5 activity to extra- and 
intracellular acidification was localized to two important amino acid residues within close 
proximity of the pore region that act as pH-sensors, namely the extracellular Glu(E)522 49, 
and the intracellular Lys(K)607 48. Further, next to the fast effects induced by pH changes 
regulating the activity of TRPV5, pH also modulates gene expression of the Ca2+ 
transporting proteins 50. 
     Third, in addition to the Ca2+- and pH-dependent mechanisms regulating TRPV5 and 
TRPV6 activity, fast, non-genomic responses to hormones have 
been observed, as well as local (extracellular) enzymatic activity 
affecting the stability of the channels present at the cell surface. 
For example, PTH increases expression of the Ca2+ transporting 
proteins, but it also activates protein kinases A and C (PKA and 
PKC), which in turn activate their subsequent protein targets via 
phosphorylation. Both for PTH-stimulated PKA and PKC 
activation an increased transcellular Ca2+ transport has been 
 
Open probability:  
Ratio of time spent 
between the open (1) and 
closed (0) state of the 
channel 
 
Interstitial space:  
Intercellular space; space 
between (adjacent) cells 
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observed in rabbit primary cultures of CNT/CCD cells 51-53. Although it is not fully 
understood whether PKA acts via direct activation of TRPV5, recent studies revealed that 
PKC-mediated phosphorylation of two specific sites in TRPV5 (Ser(S)299 and S654) 
increase Ca2+ influx via increased channel stability at the plasma membrane 54, 55. In this 
case, activation of PKC by the proteolytic enzyme tissue kallikrein (TK, a serine protease) 
increased the cell surface TRPV5 abundance by delaying the endocytosis of the channel 54.  
    Fourth, 1,25(OH)2D3-dependent TRPV5- and TRPV6-associated proteins have been 
identified that regulate channel activity directly at the plasma membrane via different 
mechanisms. Typical examples of these associated proteins are described in detail in the 
following paragraphs. 
 
Dynamic control of channel activity by calbindin-D28K
Epithelial cells are challenged by a high Ca2+ influx has to be tightly regulated to maintain 
low non-toxic cytosolic [Ca2+]. The role of calbindin proteins in this process has been 
demonstrated by the involvement of these specialized Ca2+ buffering proteins in multiple 
steps of transcellular Ca2+ transport. First, by buffering intracellular Ca2+ in the direct 
vicinity of the channel mouths of TRPV5 and TRPV6, they control a continuous flow of 
Ca2+, thereby preventing a negative feedback of ionized intracellular Ca2+ from inhibiting 
channel activity 2, 8. Second, toxic levels of intracellular Ca2+ may arise during high rates of 
transcellular Ca2+ transport and therefore the cytosolic [Ca2+] is strictly regulated by 
specialized Ca2+-binding proteins 56-58. Third, Ca2+ that enters the cell at the luminal side 
can diffuse to the basolateral side without affecting other intracellular processes before it is 
extruded into the extracellular compartment via NCX1 and/or PMCA1b. Calbindins have 
been suggested to increase the diffusional range of Ca2+ by facilitating the transport of Ca2+ 
to the basolateral surface of the cell 59. In addition, an important role of calbindins in 
1,25(OH)2D3-responsive transepithelial Ca2+ transport is supported by their consistent co-
expression with the Ca2+-transport proteins TRPV5 and TRPV6, NCX1 and PMCA1b 60. 
Conversely, genetic ablation of TRPV5 in mice resulted in a decreased expression of 
calbindin-D28K 23. As indicated above, the [Ca2+]i in close vicinity to the channel mouths of 
TRPV5 and TRPV6 tightly regulates their activities; however, until recently, the exact 
regulatory mechanism was poorly understood. In addition to mathematical models 61 and 
coordinated regulation of renal Ca2+ transport proteins 28, Lambers et al. 62 provided the 
first experimental evidence that calbindin-D28K dynamically regulates the activity of 
TRPV5. In their study they demonstrated by evanescent-field life cell microscopy and 
protein-binding analysis that calbindin-D28K translocates to the plasma membrane and 
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directly interacts with TRPV5 upon a decrease in the [Ca2+]i. 
Furthermore, co-expression of TRPV5 and calbindin-D28K in 
human embryonic kidney 293 (HEK293) cells significantly 
increased 45Ca2+ uptake in these cells. However, co-expression 
with the TRPV5-interacting Ca2+-insensitive mutant of calbindin-
D28K, in which the Ca2+-binding EF-hand structures were 
inactivated (calbindin-D28KΔEF), abolished this stimulatory effect. 
Moreover, calbindin-D28KΔEF competed with wild-type 
calbindin-D28K, resulting in a dominant-negative inhibition of 
transepithelial Ca2+ transport in primary rabbit CNT/CCD cultures 
62. Blockage of TRPV5 by ruthenium red eliminated PTH-
stimulated Ca2+ transport in these primary cell cultures and 
simultaneously decreased the expression of calbindin-D28K. 
Likewise, van Abel et al. 28 showed that the magnitude of Ca2+ 
influx via TRPV5 predominantly controls the expression of 
calbindin-D28K. Together, these indicate that differential 
calbindin-D28K expression correlates with its capacity to dynamically buffer TRPV5-
mediated Ca2+ influx. Lambers et al. also showed that the regulatory role of calbindin-D28K 
is a unique process in comparison to direct channel regulation via other Ca2+-binding 
proteins such as calmodulin 63, 64 by measuring TRPV5 activity in whole cell patch clamp 
configuration during different controlled [Ca2+]i either in the presence of calbindin-D28K or 
calbindin-D28KΔEF. They utilized ultraviolet (UV) light-induced uncaging of Ca2+ to 
increase the [Ca2+]i, inducing the negative feedback of Ca2+ on TRPV5 channel activity 
either in the presence of calbindin-D28K or calbindin-D28KΔEF. This experiment 
demonstrated that calbindin-D28K does not directly affect channel inactivation 
characteristics. These data demonstrate that calbindin-D28K dynamically controls epithelial 
Ca2+ influx by tethering the TRPV5 channel to buffer free Ca2+ in close vicinity to the pore.  
Ruthenium red:  
A polycationic reagent 
that is a potent inhibitor 
of intracellular Ca2+ 
release and extracellular 
Ca2+ entry 
 
UV light-induced 
uncaging of Ca2+:  
The cell permeable 
compound DM-nitrophen 
binds Ca2+ (caged Ca2+), 
but rapidly (< 200 µs) 
changes its Ca2+-binding 
affinity from 3 nM to 2 
mM at pH 7.0 by 
photolysis (UV light-
induced) thus releasing 
Ca2+ intracellularly 
 
 
Regulation of channel abundance at the cell surface by klotho 
The body is capable of a fast and active reabsorption of Ca2+ when the [Ca2+]e in the 
circulation drops. As shown by calbindin-D28K functioning, the epithelial cell is well 
equipped to transport and sustain high rates of Ca2+ influx. A key component to create such 
elevated Ca2+ influx is to increase TRPV5 and TRPV6 channel abundance at the epithelial 
cell surface. TRPV5 is located in or near to the apical membrane in the DCT of the kidney 
whereas in CNT a large subset of TRPV5 is located sub-apically 65. Therefore, it is 
 19
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hypothesized that these channels are shuttled from intracellular vesicles into the plasma 
membrane. In addition, high Ca2+ influx may be obtained by prolonging the length of time 
that the channels reside at the cell surface before inactivation or internalization.  
     The recent elucidation of a novel mechanism of TRPV5 regulation by the anti-aging 
hormone klotho nicely illustrates the importance of controlling channel abundance at the 
cell surface. Chang et al. 66 showed that klotho, a 1,25(OH)2D3-controlled hormone 
discovered by Kuro-o 67, 68, completely co-localized with TRPV5 at or near the apical 
membrane in DCT and CNT. In addition, it was found that klotho is present in urine, serum 
and cerebrospinal fluid 69, as well as in the supernatant obtained from transfected HEK293 
cells expressing klotho. This suggests that klotho may operate from the extracellular space 
to regulate transcellular Ca2+ transport. Expression of TRPV5 and klotho in HEK293 cells, 
or direct application of klotho supernatant to TRPV5-expressing HEK293 cells, stimulated 
TRPV5-mediated 45Ca2+ uptake 66, which implies that in vivo klotho circulates in the 
bloodstream or that it is secreted from tubular epithelium to exert its physiological effect. 
Over-expression of klotho in mice significantly extended the life span and suppressed 
symptoms of aging 70, whereas klotho-/- mice displayed 
characteristics of premature aging 68 and the pathophysiology of 
TRPV5-/- mice (i.e. disturbed Ca2+ homeostasis, vitamin D 
metabolism and bone abnormalities, as described earlier) 23. 
Further analysis of the molecular mechanism by which klotho 
stimulates Ca2+ influx included cell surface biotinylation 
experiments which revealed significant increase in plasma 
membrane localization of TRPV5 without affecting its total 
cellular expression. Interestingly, these effects could be mimicked 
by a purified β-glucuronidase, indicating that the enzymatic 
activity of klotho is responsible for the increased TRPV5 activity. 
Mutation of a predicted N-glycosylation site between TM 1 and 2 
at the asparagin residue Asn(N)358 in TRPV5 to a glutamine 
residue prevented TRPV5 glycosylation in HEK293 cells. Cells 
expressing this mutant displayed normal 45Ca2+ uptake, which - 
importantly - was unaffected by klotho. In addition, further insight 
into the mechanism by which klotho affects the glycosylation 
status of TRPV5 was recently acquired by Cha et al. 71. They 
report that Klotho removes the terminal sialic acid residues from 
the N-glycan tree, thereby enabling the binding of galectin-1 to 
 
Vesicle:  
A small intracellular, 
membrane-enclosed 
compartment often used 
to store or transport 
substances 
 
Cell surface 
biotinylation:  
Depending on the type of 
biotin, extracellularly 
applied biotin binds to 
NH2-terminal- and 
lysine-exposed primary 
amino groups of proteins 
present at the plasma 
membrane, which can be 
isolated by pull-down 
with high affinity avidin-
coupled beads 
 
N-glycosylation:  
Process or result of the 
addition of saccharides 
(sugar residues) to 
asparagine amino acid 
residues of proteins 
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the exposed underlying disaccharides. Subsequently, the coupling of this galactoside-
binding lectin leads to the accumulation of TRPV5 at the cell surface. Altogether, this 
results in increased Ca2+ influx from the lumen to preserve normal serum Ca2+ levels during 
periods of insufficient dietary Ca2+, by the reduction of Ca2+ loss via the urine. The 
enzymatic activity of klotho regulating TRPV5 channel abundance at the cell surface from 
the extracellular site demonstrates a novel mechanism to control epithelial Ca2+ entry. 
 
Modulation of TRPV5 channel activity at the plasma membrane by BSPRY 
The amount of Ca2+ uptake at the luminal membrane of the epithelial cell via TRPV5 is 
determined by the number of active TRPV5 channels at the cell surface. Klotho entraps the 
channel at the cell surface and increases Ca2+ influx per cell, while calbindin-D28K prevents 
accumulation of intracellular Ca2+ from reaching toxic values. In contrast, the molecular 
mechanisms underlying channel trafficking and regulation of its activity at the plasma 
membrane are poorly understood. Therefore, the identification and functional 
characterization of TRPV5- and TRPV6-associated proteins with known or unknown 
functions in ion channel modulation or in vesicular trafficking might explain such a 
mechanism. TRPV5, like the majority of the TRP channels, mainly localizes to vesicular 
structures throughout the cytoplasm. The identifications of the S100A10-annexin 2 protein 
complex and Rab11A, both proposed to be involved in vesicular trafficking, provided new 
insights into the regulation of TRPV5 and TRPV6 cell surface expression 37, 38. The 
S100A10-annexin 2 protein complex was shown to be involved in constitutive non-
stimulated trafficking, whereas Rab11A was identified as a molecular switch concerning 
the recycling of TRPV5 channels to the plasma membrane.  
     With the recent identification of “B-box and SPRY-domain containing protein” 
(BSPRY) 72 as a TRPV5 and TRPV6-interacting protein 73, further insight into the direct 
modulation of TRPV5 and TRPV6 activity at the plasma membrane was obtained. BSPRY 
showed complete co-localization with TRPV5 in Ca2+-transporting tubular segments of the 
kidney. In addition, stable expression of BSPRY significantly inhibited Ca2+ influx in a 
polarized kidney cell model consisting of confluent monolayers of Madin-Darby canine 
kidney (MDCK) cells expressing TRPV5. Furthermore, via cell surface biotinylation 
experiments it was demonstrated that a significant fraction of BSPRY is present at the 
plasma membrane of HEK293 cells co-expressing TRPV5 and BSPRY 73. These findings 
suggest that BSPRY is involved in an inhibitory signaling cascade that modulates TRPV5 
activity directly at the cell surface. Interestingly, BSPRY expression was inversely 
regulated by the calciotropic hormone 1,25(OH)2D3 as demonstrated by elevated mRNA 
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expression of BSPRY in kidney samples of 25-hydroxyvitamin D3-1-α-hydroxylase-/- mice 
compared to wild-type littermates 73. These knock-out mice fail to synthesize 1,25(OH)2D3, 
and TRPV5 expression is significantly down-regulated in the animals 2, 34. Together, this 
suggests that 1,25(OH)2D3 negatively regulates BSPRY expression while at the same time 
it stimulates Ca2+ influx via TRPV5.  
 
RATIONALE AND SCOPE OF THIS THESIS  
 
Regulation of TRPV5 and TRPV6 is dependent on mechanisms that directly target channel 
abundance and activity at the luminal cell surface, predominantly via channel-associated 
proteins, as described above. In addition to the long-term effects of calciotropic hormones, 
pH, and the negative feedback mechanism of cytosolic Ca2+ itself, these associated proteins 
demonstrate for example (i) the ability of the epithelial cell to sustain large rates of 
transcellular Ca2+ flux via calbindin-D28K; (ii) entrapment of channels in the plasma 
membrane to increase durability and Ca2+ influx via klotho; and, (iii) regulation of the Ca2+ 
channel directly at the cell surface - by for example BSPRY, that probably inversely 
regulates channel activity depending on the serum level of 1,25(OH)2D3 (Figure 6). 
Together, these data illustrate that the cell surface regulation of TRPV5 and TRPV6 is 
mediated within different compartments of the epithelial cell, as well as that the 
extracellular milieu has a major contribution to the channels’ activity. Previously identified 
interacting partners of TRPV5 and TRPV6 have also been characterized to affect the 
activity of the channels via distinct mechanisms. As mentioned, functional expression of 
TRPV5 and TRPV6 both require binding of the S100A10-annexin 2 protein complex 37. 
However, the internal Ca2+ sensing mechanism controlling the activity of individual 
epithelial Ca2+ channels is differentially organized. In addition to the role of the calbindin 
proteins, the Ca2+ sensor 80K-H has been shown to affect TRPV5 activity 74, however, 
regulation by the ubiquitous Ca2+ sensor calmodulin seems to be restricted to TRPV6 75. 
Further, direct phosphorylation of TRPV5 by PKC leads to increased channel stability at 
the plasma membrane, thereby adding to the diverse actions of the aforementioned 
associated proteins through the inclusion of receptor-operated signaling cascades to the 
group of processes which increase TRPV5 activity 54, 55.  
     Taken together, the concerted actions of the different mechanisms by which TRPV5 and 
TRPV6 activity are regulated provide important insights into the strict control of 
transcellular Ca2+ transport at the apical entry gate, which in turn determines the net active 
Ca2+ flux to the blood compartment. Although the outcomes of many studies focusing on 
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Figure 6. Regulation of channel activity by associated proteins from different cellular sites: 
(1) calbindin-D28K efficiently buffers free Ca2+ in close vicinity to the channel mouth and 
facilitates Ca2+ transport to the basolateral side, (2) klotho hydrolyses the N-linked 
extracellular sugar tree of TRPV5 to increase channel abundance at the luminal cell surface, 
(3) BSPRY probably inversely regulates channel activity directly at the plasma membrane, 
depending on the serum level of 1,25(OH)2D3. The regulatory mechanisms of S100A10- 
annexin2, Rab11A, CaM, 80K-H, and TK are depicted as well. See text for details.  
deciphering TRPV5 regulation were extrapolated to TRPV6 functioning, the evidence for 
distinct regulatory mechanisms between the two channels is increasingly evident. For 
instance, the essential role for calbindin-D28K regulating TRPV5 activity could not be 
verified in (genetic) studies focusing on the interplay between calbindin-D9K and TRPV6 76, 
77. Although unexpected, in calbindin-D9K-/- and/or calbindin-D9K/TRPV6-/- mice, intestinal 
Ca2+ transport remained intact 76, 77. While paracellular Ca2+ transport may contribute to this 
observed effect, administration of 1,25(OH)2D3 in these knock-out animals revealed that 
active Ca2+ absorption was still present; however, the exact mechanism by which it does so 
and the circumstances under which it is important have not been precisely defined.  
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     Many TRPV5/TRPV6-associated proteins were identified by fishing for TRPV5-
interacting proteins. It is therefore crucial to identify and establish protein studies that 
specifically focus on (cell surface) regulation of TRPV6. Moreover, to understand how the 
epithelial Ca2+ channels operate directly at the cell surface, it is important to acquire 
efficient models/tools to study channel regulation. Generation of an in vitro polarized cell 
model to study TRPV5 localization and activity, as well as tunable TRPV5 protein 
expression would provide valuable tools to further help us understand TRPV5 functioning.  
 
Unraveling the molecular mechanisms regulating TRPV5 and TRPV6 activity is 
challenging and may ultimately lead to a more complete understanding of the maintenance 
of whole body Ca2+ homeostasis. The presented studies in this thesis, therefore, aim to 
further elucidate the physiological and molecular regulation of these two epithelial Ca2+ 
channels. To this end, in Chapters 2 and 3, we applied yeast-two-hybrid and 
bioinformatical screening methods to identify putative TRPV6-associated proteins. The 
interactions of the identified proteins, RGS2 and Nipsnap1, with TRPV6 were confirmed 
by GST pull-down and co-precipitation assays, thereby minimizing false positive findings. 
Using truncated versions of TRPV6 or the associated protein, essential amino acid 
sequences for the identified interactions were revealed. Subsequently, functional 
characterization of the TRPV6-binding protein was established by electrophysiological 
recordings using the whole cell patch-clamp configuration. Also, by cell surface labeling of 
expressed proteins, the plasma membrane abundance of TRPV6 was investigated during 
the absence and presence of the identified associated proteins. Furthermore, in Chapters 4 
and 5, possible receptor-operated mechanisms that control TRPV5 expression and activity 
were characterized by either in vitro cell models using the patch clamp technique, or by in 
vivo animal studies. Utilizing these methodologies, the intracellular signaling pathway of 
the activated CaR was delineated, and the effects on the expression of renal Ca2+ transport 
proteins was investigated in orchidectomized mice either treated with or without the steroid 
hormone androgen. Next, in Chapters 6 and 7, in vitro tools to study TRPV5 plasma 
membrane regulation were established. Hence, a polarized cell line that expresses green 
fluorescent-labeled TRPV5 was generated to characterize its cellular localization and 
activation. The construction of a tunable TRPV5 protein expression system enabled the 
dynamics of protein complex formation to be studied. Finally, in Chapters 8 and 9, a 
general discussion and summary are presented with respect to the studies performed in this 
thesis.  
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Chapter 2 
SUMMARY 
 
The epithelial Ca2+ channels TRPV5 and TRPV6 constitute the apical Ca2+ entry pathway 
in the process of active Ca2+ (re)absorption. By yeast-two-hybrid and GST pull-down 
analysis we identified RGS2 as a novel TRPV6-associated protein. RGS proteins determine 
the inactivation kinetics of heterotrimeric G-protein-coupled receptor (GPCR) signaling by 
regulating the GTP-ase activity of Gα subunits. Here, we demonstrate that TRPV6 interacts 
with the N-terminal domain of RGS2 in a Ca2+-independent fashion and that over-
expression of RGS2 reduces the Na+ and Ca2+ current of TRPV6 but not that of TRPV5-
transfected HEK293 cells. In contrast, over-expression of the deletion mutant ΔN-RGS2, 
lacking the N-terminal domain of RGS2, in TRPV6-expressing HEK293 cells did not show 
this inhibition. Furthermore, cell surface biotinylation indicated that the inhibitory effect of 
RGS2 on TRPV6 activity is not mediated by differences in trafficking or retrieval of 
TRPV6 from the plasma membrane. This effect probably results from the direct interaction 
between RGS2 and TRPV6, affecting the gating properties of the channel. Finally, the 
scaffolding protein spinophilin (SPL), shown to recruit RGS2 and regulate GPCR-signaling 
via Gα, did not affect RGS2 binding and electrophysiological properties of TRPV6, 
indicating a GPCR-independent mechanism of TRPV6 regulation by RGS2.  
 
INTRODUCTION 
 
The Transient Receptor Potential (TRP) superfamily includes more than 30 different 
proteins, all of which are considered to form subunits of cation channels 1-5. Based on 
sequence homology, the TRP family can be divided in seven main subfamilies: the TRPC 
(‘Canonical’) family, the TRPV (‘Vanilloid’) family, the TRPM (‘Melastatin’) family, the 
TRPP (‘Polycystin’) family, the TRPML (‘Mucolipin’) family, the TRPA (‘Ankyrin’) 
family, and the TRPN (‘NOMPC’) family. TRPV6 is the most Ca2+ selective ion channel in 
the TRP superfamily with a Ca2+ selectivity of more than 100 times over monovalent 
cations 6, 7.  
     Recently, the electrophysiological properties of TRPV6 have been studied extensively. 
When measured in heterologous expression systems, TRPV6 displays characteristic inward 
rectifying currents carried by Ca2+ or monovalent cations when Ca2+ is omitted from the 
extracellular solution. These inward currents are blocked by Mg2+ in a voltage-dependent 
manner 8, that is removed upon neutralization of a single negatively charged amino acid 
residue (D541) within the pore region. The pore diameter of TRPV6 was recently estimated 
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at 5.4 Å by cystein scanning experiments 9. Together with its closest relative, TRPV5, 
TRPV6 shares a common feature that is the Ca2+-dependent inactivation of the currents. 
     TRPV6 is predominantly expressed in placenta, pancreas, small intestine, and colon 6, 10-
12. In these tissues TRPV6 plays a major role in Ca2+ transport (reviewed in 13, 14).  
     To date, screening and domain-mapping of the carboxyl-terminus of TRPV6 has 
revealed proteins associating with TRPV6 and subsequently the regulatory functions of 
these interacting proteins have been studied; e.g. Rab11A, NHERF4, S100A10 15-17. In 
contrast, little is known about the molecular mechanisms involved in regulation of the 
channel via its intracellular N-terminal domain. At present, six ankyrin repeats have been 
predicted in this region 18. Ankyrin repeats have been shown to act as a scaffold in 
molecular recognition to mediate protein-protein interactions 19. These, or other regions in 
the N-terminal domain of TRPV6, may bind regulatory proteins interacting in pathways 
that mediate the Ca2+-transporting activity of the channel.  
     The aim of this study was to identify regulatory proteins that interact with the N-
terminal domain of TRPV6. To this end, we identified regulator of G-protein signaling-2 
(RGS2) as a novel binding partner of TRPV6 by yeast-two-hybrid screening. RGS2 is a 
member of the RGS family of proteins that are able to terminate signaling of heterotrimeric 
G-protein-coupled receptors (GPCRs) by enhancing the GTP-ase activity of  active Gα 
subunits 20. To date, over 20 different RGS proteins have been identified, and their effector 
functions extend beyond negative regulation of GPCR signaling. RGS proteins can act as 
effector antagonists, binding to either the effector protein or the Gα subunit to prevent an 
operative physical interaction. They have also been shown to interact with a wide variety of 
auxiliary proteins, such as CaM, spinophilin (SPL) and 14-3-3 protein, which can influence 
their subcellular localization, stability and function 21. In this respect, the finding of RGS2 
as a protein interacting with TRPV6 may lead to altered channel activity by disturbances in 
protein trafficking or a direct effect at the cell surface. The putative role of RGS2 in active 
Ca2+ absorption was established by a comprehensive approach including pull-down assays, 
electrophysiological analysis and cell-surface expression of RGS2 interacting with TRPV6.  
 
EXPERIMENTAL PROCEDURES 
 
Constructs and cRNA synthesis 
The TRPV6, TRPV6 N-tail, and TRPV5 constructs were generated in pGEX 6p-2 and 
pCINeo/IRES-GFP vectors as described previously 22. The coding sequence of wild-type 
RGS2 protein was amplified from total mouse kidney cDNA material using primers with a 
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HA tag included  and cloned into the PT7Ts vector as BglII – SpeI fragment, and 
subsequently into the pCINeo/IRES-GFP vector  as an NheI – XhoI fragment. RGS2 and 
ΔN-RGS2 (deletion of the N-terminal domain of RGS2: amino acids 1-82) were subcloned 
from the PT7Ts vector without the HA-tag to the pGEX 6p-2 (Amersham Biosciences, 
Piscataway, NJ) vector using forward and reverse primers containing BamH I and XhoI 
restriction sites respectively. pT7Ts constructs were linearized, and cRNA was synthesized 
in vitro as described previously 16. In pCINeo/IRES-GFP, ΔN-RGS2 was obtained by in 
vitro mutagenesis of wild-type RGS2. All constructs were verified by sequence analysis. 
Rat-SPL (in pCMV-myc) and human-RGS2 (in pGex-KG) constructs were described 
previously 23. 
 
Yeast-two-hybrid system 
Yeast-two-hybrid experiments were performed as described previously 16. In short, the N-
tail of mouse TRPV6 was cloned in the pAS-1 yeast cloning and expression vector. Using 
this vector, the yeast strain Y153 was transformed to Trp prototrophy. Subsequently, yeast 
was transformed with a mouse kidney cDNA library (Clontech, Palo Alto, CA) present in 
the pACT2 vector, containing a leucine selection marker. Yeast cells were plated on Trp-
Leu-His selective medium containing 25 mM 3-aminotriazole. Positive colonies were 
assayed for β-galactosidase activity. Subsequently, yeast DNA of positive colonies was 
isolated and prey plasmids were rescued by electroporation into KC8-cells. Results were 
confirmed using purified library plasmids and a negative control was performed by 
replacing the pAS-1 containing the N-tail of mouse TRPV6 with the pAS-1 containing the 
N-tail of rat γ-subunit of the epithelial Na+ channel (ENaC).   
 
Reverse Transcriptase (RT)-PCR analysis 
Total RNA was isolated from different mouse tissues using TRIzol and subjected to 
reverse transcription as described 24. For RGS2 RT-PCR, the oligonucleotide primer 
sequences were as follows: forward primer with BglII restriction site 5’-GAAGATCTGCCACC 
ATGCAAAGTGCCAGTTCCTG-3’ and reverse with SpeI restriction site 5’-GGACTAGTTCATGTA 
GCATGGGGCTCCG-3’; β-actin forward 5’-ACGATTTCCCTCTCAGCTGTG-3’, reverse 5’-GTATG 
CCTCTGGTCGTACCAC-3’. For SPL the following primers were used: forward primer 5’-CTT 
AGGAACACCAAAGGCC-3’, and reverse primer 5’-GTAGTCCTTGATGAGACGC-3’. PCR 
fragments were analyzed by electrophoresis on 1 % (w/v) agarose. 
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Pull-down assays 
RGS2 pGex-KG and HA-RGS2, HA-ΔN-RGS2 and empty pGex 6p-2 constructs were 
transformed in Escherichia coli BL21 and glutathione S-transferase (GST) fusion proteins 
were expressed and purified according to the manufacturer’s protocol (Amersham 
Biosciences, Piscataway, NJ). [35S]Methionine-labeled TRPV6 N-tail was prepared using a 
reticulocyte lysate system (Promega, Madison, WI) and analyzed for pull-down with GST, 
GST-HA-RGS2 or GST-HA-ΔN-RGS2 fusion proteins immobilized on glutathione-
Sepharose 4B beads (Amersham Biosciences, Piscataway, NJ) as described previously 16. 
After extensive washing, bound proteins were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), and visualized by Coomassie staining 
and autoradiography. For pull-down with hRGS2; TRPV6/mock, SPL/mock, and 
TRPV6/SPL were transiently transfected in human embryonic kidney 293 (HEK293) cells 
and after 72 hours extracts from lyzed cells were adjusted to equal input concentrations and 
analyzed for pull-down with GST or GST-hRGS2 fusion proteins immobilized on 
gluthatione-Sepharose 4B beads. The beads were washed extensively and pulled proteins 
were analyzed by SDS-PAGE and immunoblotting.  
 
Electrophysiology and solutions 
The full-length cDNAs encoding TRPV5, TRPV6, RGS2, and ΔN-RGS2 were transiently 
transfected in HEK293 cells and patch clamp experiments were performed in the tight-seal 
whole-cell configuration at room temperature using an EPC-9 patch-clamp amplifier 
controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany), as described 
previously 25. Cells were held at 20 mV, and voltage ramps of 450 milliseconds, ranging 
from -100 to +100 mV, were applied every 5 seconds. Cell capacitance and access 
resistance were monitored continuously using the automatic capacitance compensation of 
the Pulse software. Na+ current densities were obtained by dividing the current amplitude 
measured at -80 mV during the ramp protocols by the cell capacitance. Ca2+-dependent 
inactivation was studied using a 3 seconds voltage step to –100 mV from a holding 
potential of +70 mV. From this step protocol, Ca2+ peak values were extracted by dividing 
the current at -100 mV by the cell capacitance. The standard extracellular solution (Krebs) 
contained: 150 mM NaCl, 6 mM CsCl, 1 mM MgCl2, 10 mM HEPES/NaOH, and 10 mM 
glucose, pH 7.4. The concentration of Ca2+ ranged between 1 and 10 mM. Divalent free 
(DVF) solutions did not contain added divalent cations, whereas trace amounts of divalent 
cations were removed with 100 µM EDTA. The standard internal (pipette) solution 
contained:  20  mM  CsCl,  100  mM  Cs-aspartate,  1  mM  MgCl2,  4  mM  Na2ATP,  10  mM  
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Figure 1. Tissue distribution of RGS2. RNA was extracted from different mouse tissues and 
RGS2 expression was determined by RT-PCR. The RGS2 specific band was amplified from 
all the indicated tissues (upper panel). As a control, β-actin was amplified to ensure the 
integrity of the cDNAs (lower panel). 
 
BAPTA, 10 mM HEPES/CsOH, pH 7.2. Cells were kept in a nominal Ca2+-free medium to 
prevent Ca2+ overload and exposed for a maximum of 5 minutes to a Krebs solution 
containing 1.5 mM Ca2+ before sealing the patch pipette to the cell. The analysis and 
display of patch-clamp data were performed using Igor Pro software (WaveMetrics, Lake 
Oswego, USA).  
 
Biotinylation 
TRPV6, HA-RGS2 and empty pCINeo/IRES-GFP constructs were transfected transiently 
in HEK293 cells and subjected to cell surface biotinylation as described previously 26. 
Biotinylated proteins were eluted with SDS-PAGE loading buffer, separated on 10 % (w/v) 
SDS-PAGE gel, and analyzed by immunoblotting with rabbit antiserum against TRPV6 
(1:2000) 11. 
 
Statistical Analysis  
In all experiments, the data are expressed as mean ± S.E.M. Overall statistical significance 
was determined by analysis of variance. In case of significance (p < 0.05), individual 
groups were compared using a Student’s t test. 
 
RESULTS 
 
Identification of RGS2 as a TRPV6-associated protein 
To identify proteins that interact with TRPV6, the N-terminal tail of TRPV6 was used to 
screen a library of mouse kidney cDNA by the yeast-two-hybrid technique. RGS2 was 
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identified as a positive clone and belongs to the R4 subfamily of regulator of G-protein 
signaling proteins 27. To confirm the interaction, the full-length cDNA sequence of RGS2 
was re-analyzed in a yeast-two-hybrid with the N-tail of TRPV6 as bait. The γ-subunit of 
the epithelial Na+ channel (γENaC) was used as a negative control. TRPV6 and RGS2 
displayed a strong interaction whereas TRPV6 and γENaC did not interact (data not 
shown). 
 
The RGS2 gene is ubiquitously expressed 
The expression of RGS2 in different mouse tissues was analyzed by RT-PCR. RGS2 was 
detected ubiquitously (Figure 1, upper panel). All tissues expressed β-actin that was used 
as a positive control to confirm the integrity of the cDNAs (Figure 1, lower panel). As 
negative controls, the primer sets for RGS2 and β-actin were screened in the absence of 
cDNA (depicted as H2O samples in Figure 1).  
 
TRPV6 interacts with the N-terminal domain of RGS2  
The interaction between TRPV6 and the binding domain of RGS2 was further established 
using GST pull-down assays. To this end, RGS2 and ΔN-RGS2 were expressed as GST 
fusion proteins immobilized on gluthatione sepharose 4B beads. Subsequently, these fusion 
Figure 2. Interaction of TRPV6 and RGS2. [35S]Methionine labeled TRPV6 N-tail was 
incubated with GST, GST/RGS2 or GST/ΔN-RGS2 immobilized on glutathione-sepharose 
4B beads, either in the presence (1 mM Ca2+) or absence (10 mM EGTA) of Ca2+. TRPV6 N-
tail interacted with RGS2 whereas no binding with GST/ΔN-RGS2 or GST alone was 
observed. 
 37
Chapter 2 
proteins were tested for their interaction with in vitro translated [35S]methionine-labeled N-
tail of TRPV6 in the presence or absence of 1 mM Ca2+. As shown in Figure 2, the N-tail of 
TRPV6 associated with GST-fused RGS2 in a Ca2+-independent fashion whereas no 
binding between the N-tail of TRPV6 and GST-fused ΔN-RGS2 or GST alone was 
observed, neither in the presence nor absence of Ca2+.  
 
RGS2 inhibits specifically TRPV6 activity 
To study the functional effect of RGS2 binding to TRPV6 the electrophysiological 
properties of the TRPV6 channel were investigated in the presence of RGS2. Steeply 
inward rectifying currents carried by Na+ could be measured in HEK293 cells co-
expressing TRPV6 and empty vector (mock) and in cells expressing both TRPV6 and 
RGS2 (Figure 3A,B). The current carried by Na+ was significantly reduced in cells 
expressing both TRPV6 and RGS2 (Figure 3B,C). Likewise, RGS2 co-expression 
significantly reduced the Ca2+ current in response to a hyperpolarizing voltage step in 
TRPV6-expressing cells (Figure 3D,E), while the Ca2+-dependent inactivation of the 
currents remained unchanged. In addition, the inhibitory effect of RGS2 on TRPV6-
mediated Na+ and Ca2+ currents was studied for its closest relative, TRPV5, during 
identical experimental conditions. In contrast to TRPV6, RGS2 had no significant effect on 
Na+ and Ca2+ currents recorded from TRPV5-expressing HEK293 cells (Figure 4).  
 
TRPV6 activity is inhibited by the N-terminal domain of RGS2 
To test the physiological significance of the N-terminal domain of RGS2 on TRPV6 
activity, the electrophysiological properties of TRPV6-mediated currents in HEK293 cells 
Figure 3. Inhibition of TRPV6-induced Na+ and Ca2+ currents by RGS2. HEK293 cells were 
transiently transfected with TRPV6/mock (CTRL) or TRPV6/RGS2 and subsequently 
analyzed by immunoblotting (A) and by whole-cell patch clamp. (B) Current-voltage (I/V) 
relations measured from ramp protocol in nominally DVF solution from CTRL (solid trace) 
or TRPV6/RGS2-transfected cells (dotted trace). The I/V curve shows inward rectification 
typical for TRPV6 (solid trace), which is not changed by co-expressing RGS2 (dotted trace). 
(C) Average Na+ current density at -80 mV in nominally DVF solution was 384 ± 133 pA/pF 
for CTRL cells compared to 65 ± 8 pA/pF for TRPV6/RGS2 co-expressing cells (n = 15 cells 
for each condition). (D) Averaged Ca2+ currents measured with 10 mM Ca2+ in the 
extracellular solution using the step protocol in CTRL cells (solid trace) and TRPV6/RGS2 
co-expressing cells (dotted trace). (E) Average density of the Ca2+ peak current measured as 
in (D) was 228 ± 35 pA/pF for CTRL compared to 56 ± 8 pA/pF for cells co-transfected with 
TRPV6 and RGS2 (n = 15 cells for each condition). * indicates significant difference (p < 
0.001). 
► 
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co-expressing either RGS2 or ΔN-RGS2 were determined. Inward rectifying currents 
carried by Na+ could be measured in HEK293 cells co-transfected with TRPV6 and ΔN-
RGS2 or RGS2, or with TRPV6 and mock (Figure 5A,B). The Na+ currents were 
significantly reduced in cells co-expressing TRPV6 with RGS2 whereas cells co-expressing 
ΔN-RGS2 and TRPV6 did not show this reduction (Figure 5B,C). Likewise, RGS2 
significantly reduced the Ca2+ current in response to a hyperpolarizing voltage step in 
TRPV6-expressing cells (Figure 5D,E) whereas co-expression of ΔN-RGS2 with TRPV6 
had no effect on the TRPV6-mediated current amplitude.   
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RGS2 does not affect TRPV6 abundance at the plasma membrane 
To investigate whether RGS2 influences trafficking of TRPV6, cell surface expression of 
TRPV6 in HEK293 cells co-expressing RGS2 and TRPV6 was examined using Sulfo-
NHS-LC-LC-Biotin. TRPV6 was detected in total cell lysates of TRPV6-expressing cells 
as well as in the biotinylated plasma membrane fractions of TRPV6 and TRPV6/RGS2 co-
expressing cells (Figure 6). TRPV6 expression in the biotinylated membrane fraction was 
not significantly altered by co-expression of RGS2. 
 
TRPV6 is independently regulated from the scaffolding protein SPL 
The effect of SPL on the interaction of RGS2 with TRPV6 was investigated by GST pull-
down assay. Total cell lysates of HEK293 cells transiently transfected with TRPV6, SPL, 
or TRPV6 and SPL, were prepared and equal amounts of protein were analyzed for the 
interaction with RGS2. As indicated in Figure 7, TRPV6 associated with RGS2 both in the 
presence or absence of SPL. Next, the electrophysiological properties of TRPV6-mediated 
currents were examined by whole cell patch-clamp in HEK293 cells co-expressing TRPV6 
and SPL or TRPV6 and mock. Co-expression of SPL and TRPV6 had no significant effect 
either on Na+ or Ca2+ currents, as depicted in Figure 8. 
 
DISCUSSION 
 
The present study demonstrates a novel regulatory function of RGS2 by direct inhibition of 
TRPV6 channel activity at the plasma membrane. This conclusion is based on the 
following experimental data. First, interaction of RGS2 with TRPV6 specifically inhibits 
both Na+ and Ca2+ currents through TRPV6 whereas no effect on TRPV5 activity was 
observed. Second, deletion of the N-terminal domain of RGS2 disrupts the binding with 
TRPV6 and restores the original electrophysiological properties of the channel. Third, 
► Figure 4. Activity of TRPV5 is not affected by co-expressing RGS2. HEK293 cells were 
transiently transfected with TRPV5/mock (CTRL) or TRPV5/RGS2 and analyzed using 
immunoblotting (A) and by whole-cell patch clamp. (B) I/V relations measured from ramp 
protocol in nominally DVF solution in CTRL (solid trace) or TRPV5/RGS2-transfected cells 
(dotted trace). (C) Average Na+ current density at -80 mV in nominally DVF solution was 
495 ± 130 pA/pF for CTRL cells compared to 600 ± 100 pA/pF for TRPV5/RGS2 co-
expressing cells (n = 15 cells for each condition). (D) Averaged Ca2+ currents measured with 
10 mM Ca2+ in the extracellular solution using the step protocol in CTRL cells (solid trace) 
and TRPV5/RGS2-expressing cells (dotted trace). (E) Average density of the Ca2+ peak 
current measured as in (D), was 210 ± 50 pA/pF for CTRL compared to 201 ± 35 pA/pF for 
cells co-transfected with TRPV5 and RGS2 (n = 15 cells for each condition). 
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RGS2 expression does not interfere with TRPV6 trafficking from and towards the plasma 
membrane (to mediate its inhibitory effect on channel activity). Fourth, the multi-domain 
scaffolding protein SPL does not affect binding and electrophysiological properties of 
TRPV6 in the presence of RGS2. Therefore, our data indicate that TRPV6 activity is 
regulated by RGS2 without the involvement of GPCR signaling.       
     We showed that the N-terminal tail of RGS2 is essential for the interaction with and the 
activity of TRPV6. The N-terminal domain has already been described to be an important 
regulatory site for RGS2. Together with the “RGS-box” domain, it is necessary for its 
bbbbb 
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effector protein interactions, e.g. GPCRs and/or auxiliary proteins such as SPL 23, 28, 29. In  
addition, the membrane targeting sequence has also been predicted in this domain 30, 31. 
     Patch clamp analysis of HEK293 cells transfected with TRPV6 or TRPV5 revealed that 
specifically TRPV6 activity is inhibited by co-expression of RGS2. Interestingly, an 
analogous inhibitory mechanism has only been found for CaM and TRPV6 32. Since both 
Na+ and Ca2+ currents through TRPV6 were inhibited by RGS2, and thus affecting not 
bbbb 
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specifically the Ca2+ conductance of the channel, we expected a disturbed TRPV6 
trafficking towards the cell surface. In contrast, cell surface biotinylation in TRPV6-
expressing HEK293 cells demonstrated that RGS2 does not affect channel expression in the 
biotinylated fractions. Therefore, the inhibitory effect of RGS2 is presumably mediated 
directly at the plasma membrane. 
    RGS2 needs to be recruited towards the cell surface in order to affect the gating 
properties of TRPV6. Roy and co-workers 33 showed that G-proteins recruit RGS proteins 
towards the plasma membrane. In their study, the abundance of RGS2 and RGS4 proteins 
at the plasma membrane was enhanced when the number of G proteins was increased or 
when they interacted with their GPCR. Also SPL has been shown to be involved in RGS 
protein recruitment 23. Investigating the role of SPL provided us with additional evidence 
for a direct effect of RGS2 on TRPV6 activity. Wang and co-workers 23 showed that SPL is 
a scavenger of RGS2 which forms a SPL-RGS2 protein complex that regulates Ca2+ 
signaling by binding the third intracellular domain of GPCRs. In their study, the binding of 
RGS2 with the α-adrenergic receptor (AR) was investigated by GST pull-down analysis. 
The interaction between RGS2 and the AR was significantly increased in the presence of 
SPL. Furthermore, they observed that the inhibitory effect of RGS2 on Ca2+-activated Cl- 
currents in parotid duct cells was increased in the presence of SPL. For this reason, we 
anticipated that SPL could increase the inhibitory effect of endogenously present RGS2 on 
TRPV6 activity in HEK293 cells when acting via a Gαq-coupled GPCR. RGS2 expression 
was confirmed in HEK293 cells by RT-PCR (data not shown). First, it was demonstrated 
that SPL does not change TRPV6 expression (Figure 7, top panel). Second, TRPV6- 
mediated Na+ and Ca2+ currents were not affected by SPL as well (Figure 8). Therefore, we 
Figure 5. Inhibition of TRPV6-mediated Na+ and Ca2+ currents by RGS2, but not ΔN-RGS2. 
HEK293 cells were transiently transfected with TRPV6/mock (CTRL) or TRPV6 and RGS2 
or ΔN-RGS2 and analyzed using immunoblotting (A) and by whole-cell patch clamp. (B) I/V 
relations measured from ramp protocol in nominally DVF solution from CTRL (solid trace), 
TRPV6/RGS2-transfected cells (dotted trace) and TRPV6/ΔN-RGS2-transefected cells 
(dashed trace). (C) Average Na+ current density at -80 mV in nominally DVF solution was 
268 ± 40 pA/pF for CTRL, 30 ± 5 pA/pF for cells transfected with TRPV6 and RGS2 and 
280 ± 45 pA/pF for TRPV6/ΔN-RGS2-transfected cells (n = 10 cells for each condition). (D) 
Averaged Ca2+ currents measured with 10 mM Ca2+ in the extracellular solution using the 
step protocol in CTRL cells (solid trace), TRPV6/RGS2-expressing cells (dotted trace) and 
TRPV6/ΔN-RGS2 co-expressing cells (dashed trace). (E) Average density of the Ca2+ peak 
current measured as in (D), was 200 ± 50 pA/pF for CTRL, 55 ± 10 pA/pF for TRPV6/RGS2 
co-expressing cells and 196 ± 55 pA/pF for TRPV6/ΔN-RGS2 co-expressing cells (n = 10 
cells for each condition). * indicates significant difference (p < 0.001). 
◄ 
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Figure 6. Cell-surface expression of TRPV6. HEK293 cells were transfected with TRPV6 ± 
RGS2. The extracellular parts of the proteins were biotinylated, precipitated with neutravidin 
beads, and immunoblotted for TRPV6. Samples of the lysed cells (“total cell lysates”, left 
panel) were immunoblotted in parallel to visualize the amount of expressed proteins. Both 
TRPV6 alone and TRPV6 with RGS2-transfected cells showed cell surface expression of 
these proteins, whereas mock-transfected cells did not (“plasma membrane”, right panel). 
 
conclude that the inhibitory effect of RGS2 on TRPV6 activity is independently regulated 
of a GPCR, but is rather mediated by direct interaction of RGS2 and TRPV6.  
     In conclusion, we have identified RGS2 as a novel regulatory protein specifically 
inhibiting the activity of the epithelial Ca2+ channel TRPV6. Our findings may provide 
insight in the direct regulation of different TRP channels by interacted proteins at the 
plasma membrane.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Effect of SPL on the interaction of RGS2 and TRPV6. Extracts from HEK293 cells 
transfected with TRPV6 and SPL were used for pull-down assay with GST or GST fused to 
RGS2. Pulled proteins were analyzed for TRPV6 (top panel) and SPL (lower panel) 
expression by immunoblotting.   
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Figure 8. Activity of TRPV6 is not affected by SPL. HEK293 cells were transiently 
transfected with TRPV6/mock (CTRL) or TRPV6/SPL and analyzed by immunoblotting and 
by whole-cell patch clamp. Average Na+ current density measured at -80 mV from the ramp 
protocol was 344 ± 70 pA/pF for CTRL and 335 ± 80 pA/pF for TRPV6/SPL co-expressing 
cells and average density of the Ca2+ peak current measured from the step protocol was 204 ± 
35 pA/pF for CTRL and 195 ± 40 pA/pF for TRPV6/SPL co-expressing cells (n = 12 cells for 
each condition). 
 
 
ACKNOWLEDGEMENTS 
 
We thank Dr. K.M. Druey (Molecular Signal Transduction Section, Laboratory of Allergic 
Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, Maryland 20892) for kindly providing the RGS2 antibody and J.A. 
Janssen for excellent technical assistance. This work was supported by the Dutch 
Organization of Scientific Research (NWO-ALW 814.02.001 and Zon-MW 016.006.001).  
 
 45
Chapter 2 
REFERENCES  
 
1. Birnbaumer L, Yildirim E, Abramowitz J. A comparison of the genes coding for canonical TRP channels and 
their M, V and P relatives. Cell Calcium (2003) 33:419-32. 
2. Clapham DE. TRP channels as cellular sensors. Nature (2003) 426:517-24. 
3. Montell C. The venerable inveterate invertebrate TRP channels. Cell Calcium (2003) 33:409-17. 
4. Putney JW, Jr. Capacitative calcium entry in the nervous system. Cell Calcium (2003) 34:339-44. 
5. Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell (2002) 
108:595-8. 
6. Hoenderop JG, Vennekens R, Muller D, Prenen J, Droogmans G, Bindels RJ, Nilius B. Function and 
expression of the epithelial Ca2+ channel family: comparison of mammalian ECaC1 and 2. J Physiol (2001) 
537:747-61. 
7. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium (2005) 38:233-52. 
8. Voets T, Janssens A, Prenen J, Droogmans G, Nilius B. Mg2+-dependent gating and strong inward 
rectification of the cation channel TRPV6. J Gen Physiol (2003) 121:245-60. 
9. Voets T, Janssens A, Droogmans G, Nilius B. Outer pore architecture of a Ca2+-selective TRP channel. J Biol 
Chem (2004) 279:15223-30. 
10. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA. Molecular cloning 
and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 
(1999) 274:22739-46. 
11. Nijenhuis T, Hoenderop JG, van der Kemp AW, Bindels RJ. Localization and regulation of the epithelial 
Ca2+ channel TRPV6 in the kidney. J Am Soc Nephrol (2003) 14:2731-40. 
12. Wissenbach U, Niemeyer BA, Fixemer T, Schneidewind A, Trost C, Cavalie A, Reus K, Meese E, Bonkhoff 
H, Flockerzi V. Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of 
prostate cancer. J Biol Chem (2001) 276:19461-8. 
13. den Dekker E, Hoenderop JG, Nilius B, Bindels RJ. The epithelial calcium channels, TRPV5 & TRPV6: 
from identification towards regulation. Cell Calcium (2003) 33:497-507. 
14. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev (2005) 85:373-422. 
15. van de Graaf SF, Chang Q, Mensenkamp AR, Hoenderop JG, Bindels RJ. Direct interaction with Rab11A 
targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol (2006) 
26:303-12. 
16. van de Graaf SF, Hoenderop JG, Gkika D, Lamers D, Prenen J, Rescher U, Gerke V, Staub O, Nilius B, 
Bindels RJ. Functional expression of the epithelial Ca2+ channels (TRPV5 and TRPV6) requires association 
of the S100A10-annexin 2 complex. EMBO J (2003) 22:1478-87. 
17. van de Graaf SF, Hoenderop JG, van der Kemp AW, Gisler SM, Bindels RJ. Interaction of the epithelial Ca2+ 
channels TRPV5 and TRPV6 with the intestine- and kidney-enriched PDZ protein NHERF4. Pflügers Arch 
(2006) 452:407-17. 
18. Erler I, Hirnet D, Wissenbach U, Flockerzi V, Niemeyer BA. Ca2+-selective transient receptor potential V 
channel architecture and function require a specific ankyrin repeat. J Biol Chem (2004) 279:34456-63. 
19. Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. The ankyrin repeat as molecular architecture for protein 
recognition. Protein Sci (2004) 13:1435-48. 
 46
RGS2 inhibits TRPV6 
20. De Vries L, Zheng B, Fischer T, Elenko E, Farquhar MG. The regulator of G protein signaling family. Annu 
Rev Pharmacol Toxicol (2000) 40:235-71. 
21. Abramow-Newerly M, Roy AA, Nunn C, Chidiac P. RGS proteins have a signalling complex: interactions 
between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal (2006) 18:579-91. 
22. Nilius B, Prenen J, Hoenderop JG, Vennekens R, Hoefs S, Weidema AF, Droogmans G, Bindels RJ. Fast and 
slow inactivation kinetics of the Ca2+ channels ECaC1 and ECaC2 (TRPV5 and TRPV6). Role of the 
intracellular oop located between transmembrane segments 2 and 3. J Biol Chem (2002) 277:30852-8. 
23. Wang X, Zeng W, Soyombo AA, Tang W, Ross EM, Barnes AP, Milgram SL, Penninger JM, Allen PB, 
Greengard P, Muallem S. Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 
and the third intracellular loop of G-protein-coupled receptors. Nat Cell Biol (2005) 7:405-11. 
24. van Abel M, Hoenderop JG, Dardenne O, St Arnaud R, van Os CH, van Leeuwen HJ, Bindels RJ. 1,25-
dihydroxyvitamin D3-independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. J 
Am Soc Nephrol (2002) 13:2102-9. 
25. Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, Droogmans G, Nilius B, Bindels RJ. 
Permeation and gating properties of the novel epithelial Ca2+ channel. J Biol Chem (2000) 275:3963-9. 
26. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG. The beta-glucuronidase 
klotho hydrolyzes and activates the TRPV5 channel. Science (2005) 310:490-3. 
27. Ross EM, Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein 
signaling (RGS) and RGS-like proteins. Annu Rev Biochem (2000) 69:795-827. 
28. Bernstein LS, Ramineni S, Hague C, Cladman W, Chidiac P, Levey AI, Hepler JR. RGS2 binds directly and 
selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha 
signaling. J Biol Chem (2004) 279:21248-56. 
29. Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR. Selective inhibition of alpha1A-
adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J Biol Chem 
(2005) 280:27289-95. 
30. Heximer SP, Lim H, Bernard JL, Blumer KJ. Mechanisms governing subcellular localization and function of 
human RGS2. J Biol Chem (2001) 276:14195-203. 
31. Kehrl JH, Sinnarajah S. RGS2: a multifunctional regulator of G-protein signaling. Int J Biochem Cell Biol 
(2002) 34:432-8. 
32. Lambers TT, Weidema AF, Nilius B, Hoenderop JG, Bindels RJ. Regulation of the mouse epithelial Ca2+ 
channel TRPV6 by the Ca2+-sensor calmodulin. J Biol Chem (2004) 279:28855-61. 
33. Roy AA, Lemberg KE, Chidiac P. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins 
and receptors reflects functional interactions. Mol Pharmacol (2003) 64:587-93. 
 
 
 
 
 
 
 
 
 
 
 47
Chapter 2 
 
 48
Chapter 3 
 
 
 
 
Identification of Nipsnap1 as a novel auxiliary 
protein inhibiting TRPV6 activity 
 
 
 
 
 
Joost P Schoeber1 
Catalin N Topala1 
Kyu Pil Lee1 
Tim T Lambers1 
Guénola Ricard2 
Annemiete W van der Kemp1 
Martijn A Huynen2 
Joost G Hoenderop1 
René J Bindels1
 
1Department of Physiology, Nijmegen Centre for Molecular Life Sciences. Radboud 
University Nijmegen Medical Centre, Nijmegen, 6500 HB, The Netherlands 
2Centre for Molecular and Biomolecular Informatics, Nijmegen Centre for Molecular Life 
Sciences. Radboud University Nijmegen Medical Centre, Nijmegen, 6500 HB, The 
Netherlands 
 
 
 
Pflügers Arch Eur J Physiol (2008) 457:91-101
Chapter 3 
SUMMARY 
 
The Transient Receptor Potential Vanilloid channels 5 and 6 (TRPV5/6) are the most Ca2+-
selective channels within the TRP superfamily of ion channels. These epithelial Ca2+ 
channels are regulated at different intra- and extracellular sites by the feedback response of 
Ca2+ itself, calciotropic hormones, and by TRPV5/6-associated proteins. In the present 
study bioinformatics was used to search for novel TRPV5/6-associated genes. By including 
pull-down assays and functional analysis, Nipsnap1 – a hitherto functionally 
uncharacterized globular protein - was identified as a novel factor involved in the 
regulation of TRPV6. Electrophysiological recordings revealed that Nipsnap1 abolishes 
TRPV6 currents. Subsequent biotinylation assays showed that TRPV6 plasma membrane 
expression did not change in the presence of Nipsnap1, suggesting that TRPV6 inhibition 
by Nipsnap1 is independently regulated from reduced cell surface channel expression. In 
addition, semi-quantitative reverse transcriptase PCR and immunohistochemical labeling of 
Nipsnap1 indicated that Nipsnap1 is expressed in mouse intestinal tissues - where TRPV6 
is predominantly expressed - but that it does not co-localize with TRPV5 in the kidney. In 
conclusion, this study presents the first physiological function of Nipsnap1 as an associated 
protein inhibiting TRPV6 activity that possibly exerts its effect directly at the plasma 
membrane. 
 
INTRODUCTION 
 
The highly selective Ca2+ channels TRPV5 and TRPV6 are members of the large and 
functionally diverse family of Transient Receptor Potential (TRP) ion channels and belong 
to the vanilloid subfamily. TRPV5/6 are expressed in Ca2+-transporting epithelia where 
they act as gate regulating the entry of Ca2+ 1. Whereas TRPV5 has been shown to 
constitute the apical influx mechanism during Ca2+ reabsorption from the pro-urine and to 
be essential for osteoclastic bone resorption 1-4, TRPV6 was identified to regulate Ca2+ 
absorption from the diet 1, 5-7. However, 1,25-dihydroxyvitamin D3- (1,25(OH)2D3-
)responsive expression of TRPV6 in the kidney has been shown as well 8. Moreover, a 
functional role of TRPV6 in Ca2+ transport in the kidney seems feasible since TRPV6-/- 
mice suffer from renal Ca2+ loss 9.   
     In epithelial cells active Ca2+ (re)absorption from the luminal compartment (diet, pro-
urine) to the basolateral side (blood) comprises a sequence of processes. At the apical side 
Ca2+ enters the epithelial cell via TRPV5/6 due to the steep inward electrochemical gradient 
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across the membrane 2. In the cell, Ca2+ is rapidly bound to calbindin-D9K or -D28K that 
diffuses Ca2+ from the apical to the basolateral side where the plasma membrane ATPase 
(PMCA1b) and the Na+/Ca2+-exchanger (NCX1) extrude Ca2+ into the blood compartment. 
This transcellular process is under tight and coordinated control of calciotropic hormones 
(e.g. 1,25(OH)2D3, parathyroid hormone, estrogens) that efficiently regulate the above 
mentioned process via distinct genomic and non-genomic pathways 2, 10, 11.  
     Next to hormonal regulation, the activity of TRPV5/6 is efficiently regulated by Ca2+ 
itself such that Ca2+ entry induces a negative feedback regulation of channel activity 12. This 
is essential during high levels of Ca2+ transport to prevent Ca2+ overload. Since TRPV5/6 
lack conserved Ca2+ binding sites that could translate the ambient Ca2+ concentration into 
channel activity, associated protein complexes are likely involved in this particular form of 
TRPV5/6 regulation. The Ca2+-binding proteins calmodulin, calbindin-D28K and 80K-H 
were previously identified as modulators of TRPV5 and/or TRPV6, affecting the Ca2+-
dependent activity of the epithelial Ca2+ channels 13-15. Calbindin-D28K was shown to 
translocate towards the plasma membrane and associate with TRPV5 upon a decrease of 
the intracellular Ca2+ concentration. There it locally buffers Ca2+ that enters the cell via 
TRPV5 preventing the intracellular environment to reach toxic levels of Ca2+ and to 
prevent channel inactivation. In addition, the Ca2+ sensor calmodulin was identified to 
associate with TRPV5 and TRPV6 in a Ca2+-dependent fashion, but regulation of channel 
activity was shown to be confined to TRPV6 only. Similarly, 80K-H was suggested to act 
as a Ca2+ sensor to regulate TRPV5 activity. Thus, Ca2+-dependent regulation of TRPV5/6 
activity is mediated by a number of factors. Possible explanations of how these associated 
proteins control TRPV5/6 activity could be by changing the number of TRPV5/6 channels 
at the plasma membrane or by modifications of channel activity at the cell surface. The 
molecular mechanisms that control trafficking of TRPV5/6 towards the plasma membrane 
and channel activity at the cell surface are, however, poorly understood. Recently, the 
S100A10-annexin 2 protein complex and Rab11A were identified to be essential for 
TRPV5 and TRPV6 cell surface expression 16, 17. S100A10-annexin 2 appeared to be 
involved in constitutive non-stimulated trafficking of TRPV5, whereas Rab11A was 
identified as an essential factor of a GTP-dependent mechanism controlling TRPV5 
recycling to the plasma membrane.  
     To identify new TRPV5/6-associated proteins bioinformatics was applied as a tool to 
search for genes that are within the gene co-expression network of TRPV5/6 in Homo 
sapiens or for related genes (e.g. OSM-9) in other species (i.e. Caenorhabditis elegans). 
Via this approach Nipsnap1 was identified as a novel TRPV5/6-associated protein. 
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The aim of the present study was to identify the putative role of Nipsnap1 in active Ca2+ 
(re)absorption. To this end, co-precipitation assays were performed to investigate Nipsnap1 
association to TRPV5/6. Reverse transcriptase (RT-) PCR and immunohistochemistry were 
used to investigate Nipsnap1 expression in different tissues. Furthermore, 
electrophysiological recordings of cells co-expressing Nipsnap1 and TRPV6 were used to 
study the role of Nipsnap1 in channel activity. Finally, cell surface labeling of Nipsnap1 
and TRPV6 co-expressing cells was established to investigate TRPV6 plasma membrane 
expression.  
 
MATERIALS AND METHODS 
 
Molecular biology and cell culture 
TRPV5 and TRPV6 were cloned individually into pCINeo/IRES-GFP expression vectors 
as described 18. Subsequently, TRPV5 and TRPV6 were cloned between the NheI and KpnI 
restriction sites of the eukaryotic GST-expression vector pEBG by PCR using the TRPV5 
and TRPV6 pCINeo/IRES-GFP constructs as templates. Next, TRPV6 was sub-cloned in 
the pCB7 expression vector, and tagged at the N-terminal tail with eGFP that was obtained 
by PCR using a pEGFP-C1 vector as a template. eGFP-TRPV5 was cloned as described 19. 
For co-precipitation and biotinylation experiments eGFP-fused TRPV5/6 was used to 
increase sensitivity of detection by Western-blot analysis with polyclonal anti-GFP 
antibodies. N-terminal fusion of eGFP to TRPV6 did not significantly change the 
characteristic inward rectifying Na+ and Ca2+ currents - compared to TRPV6-
pCINeo/IRES-GFP - during whole-cell patch clamp measurements (data not shown). 
Nipsnap1 cDNA was kindly provided by Dr. P. Deen (Physiology, Nijmegen Centre for 
Molecular Life Sciences, Nijmegen, The Netherlands) in the pAKT2 expression vector. By 
using this vector as a template for the Nipsnap1 coding sequence, Nipsnap1 was cloned 
into pCDNA3.1/HisC and pEBG by PCR, and into pCINeo/IRES-GFP by PCR with 
primers including the Vesicular Stomatitis Virus epitope AYTDIEMNRLGK (VSV-tag). 
All constructs were verified by sequence analysis. HEK293 cells were cultured and 
transfected as described 13.  
 
Bioinformatics 
To find potential interaction partners for TRPV5/6, the genes that are within the same gene 
co-expression network were examined. Including expression data from multiple species 
increases the reliability of the predictions that can be made about functional interactions 
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between proteins 20. There are many ways in which the expression data between species can 
be combined. Furthermore, due to species-specific gene duplications, species can contain 
multiple, closely related paralogous genes, and, in order to compare the expression data 
between species, they also have to be integrated for multiple gene pairs per species. A 
straightforward approach of combining the co-expression data is to average them between 
gene pairs. However, by averaging the co-expression data across paralogous genes and 
across species one loses sensitivity 20: many of the biologically relevant interactions will 
not be present among the highest conserved co-expressed gene pairs. Therefore, a different 
strategy was used. Instead of averaging the co-expression values, the maximum level of co-
expression was taken, both per pair of orthologous groups within each species and between 
the species. Genes were put into orthologous groups, based on the ‘euKaryotic cluster of 
Orthologous Genes (KOG)’ classification 21 [http://string.embl.de/], their levels of co-
expression were calculated, and for each pair of orthologous groups the highest level of co-
expression between all pairwise gene combinations, taking one gene from each KOG, was 
selected. From the resulting KOG-KOG co-expression values the top 50 for the KOG of 
TRPV5/6 (KOG3676) were selected and manually examined for potential TRPV5/6-
interacting proteins (see Table 1; for complete list: http://www.cmbi.ru.nl/~moti/kog3676 
_coexp.xls). The published gene expression data set assembled by Stuart et al. 22 
[http://cmgm.stanford.edu/~kimlab/multiplespecies/Data/index.html], which contains 
expression data of KOG3676 from Caernohabditis elegans and Homo sapiens, was used to 
calculate co-expression values using Spearman’s rank correlation.  
 
Co-precipitation and protein-binding domain analysis 
HEK293 cells were transiently transfected with glutathione S-transferase (GST)-Nipsnap1 
or empty vector and co-transfected with eGFP-TRPV5/6 (n = 2), Cells were lysed for 1 h 
on ice in 50 mM Tris-HCl pH 8.0 containing 5 mM EGTA, 100 mM KCl, 1 mM MgCl2, 
0.2 % (v/v) Triton-X100, 0.2 % (v/v) NP40 and a protease inhibitor cocktail [0.10 mg/ml 
leupeptin, 0.05 mg/ml pepstatin-A, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 5 
mg/ml aprotinin]. The lysates were centrifuged for 10 min at 14,000 g and cell fragments in 
the supernatants were incubated overnight with glutathione sepharose 4B beads (GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden) at 4 ºC. After extensive washing in lysis 
buffer, co-precipitation was investigated by Western-blot analysis using polyclonal anti-
GFP antibodies (kindly provided by Dr. B. Wieringa, Cell Biology, Nijmegen, The 
Netherlands). For the inverse co-precipitation, HEK293 cells were transfected with GST-
TRPV5, GST-TRPV6 or empty vector and co-transfected with VSV-Nipsnap1 or empty 
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vector. Cells were lysed as described above and co-precipitation was investigated by 
immunoblotting using anti-VSV antibodies (Sigma, St. Louis, MO, USA). To investigate 
protein-binding domains, GST pull-down assays were performed using truncated GST-
fused TRPV6 proteins and VSV-tagged Nipsnap1. GST-TRPV6, truncates, and GST were 
expressed in, and purified from, transformed Escherichia coli BL21 according to the 
manufacturer’s protocol (GE Healthcare Bio-Sciences AB). Proteins were purified from the 
raw bacterial lysates by binding the proteins to glutathione sepharose 4B beads for 3 hours 
at room temperature (RT). VSV-Nipsnap1 was transfected in HEK293 cells and after two 
days, cells were lysed as described above at 4 ºC for 1 h, centrifuged 10 min at 14,000 g, 
and subsequently the supernatant was incubated overnight with the GST-fusion proteins 
coupled to the beads. Proteins were released from the beads using SDS-PAGE sample 
buffer and subsequently analyzed by immunoblotting using anti-VSV antibodies. 
 
Generation of Nipsnap1 antiserum and immunohistochemistry 
Antiserum against Nipsnap1 was obtained by immunization of rabbits with a keyhole 
limpet-coupled synthetic peptide (EETRNAAWRKRGWDE, amino acids 244-258) 
representing the carboxyl-terminal domain of Nipsnap1. Immunohistochemical labeling of 
Nipsnap1 and Aquaporin 2 (AQP2) was performed on mouse kidney sections fixed in 4 % 
paraformaldehyde and embedded in paraffin (Histokinette). The immunohistochemistry 
was performed according to the method described 23, using rabbit Nipsnap1 antiserum 
(1:100, with secondary antibody anti-rabbit/Alexa-488 (Molecular probes, Leiden, The 
Netherlands) 1:300) or guinea pig AQP2 antiserum (1:300, with secondary antibody anti-
guinea pig/Alexa-594 (Molecular probes) 1:300) 24. 
 
Reverse Transcriptase (RT)-PCR Analysis 
Total RNA was isolated from different mouse tissues using TRIzol (Invitrogen, Carlsbad, 
CA, USA) and subjected to reverse transcription as described 25. For Nipsnap1 RT-PCR, 
the oligonucleotide primer sequences were as follows: forward primer, 5’-GGTTGTGCATCAT 
CTCTGCA-3’; reverse, 5’-CTCCTGACGGTACTTGATGG-3’ - and for β-actin, 5’-ACGATTTCCCTC 
TCAGCTGTG-3’ (forward) and 5’-GTATGCCTCTGGTCGTACCAC-3’ (reverse). PCR fragments 
were collected and analyzed by electrophoresis on 1 % (w/v) agarose. For semi-quantitative 
analysis, samples of the different duodenum and colon PCR fragments were collected after 
20, 25, 30, 35 and 40 cycles and analyzed by DNA electrophoresis. 
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Protein purification 
GST-Nipsnap1 and GST were expressed in, and purified from, transformed E. coli BL21 
according to the manufacturer’s protocol (GE Healthcare Bio-Sciences AB). GST-
Nipsnap1 and GST were purified from the raw bacterial lysates by binding the proteins to 
glutathione sepharose 4B beads for 3 hours at RT. The proteins were competed from the 
beads by incubation with 5 mM reduced glutathione (Sigma, St. Louis, MO, USA) in 50 
mM Tris (pH 8.0 with HCl)  for 10 min at RT. Released proteins were separated from 
excess reduced glutathione by column centrifugation using Microcon YM-10 columns 
(Millipore, Bedford, MA, USA) according to manufacturer’s protocol. Proteins were eluted 
from the column in standard internal (patch pipette) solution [20 mM CsCl, 100 mM Cs-
aspartate, 1 mM MgCl2, 4 mM Na2ATP, 10 mM BAPTA, 10 mM HEPES/CsOH pH 7.2] 
and protein concentration was determined according to a bovine serum albumin (BSA) 
dilution series subjected to SDS-PAGE and Coomassie staining. 
 
Electrophysiology 
Electrophysiological recordings were performed as described previously 18, 26 in the tight 
seal whole-cell configuration at room temperature using an EPC-9 patch-clamp amplifier 
computer controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany). Two 
voltage protocols were used: a ramp, to establish the current-voltage (I/V) relation in 
nominally divalent free (DVF) or in 10 mM Ca2+-containing extracellular solutions, and a 
hyperpolarizing step protocol to measure the Ca2+-dependent inactivation. Na+ current 
densities were calculated from the current at -80 mV measured with the ramp protocols, 
whereas the Ca2+ currents were calculated from the peak values at -100 mV during the step 
protocol. To investigate the effect of purified GST-Nipsnap1 (58 kDa protein, 10 nM) or 
GST (26 kDa protein, 20 nM) on TRPV6-mediated currents, proteins were infused via the 
patch pipette for 7 min before starting the recordings 27. The analysis and display of patch-
clamp data were performed using Igor Pro software (WaveMetrics, Lake Oswego, USA).   
 
Biotinylation 
HEK293 cells were transfected with eGFP-TRPV6 and empty vector, or transfected with 
eGFP-TRPV6 and VSV-Nipsnap1. The cell surface was biotinylated for 30 min at 4 ºC 
using NHS-LC-LC-biotin (0.5 mg/ml; Pierce, Etten-leur, The Netherlands). Cells were 
lysed (lysis buffer as described for co-precipitation analysis) at 4 ºC for 1 h, centrifuged 10 
min at 14,000 g, and subsequently cell fragments in the supernatant were calibrated for 
equal   input,   precipitated   using   neutravidin-coupled   beads   (Pierce),   and  analyzed  by  
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Nr. 
  
KOG 
Correlation 
in 
expression 
Expression 
set of 
species 
  
 Description of KOG 
1 KOG4597 0.9686 cel, hsa   Serine proteinase inhibitor (KU family) with thrombospondin repeats 
2 KOG4225 0.9116 cel, hsa   Sorbin and SH3 domain-containing protein 
3 KOG0619 0.9071 cel, hsa   FOG: Leucine rich repeat 
4 KOG3094 0.8733 cel, hsa   Predicted membrane protein 
5 KOG1218 0.8674 cel, hsa   Proteins containing Ca2+-binding EGF-like domains 
6 KOG0775 0.8589 cel, hsa   Transcription factor SIX and related HOX domain proteins 
7 KOG3656 0.8582 cel, hsa   FOG: 7 transmembrane receptor 
8 KOG4562 0.8555 cel, hsa   Uncharacterized conserved protein (tumor-rejection antigen MAGE in… 
9 KOG1639 0.8517 hsa   Steroid reductase required for elongation of the very long chain fatty….. 
10 KOG3362 0.8469 cel, hsa   Predicted BBOX Zn-finger protein 
11 KOG3784 0.8465 cel, hsa   Sorting nexin protein SNX27 
12 KOG2619 0.8452 cel, hsa   Fucosyltransferase 
13 KOG0753 0.8392 cel, hsa   Mitochondrial fatty acid anion carrier protein/Uncoupling protein 
14 KOG0217 0.8352 hsa   Mismatch repair ATPase MSH6 (MutS family) 
15 KOG1577 0.8337 cel, hsa   Aldo/keto reductase family proteins 
16 KOG0583 0.8322 cel, hsa   Serine/threonine protein kinase 
17 KOG0725 0.8308 cel, hsa   Reductases with broad range of substrate specificities 
18 KOG1721 0.8293 cel, hsa   FOG: Zn-finger 
19 KOG4297 0.8277 cel, hsa   C-type lectin 
20 KOG3587 0.8271 cel, hsa   Galectin, galactose-binding lectin 
21 KOG1726 0.8203 cel, hsa   HVA22/DP1 gene product-related proteins 
22 KOG0244 0.815 cel, hsa   Kinesin-like protein 
23 KOG0933 0.8085 cel, hsa   Structural maintenance of chromosome protein 2  
24 KOG4657 0.8042 hsa   Uncharacterized conserved protein 
25 KOG1095 0.8014 cel, hsa   Protein tyrosine kinase 
26 KOG0696 0.8013 cel, hsa   Serine/threonine protein kinase 
27 KOG1390 0.8013 cel, hsa   Acetyl-CoA acetyltransferase 
28 KOG3186 0.8011 hsa   Mitotic spindle checkpoint protein 
29 KOG3271 0.7986 cel, hsa   Translation initiation factor 5A (eIF-5A) 
30 KOG1936 0.7945 cel, hsa   Histidyl-tRNA synthetase 
31 KOG2061 0.7937 cel, hsa   Uncharacterized MYND Zn-finger protein 
32 KOG0842 0.7899 cel, hsa   Transcription factor tinman/NKX2-3, contains HOX domain 
33 KOG3627 0.7831 cel, hsa   Trypsin 
34 KOG0078 0.7819 cel, hsa   GTP-binding protein SEC4, small G protein superfamily, and related….. 
35 KOG2810 0.7809 hsa   Checkpoint 9-1-1 complex, RAD9 component 
36 KOG1616 0.7797 cel, hsa   Protein involved in Snf1 protein kinase complex assembly 
37 KOG0194 0.7791 cel, hsa   Protein tyrosine kinase 
38 KOG4126 0.7757 hsa   Alkaline phosphatase 
39 KOG4283 0.7715 hsa   Transcription-coupled repair protein CSA, contains WD40 domain 
40 KOG2024 0.7704 hsa   Beta-Glucuronidase GUSB (glycosylhydrolase superfamily 2) 
41 KOG2883 0.7673 cel, hsa   NIPSNAP1 protein 
42 KOG0952 0.765 cel, hsa   DNA/RNA helicase MER3/SLH1, DEAD-box superfamily 
43 KOG2134 0.7588 cel, hsa   Polynucleotide kinase 3' phosphatase 
44 KOG0242 0.7486 cel, hsa   Kinesin-like protein 
45 KOG3966 0.7477 cel, hsa   p53-mediated apoptosis protein EI24/PIG8 
46 KOG0027 0.7471 cel, hsa   Calmodulin and related proteins (EF-Hand superfamily) 
47 KOG2289 0.7471 cel, hsa   Rhomboid family proteins 
48 KOG0814 0.7459 cel, hsa   Glyoxylase 
49 KOG3571 0.7415 cel, hsa   Dishevelled 3 and related proteins 
50 KOG0553 0.7356 cel, hsa   TPR repeat-containing protein 
Table 1. TRPV5/TRPV6-correlated euKaryotic clusters of Orthologous Genes. Listed are the 
top 50 of KOGs identified by a bioinformatical search for genes that show a maximum level 
of co-expression with TRPV5/6 (see materials and methods). “cel” = expression data 
available from Caenorhabditis elegans, “hsa” = expression data available from Homo 
sapiens. 
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immunoblotting using anti-GFP antibodies (n = 3). 
 
Statistical analysis 
In all experiments, the data are expressed as mean ± S.E.M. Overall statistical significance 
was determined by analysis of variance. In case of significance, differences between the 
means of two groups were analyzed by unpaired Student’s t test. P values < 0.05 were 
considered significant. 
 
RESULTS 
 
Identification of Nipsnap1 as a TRPV5/6-associated protein 
To identify novel TRPV5/6-associated proteins, co-expression data were used to identify 
genes that have a correlated expression pattern with TRPV5/6 across different species and 
conditions (see materials and methods). The top 50 KOGs that have high co-expression 
values with the KOG of TRPV5/6 (KOG3676, see Table 1) were examined. This list 
already includes a number of proteins that have been characterized as regulatory proteins of 
TRPV5/6 - e.g. nr. 10: BSPRY (B-box and SPRY-domain containing protein 28), and nr. 
46: Calmodulin 13. Because of a hypothesized role in vesicular trafficking 29, the KOG2883 
that contains the Nipsnap proteins (nr. 41) was selected to further analyze its putative role 
in TRPV5/6 regulation. 
 
Nipsnap1 interacts with TRPV5 and TRPV6 
Interaction of Nipsnap1 and TRPV5/6 was investigated by pull-down analysis. Nipsnap1 
was co-precipitated with TRPV5/6 from HEK293 cells transiently expressing VSV-
Nipsnap1 and GST-TRPV5/6 (Figure 1A). Likewise, TRPV5/6 were co-precipitated with 
Nipsnap1 from HEK293 cells transiently expressing eGFP-TRPV5/6 and GST-Nipsnap1 
(Figure 1B). Nipsnap1 interacted with both TRPV5 and TRPV6.  
 
Tissue distribution and immunolocalization of Nipsnap1 
TRPV5 and TRPV6 are mainly expressed in Ca2+-transporting tissues. To investigate the 
expression of Nipsnap1 in mouse tissues, the distribution of Nipsnap1 was assessed in a 
cDNA tissue panel by RT-PCR. Nipsnap1 mRNA was ubiquitously expressed, but not 
detected in spleen (Figure 2A). All tissues expressed β-actin that was used as a positive 
control to confirm the integrity of the cDNAs. As negative controls, the primer sets for 
Nipsnap1 and β-actin were screened in the absence of cDNA (depicted as H2O samples in 
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Figure 2A). Next, Nipsnap1 protein expression was localized in mouse kidney sections by 
immunohistochemical labeling. Nipsnap1 did not co-localize with TRPV5 that is expressed 
in the distal convoluted tubules of the kidney cortex (data not shown). Moreover, Nipsnap1 
protein was specifically detected in the inner medulla collecting ducts where it co-localized 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Interaction of Nipsnap1 and TRPV5/TRPV6. (A) VSV-Nipsnap1 was transiently 
co-transfected with GST-TRPV5, GST-TRPV6, or GST (mock) in HEK293 cells. As 
additional controls, GST-TRPV5/6 were co-transfected with empty vector (empty). Proteins 
from lysed cells were pulled with glutathione sepharose 4B beads and investigated by 
immunoblotting using anti-VSV antibodies. Nipsnap1 interacted with GST-TRPV5 (upper 
panel) and GST-TRPV6 (lower panel) whereas no binding with GST alone was observed. (B) 
eGFP-TRPV5/6 were transiently co-transfected with GST-Nipsnap1 or mock in HEK293 
cells. Proteins from lysed cells were pulled and investigated by immunoblotting using anti-
GFP antibodies. TRPV5 (upper panel) and TRPV6 (lower panel) interacted with GST-
Nipsnap1 whereas no binding with GST alone was observed. 
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Figure 2. Expression and localization of Nipsnap1 in mouse tissues. (A) Tissue distribution of 
Nipsnap1. RNA was extracted from different mouse tissues and Nipsnap1 expression was 
determined by RT-PCR (upper panel). As positive controls, β-actin was amplified to ensure 
the integrity of the cDNAs (lower panels). As negative controls, the primer sets for Nipsnap1 
and β-actin were screened in the absence of cDNA (depicted as H2O samples). (B) 
Immunolocalization of Nipsnap1. Kidney sections were co-stained with antibodies against 
Nipsnap1 and AQP2. Immunopositive staining at the apical side of inner medullary collecting 
ducts is shown for Nipsnap1 (green) and AQP2 (red). A full color image can be found at 
www.physiology-nijmegen.nl > ion transport > publications. (C) Differential expression of 
Nipsnap1 in mouse duodenum and colon. RNA was extracted from duodenum and colon and 
Nipsnap1 (upper panel) and β-actin (positive controls, lower panel) expression was 
determined by RT-PCR. As negative controls, the primer sets for Nipsnap1 and β-actin were 
screened in the absence of cDNA (depicted as H2O samples). “20, 25, 30, 35, 40” indicate 
numbers of PCR cycles. 
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with AQP2 at the apical side (Figure 2B). TRPV6, but not TRPV5, is expressed in this 
segment of the nephron. However, TRPV6 expression levels are higher in Ca2+-transporting 
tissues of the gastro-intestinal tract and in prostate 8. To further investigate Nipsnap1 co-
expression in mouse tissue samples of duodenum and colon, the expression of Nipsnap1 
was assessed by semi-quantitative RT-PCR. Nipsnap1 mRNA is expressed in both 
duodenum and colon, with higher expression in colon (Figure 2C, upper panel).  
 
Nipsnap1 binding motifs in TRPV6 
The functional role of Nipsnap1 was further studied for TRPV6 only since TRPV5 and 
Nipsnap1 do not co-localize in kidney. To identify the Nipsnap1 interaction domain(s) of 
TRPV6, a series of amino- and carboxyl-terminal deletion mutants were constructed as 
depicted in Figure 3A,B. Truncated forms of TRPV6 were fused to GST and Nipsnap1 
binding was determined by GST pull-down assays as described above. The interaction 
between the TRPV6 amino-terminus and Nipsnap1 was abolished when the amino-
terminus was truncated at amino acid position 83, whereas truncations at positions 118, 168 
and 246 did not disrupt the interaction with Nipsnap1 (Figure 3A). The association between 
the carboxyl-terminus of TRPV6 and Nipsnap1 was observed with all truncated proteins 
used (Figure 3B), indicating that an essential binding domain is present within the smallest 
investigated binding region, i.e. just after the last transmembrane segment of TRPV6. 
 
Nipsnap1 inhibits TRPV6 activity 
To study the physiological role of Nipsnap1 and TRPV6 interaction, the activity of the 
channel was investigated by whole-cell patch clamp measurements in HEK293 cells 
transiently co-expressing Nipsnap1 and/or TRPV6. Steeply inward rectifying currents 
carried by Na+ could be measured in HEK293 cells co-expressing TRPV6 and empty vector 
(mock) (Figure 4A). These currents were abolished in cells co-expressing TRPV6 and 
Nipsnap1 (Figure 4A). Likewise, Nipsnap1 co-expression significantly reduced the Ca2+ 
current in response to a hyperpolarizing voltage step in TRPV6-expressing cells (Figure 
4B), while the Ca2+-dependent inactivation of the currents in the TRPV6 and mock co-
transfected cells remained unchanged. In addition, Nipsnap1 was purified and applied via 
► Figure 3. Nipsnap1 binding motifs in TRPV6. VSV-Nipsnap1 was incubated with GST, or 
with GST fused to TRPV6 amino- (A) and carboxyl-terminal (B) truncations as indicated, and 
subsequently analyzed by immunoblotting using anti-VSV antibodies. Input control 
represents 2.5 % of the total pull-down input. Depicted TRPV6 amino acid sequences: “m” = 
Mus musculus, “r” = Rattus norvegicus, “h” = Homo sapiens. Conserved amino acids are 
boxed in gray.  
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the patch pipette into TRPV6-expressing cells during the whole cell patch-clamp 
configuration. Via this approach it was shown that Nipsnap1 significantly inhibits TRPV6-
mediated Na+ and Ca2+ currents as well (Figure 5A,B), whereas it did not change the 
electrophysiological characteristics of the currents traced.  
 
Effect of Nipsnap1 on TRPV6 cell surface expression 
To investigate whether Nipsnap1 affects TRPV6 activity by influencing its expression at 
the plasma membrane, cell surface biotinylation was applied to HEK293 cells expressing 
eGFP-TRPV6 and VSV-Nipsnap1, or eGFP-TRPV6 and mock. Co-expression of Nipsnap1 
did not change the plasma membrane expression of eGFP-TRPV6 (Figure 6, upper panel). 
The total expression of Nipsnap1 was determined in the total cell lysates of each condition 
tested (Figure 6, lower panel). 
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DISCUSSION 
 
The present study identified the first physiological function of Nipsnap1 as a negative 
modulator of TRPV6-mediated Ca2+ influx. This conclusion is based on the following 
observations: First, co-precipitation experiments revealed that Nipsnap1 interacts with 
TRPV5 and TRPV6. Second, Nipsnap1 is ubiquitously expressed; however, its 
physiological relevance seems to be restricted to TRPV6 when compared with TRPV5. 
Third, electrophysiological recordings showed that TRPV6 currents were blocked both in 
an over-expression situation of Nipsnap1 in TRPV6-expressing cells as well as by 
Nipsnap1 protein infusion into TRPV6-expressing cells. Forth, cell surface labeling assays 
revealed that TRPV6 plasma membrane expression was not affected by Nipsnap1, 
suggesting that TRPV6 inhibition by Nipsnap1 is not due to reduced cell surface channel 
abundance. 
     Bioinformatical analysis of co-expression data was used to search for putative 
bbbbbbbbb 
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TRPV5/6-associated proteins. This approach revealed a number of associated KOGs, as 
listed in Table 1, that have a relatively strong correlated gene expression with TRPV5/6. By 
subsequent detailed analysis of the list for candidates with a putative role in (ion) transport 
function, trafficking, scaffolding, the Nipsnap KOG was selected for further experimental 
analysis.  
     Nipsnap1 is a member of an evolutionary well-conserved gene family with a putative 
role in vesicular trafficking since in Caernohabditis elegans Nipsnap localizes to a 
polycistronic operon encoding 4-nitrophenylphosphatase and SNAP25-like proteins 29. 
SNAP25 is involved in lipid bi-layer fusion as a t-SNARE by docking a vesicle to its target 
membrane. However, at present limited empirical evidence is available indicating that the 
NIPSNAP protein family actually is involved in vesicular trafficking. The localization of 
GFP-tagged TassC (target for Salmonella secreted protein C), a NIPSNAP homologue 
originally annotated as Nipsnap4, to distinct vesicular structures in phagocytic cells (i.e. 
macrophages) favors the hypothesis of a function in vesicular trafficking. TassC/Nipsnap4 
was identified by yeast two-hybrid screening as an interacting partner of the Salmonella 
virulence protein SpiC 30. SpiC interferes with intracellular trafficking in host cells of 
Samonella enterica by preventing the maturation of early endosomes and their fusion with 
lysosomes 31. Indicated by the survival of a SpiC-deficient Salmonella strain in Nipsnap4 
knockdown macrophages, Nipsnap4 was identified to act as a host cell factor. Together, 
Lee et al. were able to show that Nipsnap4 determines vesicular trafficking in macrophages 
and that it is inactivated by Salmonella SpiC - thereby enabling host cell infection. Thus, 
although the normal function of the Nipsnap protein family remains elusive they share 
bbbb   
 
Figure 4. Inhibition of TRPV6-mediated Na+ and Ca2+ currents by Nipsnap1. HEK293 cells 
were transiently transfected with TRPV6 and mock, or with TRPV6 and Nipsnap1, and 
subsequently analyzed by whole-cell patch clamp. (A) Current-voltage (I/V) relations 
measured from ramp protocol in nominally DVF solution from control (TRPV6 and mock, 
solid trace) and TRPV6/Nipsnap1-transfected cells (dashed trace). The I/V curve shows 
inward rectification typical for TRPV6 (solid trace), which is abolished by co-expression of 
Nipsnap1 and TRPV6 (dashed trace). The averaged Na+ current densities at -80 mV in 
nominally DVF solution were 670 ± 72 pA/pF for TRPV6 control cells (TRPV6/mock) 
compared to 11 ± 2 pA/pF for TRPV6/Nipsnap1 co-expressing cells (n = 5 cells for each 
condition). (B) Averaged Ca2+ currents measured with 10 mM Ca2+ in the extracellular 
solution using the step protocol in control (TRPV6 and mock, solid trace) and 
TRPV6/Nipsnap1 co-expressing cells (dashed trace). The averaged density of the Ca2+ peak 
current measured was 198 ± 20 pA/pF for TRPV6 control cells (n = 6 cells) compared to 22 ± 
6 pA/pF for cells co-transfected with TRPV6 and Nipsnap1 (n = 5 cells). * indicates 
significant difference (p < 0.002). 
 ◄ 
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characteristics generally important for ion channel functioning.  
     The regulation of Nipsnap1 mRNA has not yet been described; however, the different 
members of the Nipsnap gene family are ubiquitously expressed at the mRNA level in 
human tissues 29, 30, 32. Moreover, our Nipsnap1 RT-PCR data indicates that Nipsnap1 is 
expressed in (re-)absorptive Ca2+-transporting tissues, which supports a putative 
bbbbbbbbb 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Nipsnap1 infusion in cells inhibits TRPV6-mediated Na+ and Ca2+ currents. 
HEK293 cells were transiently transfected with TRPV6 and infused with GST-Nipsnap1 or 
GST alone (CTRL) and analyzed by whole-cell patch clamp. (A) I/V relations measured from 
ramp protocol in nominally DVF solution from GST-infused (solid trace) and GST-
Nipsnap1-infused cells (dashed trace). The average Na+ current density at -80 mV in 
nominally DVF solution was 1358 ± 120 pA/pF for CTRL and 480 ± 100 pA/pF for cells 
infused with GST-Nipsnap1 (n = 5 cells for each condition). (B) Averaged Ca2+ currents 
measured with 10 mM Ca2+ in the extracellular solution using the step protocol in GST-
infused cells (solid trace) and GST-Nipsnap1-infused cells (dashed trace). The average 
density of the Ca2+ peak current measured was 614 ± 85 pA/pF for CTRL and 170 ± 25 
pA/pF for cells infused with GST-Nipsnap1 (n = 5 cells for each condition). * indicates 
significant difference (p < 0.001). 
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physiological function of Nipsnap1 in the regulation of the Ca2+ balance. To maintain 
correct body Ca2+ homeostasis, TRPV5 and TRPV6 have been characterized to be 
functionally expressed in kidney and intestine, respectively (reviewed in 1). Given these 
findings, we decided to study the functional role of Nipsnap1 for TRPV6 only, since 
Nipsnap1 and TRPV5 do not co-localize in the renal cortex.  
     Nipsnap1 interacts with conserved amino- and carboxyl-terminal domains of TRPV6 
and the physiological role of the binding to TRPV6 was studied by whole-cell patch clamp 
analysis. This revealed that Nipsnap1 abolished TRPV6-mediated Na+ and Ca2+ currents, 
thereby being the most potent inhibitor of TRPV6 activity identified at present. To further 
substantiate that abolishment of TRPV6-mediated currents was an effect of Nipsnap1, 
TRPV6-expressing HEK293 cells were infused with purified Nipsnap1 protein via a 
ruptured membrane patch. Together, the electrophysiological recordings of the over-
expressing cells and the infused cells revealed a strong negative correlation between 
increased Nipsnap1 presence and TRPV6 activity.  
     Nipsnap1 can act at different intracellular processes to regulate TRPV6 activity; first, it 
may control the trafficking pathway of TRPV6 from ER/Golgi towards the plasma 
membrane; second, it possibly affects the recycling of TRPV6 from and towards the plasma 
membrane; or third, it could influence the durability of active TRPV6 at the plasma 
membrane. As it was shown that Nipsnap1 inhibits TRPV6 activity, this may be explained 
b 
 
 
 
 
 
 
 
 
 
 Figure 6. Cell-surface expression of TRPV6. HEK293 cells were transfected with eGFP-
TRPV6 and mock, or eGFP-TRPV6 and VSV-Nipsnap1. The extracellular parts of the 
proteins were biotinylated, precipitated with neutravidin beads and immunoblotted for 
TRPV6 and Nipsnap1 to visualize the plasma membrane fraction (“plasma membrane”, right 
panels). Samples of the lysed cells (“total cell lysates”, left panels) were immunoblotted in 
parallel to visualize the amount of expressed proteins. As negative controls, mock cells were 
used and for TRPV6-transfected cells biotin was omitted from the procedure (indicated as 
“w/o biotin”). 
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by a reduced cell surface expression of TRPV6 or by a decreased activity of channels 
present at the plasma membrane. The initial characterization of TRPV6 revealed that this 
channel displays constitutive activity 1. Therefore, changes in channel abundance at the cell 
surface are an efficient way to regulate Ca2+ entry. Furthermore, since both Na+ and Ca2+ 
currents through TRPV6 were inhibited by Nipsnap1, and thus affecting not specifically the 
Ca2+ conductance of the channel, disturbed trafficking of TRPV6 towards the cell surface 
might trigger the effect. However, by cell surface biotinylation it was demonstrated that 
TRPV6 plasma membrane expression is not affected by Nipsnap1. Thus, the decreased 
activity of TRPV6 observed by whole cell patch clamp analysis is likely mediated via a 
direct inhibition of TRPV6 activity at the cell surface.  
     In conclusion, this study demonstrates that Nipsnap1 can modulate TRPV6-mediated 
Ca2+ entry. Nipsnap1 likely regulates the activity of TRPV6 present at the cell surface, 
thereby suggesting that the family of Nipsnap proteins is able to affect physiological 
processes via mechanisms independent of vesicular trafficking. 
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Chapter 4 
SUMMARY 
 
The extracellular Ca2+-sensing receptor (CaR) is a key-player in plasma Ca2+ homeostasis. 
It is essentially expressed in the parathyroid glands and along the kidney nephron. The 
distal convoluted tubules (DCT) and connecting tubules (CNT) in the kidney are involved 
in active Ca2+ reabsorption, but the function of the CaR has remained unclear in these 
segments. Here, the Ca2+-selective Transient Receptor Potential Vanilloid-subtype 5 
channel (TRPV5) determines active Ca2+ reabsorption by forming the apical entry gate. In 
this study we show that the CaR and TRPV5 co-localize at the luminal membrane of 
DCT/CNT. Furthermore, by patch-clamp and Fura-2-ratiometric measurements we 
demonstrate that activation of the CaR leads to elevated TRPV5-mediated currents and 
increases intracellular Ca2+ concentrations in cells co-expressing TRPV5 and the CaR. 
Activation of the CaR initiated a signaling cascade that activated phorbol 12-myristate 13-
acetate (PMA)-insensitive protein kinase C (PKC) isoforms. Importantly, mutation of two 
putative PKC phosphorylation sites, S299 and S654, in TRPV5 prevented the stimulatory 
effect of CaR activation on channel activity, as did a dominant negative CaR construct, 
CaRR185Q. Interestingly, the activity of TRPV6, TRPV5’ closest homologue, was not 
affected by the activated CaR. We conclude that activation of the CaR stimulates TRPV5-
mediated Ca2+ influx via a PMA-insensitive PKC isoform pathway.  
 
INTRODUCTION  
 
Maintenance of body Ca2+ homeostasis is of vital importance for many physiological 
functions including intracellular signaling processes, neuronal excitability, muscle 
contraction and bone formation. The extracellular free ionized Ca2+ concentration ([Ca2+]e) 
is maintained by a homeostatic mechanism tightly controlling the concerted actions of 
intestinal Ca2+ absorption, renal Ca2+ reabsorption and exchange of Ca2+ to and from bone. 
Changes in [Ca2+]e are sensed in different tissues by a Ca2+-sensing receptor (CaR). The 
cloning and functional characterization of the CaR from parathyroid 1, kidney 2 and other 
cell types 3-5 has clarified the mechanisms through which Ca2+ exerts its direct actions on 
various cells and tissues. In the parathyroid glands, the CaR mediates the inhibitory effect 
of elevated blood ionized Ca2+ on parathyroid hormone (PTH) secretion, the body’s main 
calciotropic hormone. As a G protein-coupled receptor (GPCR), the CaR determines 
intracellular signaling cascades that result in oscillations of intracellular Ca2+ concentration 
([Ca2+]i), and activation of mitogen-activated protein kinases 6. In addition to the signaling 
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cascade of the CaR, which leads to reduced PTH secretion, sustained CaR activation 
influences the expression of the PTH gene 7 and parathyroid cell proliferation 8. 
Furthermore, the CaR is expressed in other tissues implied in maintaining body calcium 
homeostasis as well; i.e. intestine 5, kidney 9 and bone 10. 
In kidney, CaR protein expression is prominently observed in proximal tubules, thick 
ascending limbs (TAL) of Henle’s loop, and (medullary) collecting tubules 11,12. Notably, 
the side of the cell at which the CaR is detected in these segments of the nephron differs. In 
proximal tubules, the CaR is expressed in apical brush-border membranes, while in TAL 
the receptor is found at the basolateral side 11,13. Finally, in cortical and inner medullar 
collecting ducts the CaR is localized on the luminal membrane 11,12,14. Whereas the role of 
CaR in TAL has been clearly demonstrated 12,15,16, the functional importance of CaR 
expressed in distal convoluted tubules (DCT) and connecting tubules (CNT) - where active 
Ca2+ reabsorption takes place 17 - remains elusive. The DCT and CNT account for ~15 % of 
total renal Ca2+ reabsorption and are generally considered as the fine-tuning sites of urinary 
Ca2+ excretion 17. Here, in the apical compartment, the Transient Receptor Potential 
Vanilloid-subtype 5 (TRPV5) channel is the gatekeeper for active Ca2+ reabsorption 18,19. 
TRPV5 is a specialized epithelial ion channel that is remarkably selective for Ca2+ (PCa/PNa 
~ 100) 20. The channel is characterized by an inward rectifying signature of the current-
voltage (I/V) relation 20 that determines its activity. 
Thus, from previous studies, the CaR and TRPV5 appear to be expressed in the 
DCT/CNT. However, whether they co-localize and are functionally coupled was not 
known.  The aim of the present study was, therefore, to investigate the functional link 
between the CaR and TRPV5. To this end, the putative role of the CaR in regulating 
TRPV5 activity was assessed using a combined approach including immunohistochemical 
labeling, [Ca2+]i measurements and patch-clamp recordings. 
 
MATERIALS AND METHODS  
 
Immunohistochemistry 
Tissue samples from surgically resected kidneys were collected under Local Research 
Ethics Committees protocols, and all patients gave informed consent. Samples were 
dissected from primary renal cell carcinomas and corresponding non-neoplastic kidney 
tissue. Parts of the tissue were snap frozen in liquid nitrogen and mounted in OCT 
compound on dry ice. 4 µm sections were cut from the resulting normal human kidney 
frozen OCT block onto strongly adhesive Superfrost Plus slides (Thermo scientific, 
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Waltham, MA, USA) and stored at -80 °C. Upon use, the sections were heated to 37 °C for 
20 min, washed in Tris-buffered saline-Tween 20 (TBS-T), and fixed in methanol at -20 °C 
for 20 min. Immunohistochemistry was performed using the Renaissance TSA 
Fluorescence Tyramide Signal Amplification Kit (Perkin Elmer, Waltham, MA, USA). 
Peroxidase activity within the rehydrated tissue was quenched using 0.3 % H2O2 for 10 
min. Non-specific primary antibody binding was prevented by incubating the sections with 
TNB blocking buffer for 30 min. The first primary antibody (guinea pig anti-TRPV5 19, 
1:100) was incubated on the sections for 1 h and subsequently washed off using Phosphate-
buffered saline-Tween 20 (PBS-T). Next, the sections were incubated with a horse radish 
peroxidase-labelled anti-guinea pig secondary antibody (Abcam, Cambridge, UK; 1:500) 
for 30 min. After washing, a working solution of amplification reagent (TSA kit) was 
applied for 10 min. Sections were again thoroughly washed with PBS-T and then blocked 
with serum-free protein block (DAKO, Carpinteria, CA, USA) for 10 min. The second 
primary antibody (rabbit anti-CaR; United States Biological, Swampscott, MA, USA; 
1:200) was applied to the sections for 1 h. After several thorough PBS-T washes, the 
sections were incubated with a fluorescent secondary antibody (Chicken anti-rabbit IgG 
594; Molecular Probes, Eugene, OR, USA; 1:400) for 1 h and counterstained with a 
Hoechst nuclear stain (1:10000 dilution of a 10 mg/ml stock solution) for 10 min. The 
slides were then mounted using Prolong Gold mounting medium (Molecular Probes) for 
long-term storage. As negative controls, the primary antibody was either omitted (TRPV5 
labeling) or replaced by an irrelevant rabbit IgG antibody (DAKO, Carpinteria, CA, USA) 
(CaR labeling). Photographs were taken with an Olympus BX61 microscope. 
 
DNA constructs and cell culture 
The rabbit TRPV5-pCINeo/IRES-GFP and mouse TRPV6-pCINeo/IRES-GFP vectors 
were generated as described previously 21,22. Single and combined protein kinase C (PKC) 
TRPV5 mutants were generated by alanine amino acid substitution of the six putative 
phosphorylation sites (S144A, S299A, S316A, S654A, S664A, S698A) using in vitro 
mutagenesis (Quick-Change Site-Directed Mutagenesis kit, Stratagene, La Jolla, CA, 
USA). The carboxyl-terminally GFP-tagged human CaR in the pcDNA3.1 vector was 
generated as described previously 23. Human embryonic kidney-293 (HEK293) cells were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) (BioWhittaker, Walkersville, 
MD, USA) containing 10 % (v/v) fetal calf serum, 2 mM L-glutamine, 0.1 % (w/v) 
NaHCO3, 0.1 mM Gibco MEM non essential amino acids (Invitrogen, Carlsbad, CA, USA) 
and 10 μg/ml ciproxin at 37 °C in a humidity-controlled incubator with 5 % (v/v) CO2. 
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Cells were transiently transfected at 70 % of confluence using Lipofectamin 2000 
(Invitrogen Life Technologies, Breda, The Netherlands). After 24-48 h, cells were used for 
Fura-2 or patch-clamp experiments. Prior to the assays, cells were incubated for 1 h in 
serum-free medium containing neomycin (Neo) or L-phenylalanine (L-Phe) (Sigma, St 
Louis, MO, USA). Serum-free medium was used to minimize the risk of atypical responses 
that may activate the CaR. To down-regulate the phorbol-12-myristate-13-acetate (PMA)-
sensitive PKC isoforms 24 cells were incubated overnight with PMA. 
 
Fura-2 measurements 
Intracellular Ca2+ concentration measurements were performed as described previously 
25,26. Shortly, HEK293 cells co-transfected with the CaR and TRPV5 or empty vector were 
loaded for 20 minutes with 3 µM Fura-2 AM (Invitrogen, Leiden, The Netherlands) in the 
presence of 100 nM pluronic (Invitrogen, Leiden, The Netherlands) and 500 µM 
probenecid (Sigma, St Louis, MO, USA) in DMEM and incubated at 37 °C before starting 
the measurements. Since phenol red in DMEM interferes with the Fura-2 recordings, the 
experiments were performed in HEPES/Tris buffer (132.6 mM NaCl, 5.8 mM glucose, 4.2 
mM KCl, 1 mM MgCl2 and 1.2 mM CaCl2, 10 mM HEPES,  pH 7.4  with Tris) 
supplemented with 500 µM probenecid. At the specified time-points, neomycin was added 
from a stock solution to reach a final concentration of 200 µM in the recording chamber. 
The Fura-2 dye was excited alternatively at 340 and 380 nm using a monochromator 
(Polychrome IV; TILL Photonics, Gräfelfing, Germany). Fluorescence emission light 
wavelength was directed by a 560DRLP dichroic mirror (Omega Optical, Brattleboro, VT, 
USA) through a 565ALP emission filter (Omega) on a CoolSNAP HQ monochrome 
charge-coupled device (CCD) camera (Roper Scientific, Vianen, The Netherlands). All 
hardware was controlled by Metafluor 6.0 software (Universal Imaging, Downingtown, 
PA, USA). 
 
Electrophysiology and solutions 
Patch-clamp experiments were performed as described previously 20 in the tight seal 
whole-cell configuration at room temperature using an EPC-9 patch-clamp amplifier 
computer controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany). Two 
voltage protocols were used: a ramp from -100 to +100 mV with a holding potential of +20 
mV, to establish the current-voltage (I/V) relation in nominally divalent-free (DVF) 
solution or in 10 mM Ca2+-containing extracellular solutions, and a hyperpolarizing step 
protocol to -100 mV to measure the Ca2+-dependent inactivation. Both TRPV5 and TRPV6 
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channels conduct monovalent ions when Ca2+ ions are omitted from the extracellular 
solution 27. Na+ current densities were calculated from the current at -80 mV during the 
ramp protocols while the Ca2+ currents values were extracted from the peak current at –100 
mV during the step protocol. The standard extracellular solution (Krebs) contained: 150 
mM NaCl, 6 mM CsCl, 1 mM MgCl2, 10 mM HEPES/NaOH, pH 7.4, and 10 mM glucose. 
DVF solutions did not contain added divalent cations, whereas trace amounts of divalent 
cations were removed with 100 µM EDTA. The standard internal (pipette) solution 
contained: 20 mM CsCl, 100 mM Cs-aspartate, 1 mM MgCl2, 4 mM Na2ATP, 10 mM 
BAPTA, 10 mM HEPES/CsOH, pH 7.2. Cells were kept in nominal Ca2+-free medium to 
prevent Ca2+ overload and exposed for a maximum of 5 min to a Krebs solution containing 
1.5 mM Ca2+ before sealing the patch pipette to the cell. The analysis and display of patch-
clamp data were performed using Igor Pro software (WaveMetrics, Lake Oswego, OR, 
USA). 
 
Statistical analysis 
In all experiments, data is expressed as mean ± SEM. Overall statistical significance was 
determined by analysis of variance. In case of significance, differences between the means 
of two groups were analyzed by unpaired Student’s t-test, while multiple comparisons 
between groups were performed by Bonferroni post hoc tests. p < 0.05 was considered as 
significant. 
 
RESULTS 
 
CaR co-localizes with TRPV5 at the apical membrane of DCT/CNT 
The localization of TRPV5 and the CaR was investigated in human frozen kidney sections 
by immunohistochemical staining. TRPV5 and the CaR co-localized at the apical 
membrane of the DCT/CNT, and sub-apically in vesicular structures (Figure 1). CaR 
expression was also observed in areas at the apical membrane where TRPV5 was not 
expressed (indicated by arrowheads in Figure 1). 
 
CaR activation stimulates TRPV5 activity  
The potential role of the CaR regulating TRPV5 activity was first investigated by 
measuring changes in [Ca2+]i with the Ca2+-sensing dye Fura-2. Non-transfected HEK293 
cells do not endogenously express the CaR 28, which was confirmed in our study since 
application of the known CaR agonist neomycin (200 µM) failed to increase [Ca2+]i (Figure  
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Figure 1. Co-localization of the CaR and TRPV5 in DCT/CNT segments of human kidney 
cortex. Kidney sections were co-stained with antibodies against the CaR and TRPV5. 
Immunopositive co-staining at the apical side and in sub-apically localized vesicular 
structures is shown for the CaR (red) and TRPV5 (green). A full color image can be found at 
www.physiology-nijmegen.nl > ion transport > publications. Arrows point to areas of co-
localization, and arrowheads indicate regions were the CaR is expressed, but not TRPV5. 
Images are 20 x magnifications and insets 100 x. 
2A). Subsequently, HEK293 cells were co-transfected with the CaR and an empty vector, 
or with the CaR and TRPV5. Activation of the CaR with neomycin significantly increased 
[Ca2+]i of cells co-transfected with the CaR and empty vector (140 ± 4 %), and of those co-
expressing the CaR and TRPV5 (138 ± 3 %), as depicted in Figure 2A. 
     To address the effect of CaR activation on TRPV5-mediated currents, HEK293 cells 
were co-transfected with the CaR and TRPV5, or with an empty vector, and incubated for 1 
h with the membrane-impermeant CaR agonists neomycin (200 µM) or L-phenylalanine 
(L-Phe; 3.5 mM).  Subsequently, the cells were functionally characterized using whole 
cellpatch-clamp measurements. The amplitude of the inward-rectifying Na+ currents 
measured at -80 mV from the neomycin- or L-Phe-treated cells (Figure 2B,C) was 
significantly increased compared to non-treated control cells, as depicted in Figure 2C, 
whereas the current-voltage relation (I/V) of the currents remained unaffected. Pre-
incubation with either neomycin or L-Phe increased the inward Ca2+ currents elicited by the 
step protocol, without affecting the Ca2+-dependent inactivation of the TRPV5 currents 
(Figure 2D,E). 
     The specificity of the effect of CaR activation on TRPV5-mediated currents was 
investigated using HEK293 cells transfected with TRPV5 alone. When these cells were 
incubated with 200 µM neomycin for 1 h, the I/V relation (Figure 3A) and the amplitude at 
-80 mV (Figure 3B) of the TRPV5-mediated Na+ currents remained identical to those 
observed in non-treated control cells. Moreover, Ca2+-dependent inactivation and the peak 
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value of the TRPV5-mediated inward Ca2+ currents recorded from the neomycin-stimulated 
cells were similar to the traces measured in control cells (Figure 3C,D). 
     To specifically address the role of the CaR in the observed increased activity of TRPV5, 
a loss-of-function CaR mutant (CaRR185Q) 29,30 was used. Transient expression of CaRR185Q 
in HEK293 cells has previously been shown to substantially attenuate Ca2+-evoked 
accumulation of total inositol phosphates (IP), while co-transfection of normal and mutant 
receptors showed an EC50 (the level of [Ca2+]e eliciting a half-maximal increase in IPs) 37 
% higher than for the wild-type CaR alone 29. Therefore, it appears that CaRR185Q exerts a 
dominant negative effect over the wild-type receptor. CaRR185Q was co-transfected with 
TRPV5 in HEK293 cells, stimulated with neomycin, and analyzed by the patch-clamp 
whole cell configuration. The I/V relation and the current amplitude at -80 mV of TRPV5-
mediated Na+ currents measured from the neomycin-incubated cells (Figure 4A,B) were not  
significantly different from currents measured in non-treated control cells. The Ca2+- 
dependent inactivation (Figure 4C) as well as the peak value (Figure 4D) of the inward 
Ca2+ currents also remained unaffected after neomycin stimulation, compared to non-
treated control cells. 
To determine the specificity of the effect of CaR on TRPV5-mediated currents, TRPV6 
- the closest relative of TRPV5 - was co-transfected with the CaR in HEK293 cells. After 
stimulation of the CaR with neomycin, TRPV6-mediated inward Na+ currents recorded 
with the ramp protocol were not different in their I/V relation (Figure 5A) or amplitude at -
80 mV (Figure 5B) compared to non-treated control cells. Likewise, the Ca2+-dependent 
bbbbbb 
► Figure 2. Functional correlation between the CaR and TRPV5 co-expressed in HEK293 
cells. (A) Ratiometric Fura-2 measurements from cells co-transfected with the CaR and 
TRPV5 (filled circles) or the CaR and empty vector (empty circles), or non-transfected cells 
(squares), stimulated with neomycin (200 µM) at the time point indicated by the arrow. (B) 
I/V relations, measured using voltage ramps in DVF extracellular solution, from HEK293 
cells co-transfected with the CaR and TRPV5, incubated with neomycin (dotted trace) or 
with L-Phe (dashed trace), or non-treated (solid trace). (C) Average Na+ currents density at -
80 mV in DVF solution were 575 ± 80 pA/pF (n = 12 cells) and 580 ± 95 pA/pF (n = 8 cells) 
for cells treated with neomycin or with L-Phe, respectively, compared to 405 ± 40 pA/pF for 
control (CTRL), non-treated cells (n = 10 cells). (D) Averaged Ca2+ currents, measured with 
10 mM Ca2+ in the extracellular solution using the step protocol, from CaR and TRPV5 co-
transfected HEK293 cells treated with neomycin (dotted trace), or treated with L-Phe (dashed 
trace), or non-treated (solid trace). (E) Averaged density of the Ca2+ peak current measured 
as in (D) was 220 ± 25 pA/pF (n = 12 cells) for neomycin-treated cells and 239 ± 40 pA/pF (n 
= 8 cells) for L-phe-treated cells, compared to 118 ± 10 pA/pF (n = 10 cells) for CTRL, non-
treated cells. *p < 0.05 vs. CTRL cells. 
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inactivation of the TRPV6 currents (Figure 5C) and the peak Ca2+ current recorded with the 
step protocol from neomycin-treated cells were comparable to non-treated control cells 
(Figure 5D). 
 
Phosphorylation of TRPV5 by PKC is required for CaR-dependent channel 
activation 
To elucidate the molecular mechanism downstream of CaR activation leading to increased 
TRPV5 activity, a sextuple PKC phosphorylation deficient mutant of TRPV5 having all 
putative PKC phosphorylation sites in TRPV5 changed to alanines was co-transfected with 
the CaR in HEK293 cells. Subsequent to neomycin incubation, the inward rectification of 
bb 
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the I/V relation (Figure 6A), as well as the amplitude at -80 mV of the Na+ currents, were 
measured and were not significantly different from non-treated control cells (Figure 6B). 
The peak value and the Ca2+-dependent inactivation of the inward Ca2+ currents were 
unaffected by neomycin when compared to non-treated control cells (Figure 6C,D). 
Subsequently, the putative PKC phosphorylation sites were individually mutated into an 
alanine residue. Stimulation of the CaR with neomycin increased Ca2+ currents of all single 
TRPV5-PKC mutants except of S299A and S654A (Figure 6E).  
     To determine which of the PKC isoforms was involved in the increased TRPV5-
mediated currents consequent to CaR activation, HEK293 cells were incubated overnight 
with 1 µM of phorbol ester (PMA) to down regulate the PMA-sensitive PKC isoforms. 
Then, the PMA- pretreated cells were incubated with 200 µM neomycin for 1 h. CaR 
bbbbb 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. CaR activation is required to increase TRPV5-mediated currents. (A) I/V relations 
measured using voltage ramps in DVF extracellular solution from TRPV5-transfected 
HEK293 cells treated with neomycin (dotted trace), or non-treated (solid trace). (B) 
Averaged Na+ currents densities at -80 mV in DVF solution were 1185 ± 125 pA/pF (n = 8 
cells) for neomycin-treated cells compared to 1200 ± 125 pA/pF for CTRL cells (n = 6 cells). 
(C) Averaged Ca2+ currents, measured with 10 mM Ca2+ in the extracellular solution using 
the step protocol, from TRPV5-transfected HEK293 cells treated with neomycin (dotted 
trace), or non-treated (solid trace). (D) Averaged density of the Ca2+ peak current measured 
as in (C) was 305 ± 40 pA/pF (n = 8 cells) for neomycin-treated cells compared to 280 ± 38 
pA/pF (n = 6 cells) for CTRL cells.  
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activation increased the TRPV5-mediated Na+ (Figure 7B) and Ca2+ currents (Figure 7D) 
vs. non-treated CaR activation increased the TRPV5-mediated Na+ (Figure 7B) and Ca2+ 
currents (Figure 7D) vs. non-treated control cells. The I/V relations (Figure 7A) and the 
Ca2+-dependent inactivation (Figure 7C) remained identical to control cells. Overnight 
incubation with PMA had no effect on control TRPV5-mediated currents, which is in line 
with previous findings 31. 
 
DISCUSSION 
 
The present study demonstrated that activation of the CaR stimulates TRPV5 activity. This 
conclusion is based on the following experimental data. First, the CaR and TRPV5 co-
localize at the luminal membrane of the DCT/CNT. Second, both Ca2+ and Na+ TRPV5-
mediated currents were stimulated after CaR activation by neomycin or L-Phe. Third, CaR 
stimulation influences specifically TRPV5, since the currents of its closest relative, 
TRPV6, were unaffected. Fourth, obstruction of the CaR signaling pathway using a 
dominant negative mutant of the CaR normalized the amplitude of the TRPV5-mediated 
currents to their non-stimulated values. Fifth, the stimulatory effect of CaR activation on 
TRPV5-mediated currents was mediated via the PKC pathway and required two conserved 
PMA-insensitive PKC phosphorylation sites (S299 and S654) in TRPV5. 
     Immunolocalization studies in rats revealed that the CaR is expressed essentially 
throughout the whole nephron with highest levels in the TAL 9. In this nephron segment, 
where it is expressed at the basolateral membrane, CaR inhibits passive Ca2+ reabsorption 
by reducing the negative potential that drives this process 13,16. In contrast to TAL, we 
showed that the CaR is apically expressed in DCT and CNT, where Ca2+ reabsorption 
occurs against a concentration gradient via an active mechanism in which TRPV5 plays a 
crucial role. Our immunohistochemistry data also demonstrated partial co-localization of 
the CaR and TRPV5 in vesicular structures sub-apically. This possibly indicates that the 
CaR recruits to the luminal membrane together with TRPV5. Electrophysiological 
recordings revealed that the CaR enhanced TRPV5 activity and, therefore, that this effect 
may account for distinct roles of the CaR in DCT and CNT compared to the TAL. In the 
proximal segments CaR senses [Ca2+]e in the blood contributing to the passive reabsorption 
of Ca2+. However, in DCT and CNT the apically expressed CaR is likely activated by 
increased [Ca2+]e in the pro-urine and thereby stimulates active Ca2+ reabsorption. This 
latter process suggests a local feedback mechanism in DCT and CNT, activated by 
increased [Ca2+]e in the pro-urine, besides the hormonal regulation that responds to [Ca2+]e 
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in the blood. Ultimately, this mechanism could minimize the Ca2+ loss via the urine by 
stimulating active Ca2+ reabsorption.  
     Interestingly, an earlier study by Blankenship et al. 32 showed that in Madin-Darby 
Canine Kidney (MDCK) cells – serving as a cell model for the distal convoluted tubule – 
activation of the basolateral CaR inhibits Ca2+ transport by decreasing PMCA activity. 
Although these findings need to be confirmed in vivo, the data suggests that PMCA activity 
is down-regulated upon sensing hypercalcemia by the CaR. Our results, however, point to 
hypercalciuria-induced activity of the apically expressed CaR. Together, these findings 
further indicate that the CaR manifests distinct regulatory roles depending on its cellular 
localization (apical vs. basolateral cell membrane). In addition, we previously showed that 
b 
      
Figure 4. TRPV5-mediated currents are unaffected by stimulation of CaRR185Q (A) I/V 
relations measured using voltage ramps in DVF extracellular solution from HEK293 cells co-
transfected with a dominant negative construct (CaRR185Q) and TRPV5 and treated with 
neomycin (dotted trace), or non-treated (solid trace). (B) Averaged Na+ currents densities at -
80 mV in DVF solution were 1000 ± 130 pA/pF (n = 8 cells) for neomycin-treated cells 
compared to 840 ± 215 pA/pF for CTRL cells (n = 5 cells). (C) Averaged Ca2+ currents, 
measured with 10 mM Ca2+ in the extracellular solution using the step protocol, from 
HEK293 cells co-transfected with the CaRR185Q and TRPV5 and treated with neomycin 
(dotted trace) or non-treated (solid trace). (D) Averaged density of the Ca2+ peak current 
measured as in (C) was 290 ± 40 pA/pF (n = 8 cells) for neomycin-treated cells compared to 
330 ± 90 pA/pF (n = 5 cells) for CTRL cells. 
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activation of another GPCR, the bradykinin receptor subtype 2 (B2R), by tissue kallikrein 
(TK) increases TRPV5-mediated Ca2+ reabsorption 31. TK acts from the tubular 
compartment as an auto- and/or paracrine factor to regulate active Ca2+ reabsorption, also 
supporting our hypothesis on the existence of local regulatory mechanisms in DCT and 
CNT for efficient control of the Ca2+ balance. 
     Activation of the CaR in both native and recombinant expression systems elicits 
intracellular Ca2+ release, most likely via IP3-mediated signaling down-stream of Gq. In our 
hands, we confirmed these findings and demonstrated that these responses are not affected 
by the presence of TRPV5. Indeed, an identical response was observed for cells co-
transfected with the CaR and an empty vector as well as for those co-transfected with the 
bb 
Figure 5. TRPV6 activity is unaffected upon CaR activation. (A) I/V relations measured using 
voltage ramps in DVF extracellular solution from HEK293 cells co-transfected with the CaR 
and TRPV6 and treated with neomycin (dotted trace), or non-treated (solid trace). (B) 
Averaged Na+ currents density at -80 mV in DVF solution were 423 ± 115 pA/pF (n = 8 cells) 
for neomycin-treated cells compared to 391 ± 42 pA/pF for CTRL cells (n = 13 cells). (C) 
Averaged Ca2+ currents, measured with 10 mM Ca2+ in the extracellular solution using the 
step protocol, from HEK293 cells co-transfected with the CaR and TRPV6, treated with 
neomycin (dotted trace), or non-treated (solid trace). (D) Averaged density of the Ca2+ peak 
current measured as in (C) was 102 ± 29 pA/pF (n = 8 cells) for neomycin-treated cells 
compared to 80 ± 10 pA/pF (n = 6 cells) for CTRL cells. 
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CaR and TRPV5. The lack of an expected [Ca2+]i increase in CaR and TRPV5 co-
transfected cells compared with CaR and mock co-transfected cells may result from the fast 
inactivation of the channel. The present study also demonstrated that CaR activation 
initiates a signaling pathway that activates PKC isoforms which in turn stimulate TRPV5 
activity. Moreover, by using chronic (overnight) PMA incubation to down-regulate α, β and 
ε isoforms of PKC, but not PKC ζ 24, we imply that a PMA-insensitive isoform of PKC is 
responsible for the enhanced TRPV5 currents upon activation of the CaR. This latter PKC 
isoform is presumably involved in the increase of TRPV5 currents since the measured 
stimulatory effect was similar to cells that were not treated overnight with PMA. Likewise, 
in primary cultures of rabbit kidney CNT and cortical collecting tubules, stimulation of 
active transepithelial Ca2+ transport also involves PMA-insensitive PKC isoforms 33. 
In a study of Davies and colleagues 34 it was shown that PKC-dependent feedback 
phosphorylation of the CaR is stimulated by activation of the CaR and subsequently 
increases CaR expression and its down-stream signaling. However, besides this feedback 
mechanism, the effect of PKC-dependent stimulation of TRPV5 activity should be specific 
for the channel since the activity of TRPV6 was not affected by activation of the CaR. 
     Our study delineated the conserved residues S299 and S654 as the PKC phosphorylation 
sites involved in the increased activity of TRPV5. Since the serine residue S654 is not 
conserved in TRPV6, this implies that both serines are apparently critical for the increase in 
TRPV5 activity upon activation of CaR. The absence of this serine residue in TRPV6 may 
explain its insensitivity to neomycin activation of the CaR. Interestingly, TRPV6 activity 
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► Figure 6. The effect of CaR activation on TRPV5-mediated currents involves the PKC 
signaling pathway. (A) I/V relations measured using voltage ramps in DVF extracellular 
solution from HEK293 cells co-transfected with the CaR and TRPV5 - mutated for all its six 
putative PKC phosphorylation sites - and treated with neomycin (dotted trace), or non-treated 
(solid trace). (B) Averaged Na+ currents densities at -80 mV in DVF solution were 806 ± 90 
pA/pF (n = 10 cells) for neomycin-treated cells compared to 846 ± 90 pA/pF for CTRL cells 
(n = 5 cells). (C) Averaged Ca2+ currents, measured with 10 mM Ca2+ in the extracellular 
solution using the step protocol, from HEK293 cells co-transfected with the CaR and TRPV5, 
treated with neomycin (dotted trace), or non-treated (solid trace). (D) Averaged density of the 
Ca2+ peak current measured as in (C) was 335 ± 35 pA/pF (n = 10 cells) for neomycin-treated 
cells compared to 319 ± 40 pA/pF (n = 5 cells) for CTRL cells. (E) Point mutation of the 
PKC phosphorylation site S299 or S654 did not affect Ca2+ currents in comparison with the 
other four PKC mutants upon CaR stimulation with neomycin. Data are expressed as 
percentage of Ca2+ currents measured from neomycin-treated cells transfected with the 
indicated point mutants of TRPV5 and are normalized to non-treated CTRL cells (n = 12 cells 
for each mutant). *p < 0.05 vs. CTRL cells. 
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was also unaffected by TK 31 that activates the B2R. Besides this, both CaR activation and 
TK-mediated B2R activation manifest their effect on the same PKC phosphorylation sites 
and both increase TRPV5 activity, suggesting a common mechanismdown-stream of a Gq-
protein-coupled receptor regulating TRPV5 functioning. In addition, future studies using 
cells expressing the S299 and S654 TRPV5 mutants together with the CaR or B2R that are 
analyzed by the whole cell perforated patch clamp configuration may even strengthen these 
findings. Importantly, the study of Gkika et al. 31 demonstrated that phosphorylation of 
TRPV5 amino acid residues S299 and S654 leads to increased plasma membrane 
expression and delayed channel retrieval from the cell surface, explaining the enlarged 
channel activity. This also suggests that stimulation of TRPV5-mediated currents upon CaR 
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Figure 7. TRPV5 activity is stimulated by PMA-insensitive PKC isoforms downstream of 
CaR activation. 24 hours incubation with 1 µM PMA was used to down-regulate the PMA-
sensitive PKC isoforms in cells co-transfected with the CaR and TRPV5. (A) I/V relations 
measured using voltage ramps in DVF extracellular solution from cells co-transfected with 
the CaR and TRPV5, treated with neomycin (dotted trace), or non-treated (solid trace). (B) 
Stimulation of the CaR with neomycin significantly increased TRPV5-mediated Na+ currents 
(1477 ± 180 pA/pF) compared to non-stimulated CTRL cells (881 ± 56 pA/pF) (n = 10-17 
cells for each condition). (C) Averaged Ca2+ currents, measured with 10 mM Ca2+ in the 
extracellular solution using the step protocol, from HEK293 cells co-transfected with the CaR 
and TRPV5 and treated with neomycin (dotted trace), or non-treated (solid trace). (D) 
Stimulation of the CaR with neomycin significantly increased TRPV5-mediated Ca2+ currents 
(294 ± 40 pA/pF) compared to non-stimulated CTRL cells (186 ± 14 pA/pF) (n = 10-17 cells 
for each condition). *p < 0.05 vs. CTRL cells. 
 
activation is initiated via an identical mechanism, rather than resulting from increased open 
probability of the channel. Thus, PKC phosphorylation of TRPV5 could regulate the 
balance between constitutive exocytosis and endocytosis in favor of the first leading to the 
accumulation of TRPV5 at the cell surface. This explanation is in agreement with the 
recent findings of Cha and co-workers 35, demonstrating that activated PKC inhibits 
constitutive caveolin-dependent endocytosis of TRPV5, leading to accumulation of the 
channel at the cell surface. Inhibition of caveolin-dependent endocytosis is mediated via 
 86
CaR activation stimulates TRPV5 
phosphorylation of the exact same serine residues as identified in the current study and that 
of Gkika et al. To initiate PKC-dependent phosphorylation of TRPV5, Cha et al. co-
expressed TRPV5 with the type 1 PTH receptor (PTH1R) in cells and activated the receptor 
with PTH. Together, these results show that differently (cation-, hormone-)activated Gq-
protein-coupled receptors (CaR, B2R, PTH1R) can initiate an identical PKC-dependent 
mechanism leading to phosphorylation of TRPV5 serine residues S299 and S654, which in 
turn increases TRPV5 activity via delayed channel retrieval. In conclusion, we postulate a 
functional role for the apically expressed CaR in DCT and CNT segments of the kidney, 
where TRPV5 is predominantly present. These results attest the existence of local feedback 
mechanisms that could rapidly adapt renal Ca2+ reabsorption to increased Ca2+ levels in the 
pro-urine independently of hormonal regulation. 
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Chapter 5 
SUMMARY 
 
Sex differences in renal handling of Ca2+ have previously been reported. However, the 
overall contribution of androgens to these sex differences remains uncertain. The aim of 
this study was to determine whether testosterone affects active renal Ca2+ reabsorption by 
regulating the Ca2+ transport proteins Transient Receptor Potential Vanilloid-subtype 5 
(TRPV5) and calbindin-D28K. Male mice, compared to females, had a higher urinary Ca2+ 
excretion accompanied by reduced renal expression of Ca2+ transporters. In addition, 
androgen deficient bilaterally orchidectomized (ORX) mice excreted less Ca2+ in their urine 
than sham-operated controls. ORX-induced hypocalciuria was normalized after 
testosterone replacement. Consistently, androgen deficiency resulted in augmentation of 
both renal mRNA and protein abundance of TRPV5 and calbindin-D28K, which in turn was 
suppressed by testosterone treatment. Importantly, no significant differences in serum 
estrogen, parathyroid hormone or 1,25-dihydroxyvitamin D3 levels were observed between 
control, ORX and testosterone-supplemented ORX mice. Moreover, androgens directly 
affect renal Ca2+ reabsorption, as primary cells of rabbit connecting tubules/cortical 
collecting ducts incubated with the selective non-aromatizable androgen 
dihydrotestosterone showed a reduced transcellular Ca2+ transport. In conclusion, this study 
demonstrates that sex differences in renal Ca2+ handling are in part mediated by the 
inhibitory actions of androgens on TRPV5-mediated active renal Ca2+ transport. 
 
INTRODUCTION  
 
Several studies have reported sex differences in the urinary Ca2+ excretion, showing a 
greater urinary Ca2+ loss in males than in females 1, 2. In addition, estrogens have been 
shown to increase the renal reabsorption of Ca2+, which is in good agreement with the 
observed gender differences 3. Presently, it remains unclear whether androgens play an 
opposing role to estrogens in modulating renal Ca2+ reabsorption. The androgen receptor 
(AR) is expressed in renal epithelial cells 4, and a growing body of evidence points to sex 
differences in various functional characteristics of mammalian kidneys; for example, a 
higher glomerular filtration rate in the male rat kidney (possibly due to higher renal plasma 
flow and lower vascular resistance) (reviewed in 5). However, the role of androgens in 
regulating renal Ca2+ handling remains poorly characterized.  
     In the kidney, Ca2+ re-enters the blood by passive paracellular as well as active 
transcellular reabsorption. The active Ca2+ reabsorptive component is restricted to the distal 
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convoluted tubules (DCT) and the connecting tubules (CNT) 6-9. Here, Ca2+ enters the 
epithelial cell via the highly Ca2+-selective ion channel Transient Receptor Potential 
Vanilloid-subtype 5 (TRPV5). Subsequently, Ca2+ is bound to calbindin-D28K that 
transports Ca2+ from the apical to the basolateral side where the Na+/Ca2+-exchanger 
(NCX1) and the plasma membrane ATPase (PMCA1b) extrude Ca2+ into the peritubular 
lumen 6.  
     Active Ca2+ reabsorption is critical in determining the final urinary Ca2+ excretion, and 
has been demonstrated to be regulated by calciotropic hormones, including parathyroid 
hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) 6, 10, 11. Estrogens have also 
been shown to affect the active regulation of the (renal) Ca2+ balance, although sex 
hormones are usually not considered as calciotropic factors 6, 12. 
     The present study aims to determine whether androgens affect active Ca2+ reabsorption 
by regulating the expression of the Ca2+ transport proteins TRPV5 and calbindin-D28K, in 
an effort to elucidate the sex differences in renal Ca2+ handling. Because androgen and 
androgen deficiency also affect bone mineralization via a long-term process 13, we 
evaluated the short-term effects of androgen on the expression of the renal Ca2+ transporters 
at the mRNA and protein level in orchidectomized (ORX) mice and ORX mice receiving 
testosterone replacement. In addition, to exclude possible secondary effects of androgens 
on other hormonal systems or bone turnover, non-aromatizable dihydrotestosterone (DHT) 
was applied to an isolated cell system of primary renal CNT/cortical collecting duct cells 
(CCD) in which transepithelial Ca2+ transport was measured. 
 
MATERIALS AND METHODS  
 
Animal experiments  
Experiment A: male (n = 15) and female (n =15) C57BL6 mice, 12 weeks of age, were 
housed in a light and temperature-controlled room with ad libitum access to deionized 
drinking water and standard chow (0.28 % (wt/wt) NaCl, 1.00 % (wt/wt) Ca, 0.22 % 
(wt/wt) Mg; LabDiet, USA). After acclimatization, mice were housed in couples in 
metabolic cages and 24 h urine was collected. After urine sampling, animals were 
sacrificed and blood and kidney samples were taken. 
     Experiment B: male C57BL6 mice (n = 36), 12 weeks of age, were housed and fed as 
described for experiment A. After acclimatization, the mice were randomly allocated to 
either a sham or bilateral ORX operation under (1.5 %) halothane anesthesia and divided 
into three groups (n = 12 in each group): (i) sham-operated mice serving as control animals; 
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(ii) ORX mice treated with vehicle; (iii) ORX mice treated with Sustanon 250 (ORX+T) 
subcutaneously (250 mg/kg/week; Sustanon 250 is a long-acting mixture of testosterone 
ester 14) (Organon Laboratories Ltd, Cambridge, UK). The operation was performed under 
halothane anesthesia. After 2 weeks, these mice were housed in couples in metabolic cages 
and 24 h urine was collected. Thereafter, animals were sacrificed and blood and kidney 
samples were taken.  
     The animal ethics boards of the National Defense Medical Center (Taipei, Taiwan) 
approved all animal experimental procedures. 
 
Urine and serum analyses 
Urine and serum concentrations of Cr and Ca2+ were determined using an automated 
analyzer (AU 5000 chemistry analyzer, Olympus, Tokyo, Japan). Serum 1,25(OH)2D3 
levels were determined by an [I125]1,25(OH)2D3 RIA assay (DiaSorin, Stillwater, MN, 
USA). Serum PTH concentrations were determined by IMMULITE PTH assay (Siemens 
Medical Solutions Diagnostics, Los Angeles, CA, USA). Both serum testosterone and 
estrogen concentrations were measured using chemiluminescence immunoassays (Siemens 
Medical Solutions Diagnostics, Tarrytown, N.Y., USA). 
 
Expression of renal Ca2+ transporters 
To determine mRNA expression levels, total RNA was extracted from kidney using Trizol 
Total RNA Isolation Reagent (Sigma, St Louis, MO, USA). The obtained total RNA was 
subjected to DNase treatment to prevent genomic DNA contamination. Thereafter, 1.5 µg 
of total RNA was reverse transcribed by Moloney-murine leukemia virus-reverse 
transcriptase (Promega, Madison, WI, USA), as described previously 3. The obtained 
cDNA was used to determine TRPV5 and calbindin-D28K mRNA levels in kidney cortex by 
real-time quantitative RT-PCR, using the ABI Prism 7700 Sequence Detection System (PE 
Biosystems, Rotkreuz, Switzerland). The expression level of the housekeeping gene 
hypoxanthine-guanine phosphoribosyl transferase (HPRT) was used as an internal control 
to normalize differences in RNA extractions and reverse transcription efficiencies. The 
primers and fluorescent probes used are as previously described (MDBIO, Taipei, Taiwan) 
3, 15. 
For protein expression quantification, total kidney lysates of the mice were prepared 
and analyzed as described previously 16. Briefly, proteins in kidney lysates were separated 
using SDS-PAGE and subsequent electro-transferred to polyvinylidene fluoride membranes 
(Immobilon-P,  Millipore  Corporation,  Bedford,  MA).   Blots  were   incubated  with  rabbit 
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Table 1. Serum biochemistry of sham-operated and ORX mice with or without testosterone 
replacement (Sustanon 250, 250 mg/kg/week subcutaneously, 2 weeks). PTH, parathyroid 
hormone; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3. a p < 0.05 vs. sham-operated mice; b p < 
0.05 vs. ORX mice. n = 8 samples per parameter. 
 
  
 Sham ORX ORX+T 
Ca2+ (mmol/l) 2.8 ± 0.1 2.6 ± 0.1 2.5 ± 0.1 
Testosterone (ng/dl) 499 ± 129 59 ± 11 a 1005 ± 291 a, b
Estrogen (pg/ml) 63 ± 16 36 ± 12 50 ± 10 
PTH (pg/ml) 24 ± 7 21 ± 6 25 ± 7 
1,25(OH)2D3 (pmol/ml) 156 ± 19 130 ± 11 143 ± 17 
 
 
anti-calbindin-D28K (Sigma, St Louis, MO, USA) or rabbit β-actin (Sigma) polyclonal 
antibodies. Subsequently, the blots were incubated with a goat anti-rabbit peroxidase-
labeled secondary antibody (Sigma). Immunoreactive protein was detected by the enhanced 
chemiluminescence method (Pierce, Rockford, IL, USA). Protein expression of the 
immunopositive bands was quantified by the use of pixel density scanning and computed 
calculation using the Molecular Analyst software of BioRad Laboratories (Hercules, CA, 
USA). 
 
Immunohistochemical labeling of renal Ca2+ transporters 
Kidneys were immersion-fixed in 1 % (wt/v) periodate-lysine-paraformaldehyde fixative 
for 2 h at room temperature, and incubated overnight at 4 °C in phosphate-buffered saline 
containing 15 % (wt/v) sucrose. Subsequently, 7 μm sections were cut from liquid nitrogen 
frozen kidney tissue samples for immunohistochemistry as described previously 17. For 
detection of TRPV5 protein abundance, kidney sections were stained with a guinea pig 
anti-TRPV5 antibody, as described 17, and a mouse anti-calbindin-D28K antibody (Sigma). 
TRPV5 and calbindin-D28K were visualized by staining those sections with goat anti-guinea 
pig and goat anti-mouse Alexa 488-conjugated anti-IgGs (Sigma), respectively. Next, to 
semi-quantify the TRPV5 protein expression, 5 digital images of each kidney section were 
taken with a Zeiss Axioskop microscope (Carl Zeiss, Inc., Thornwood, NY, USA) and the 
integrated optical density (IOD) was measured by computer analysis with the Image-Pro 
Plus version 3.0 software (Media Cybernetics, Silver Spring, MD).  
Double staining using anti-TRPV5 and a rabbit anti-AR antibody (N-20, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) was performed using the TSA™ Plus Fluorescein 
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amplification system (Perkin Elmer, Groningen, The Netherlands) for TRPV5 and a goat 
anti-rabbit IgG conjugated to Alexa 594 for visualization of the AR. Confocal pictures were 
acquired with an Olympus FV1000 laser scanning microscope (Center Valley, PA, USA). 
Differential interference contrast (DIC) was superimposed on the fluorescence images. 
 
Primary cultures of rabbit CNT/CCD and determination of transepithelial Ca2+ 
transport 
Rabbit kidney CNT and CCD cells were immunodissected from the kidney cortex of New 
Zealand White rabbits and set in primary culture on permeable filter supports (0.33 cm2; 
Corning-Costar, Cambridge, MA, USA), as previously described in detail 18. Five days 
after seeding, cells were incubated for 24 h with 10 nM (5α,17β)-17-Hydroxy-androstan-3-
one (dihydrotestosterone (DHT); Sigma), or vehicle (ethanol absolute), at the apical and 
basolateral compartments. Transport assays were performed on confluent monolayers the 
following day as described 18. Ca2+ reabsorption was calculated in nmol/h/cm2 and 
subsequently converted to percentage of Ca2+ transport in vehicle-treated CNT/CCD 
monolayers.  
 
Statistical analyses 
Values are expressed as means ± S.E.M. Statistical significance (p < 0.05) between groups 
was determined by an unpaired Student’s t-test (for comparisons between two individual 
groups), or  by  one-way  analysis of  variance (for multiple comparisons). All analyses were  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Mice sex differences in urinary Ca2+ excretion. (A) 24 h urine Ca2+ excretion and 
(B) Ca2+/Cr ratio were determined in both female and male mice. Data are presented as means 
± S.E.M. Cr, creatinine.  * p < 0.05 male vs. female mice. n = 8 samples per group. 
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Figure 2. Mice sex differences in the expression of renal Ca2+ transporters. (A) renal mRNA 
expression of TRPV5 and calbindin-D28K were determined by real-time quantitative RT-PCR 
analysis, expressed as the ratio of HPRT, and depicted as percentage of female mice. (B) 
Immunoblots of protein samples (10 μg each) from homogenates of kidney tissues were 
labeled with antibodies against calbindin-D28K or β-actin (C) Expression of calbindin-D28K 
protein was quantified by computer-assisted densitometry analysis and presented as the ratio 
to β-actin expression levels, in relative percentages compared with female mice. Data are 
presented as means ± S.E.M. * p < 0.05 male vs. female mice. n = 6 samples per group. 
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performed using the Statview Statistical Package Software (Power PC, version 4.51, 
Berkeley, CA, USA). 
 
RESULTS 
 
Sex differences for urinary Ca2+ excretion and renal expression of Ca2+ 
transporters 
To investigate whether sex differences affect renal Ca2+ handling, 24 h urinary Ca2+ 
excretion and Ca2+/Cr ratios were determined in age-matched male and female mice. Body 
weight (26.7 ± 0.8 in male vs. 25.4 ± 1.8 g in female) and diuresis (1.3 ± 0.5 in male vs. 1.1 
± 0.3 ml/24 h in female) was not significantly different between both sexes. Male mice, in 
comparison to females, demonstrated a significant higher 24 h urinary Ca2+ excretion (4.1 ± 
0.3 vs. 3.3 ± 0.2 μmol/day) and Ca2+/Cr ratio (0.23 ± 0.03 vs. 0.18 ± 0.02) (Figure 1). These 
functional differences were paralleled by a significant decline in the renal mRNA 
expression of TRPV5 and calbindin-D28K (Figure 2A). For calbindin-D28K abundance, this 
was confirmed by immunoblotting (Figure 2B); densitometrical analysis of the 
immunoblots showed significantly less calbindin-D28K protein expression in male than in 
female mice (Figure 2C). Similarly, computerized analysis of immunohistochemical 
images revealed a significant decrease in TRPV5 and calbindin-D28K abundance in male 
mice as compared to female mice (Figure 3). 
 
Localization of the androgen receptor in mouse kidney 
The possible effect of androgens regulating the expression of renal Ca2+ transporters is 
likely mediated via binding of the steroid hormone to the androgen receptor (AR). To 
investigate whether the AR is localized in TRPV5-expressing cells, immunohistochemical 
labeling of TRPV5 and the AR was performed using mouse kidney sections. As depicted in 
Figure 4, TRPV5 and the AR are co-expressed in renal epithelial cells.  
 
Effects of ORX and testosterone treatment on serum and urine parameters 
To specifically address the effects of androgens on renal Ca2+ handling, urine (fractional) 
Ca2+ excretion was measured in sham-operated and ORX mice, and in ORX mice 
supplemented  with  testosterone  (ORX+T).  Importantly, the body weight of mice between 
sham-operated, ORX and ORX+T groups was not different (27.1 ± 0.7, 26.1 ± 0.9, and 
26.9 ± 0.9 g, respectively). ORX significantly decreased urinary excretion of Ca2+ (4.4 ± 
0.3 (sham-operated) vs. 2.3 ± 0.2 (ORX) μmol/day) and the Ca2+/creatinine (Cr) ratio (0.28 
± 0.05 (sham-operated) vs. 0.16 ± 0.03 (ORX))  (Figure 5).  A change in renal transport was 
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apparent, as the fractional Ca2+ excretion was significantly reduced (0.94 ± 0.12 (sham-
operated) vs. 0.49 ± 0.04 (ORX) %). Testosterone supplementation of ORX mice restored 
renal Ca2+ excretion (4.3 ± 0.3 μmol/day) and the Ca2+/Cr ratio (0.25 ± 0.03) to values 
comparable  with  the  sham-operated  mice.  Table  1  summarizes  the effects  of  ORX  and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Mice sex differences between protein expression of Ca2+ transporters in kidney. (A) 
Representative images of immunohistochemical staining of TRPV5 and calbindin-D28K in 
male and female kidney cortex. (B) Semi-quantification of renal TRPV5 and calbindin-D28K 
protein abundance was performed by computerized analysis of immunohistochemical images. 
Data were calculated as IOD (arbitrary units) and depicted as percentage of female mice. 
Data are presented as means ± S.E.M. * p < 0.05 male vs. female mice. n = 8 samples per 
group.  
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testosterone replacement therapy on systemic Ca2+ handling, calciotropic hormones, and 
sex hormones. Serum testosterone levels were reduced effectively in untreated ORX mice, 
whereas supplementation with Sustanon 250 resulted in significantly higher serum 
testosterone levels. Importantly, serum PTH, 1,25(OH)2D3, and estrogen levels were not 
significantly different in ORX mice as compared to sham-operated and ORX+T mice. 
 
Effects of ORX and testosterone treatment on the expression of renal Ca2+ 
transporters  
To address the molecular mechanism responsible for the effect of testosterone on renal 
Ca2+ handling, the expression of TRPV5 and calbindin-D28K genes were examined using 
real-time quantitative reverse transcriptase (RT-) PCR, immunoblotting and 
immunohistochemistry. ORX mice demonstrated a 3.2-fold increase in TRPV5 and a 2.0-
fold increase in calbindin-D28K mRNA expression as compared to sham-operated mice 
(Figure 6A). Conversely, administration of testosterone to ORX mice (ORX+T) resulted in 
a significant decrease of TRPV5 and calbindin-D28K mRNA expression (Figure 6A, dashed 
bars). As determined by semi-quantitative immunoblotting, protein abundance of 
calbindin-D28K was increased in ORX mice compared to sham-operated mice (Figure 
6B,C). In accordance, calbindin-D28K protein abundance in ORX+T mice was comparable 
to the sham-operated controls (Figure 6B,C). In line with the above, semi-quantification of 
protein expression, the immunohistochemical labeling experiments revealed a significant 
up-regulation of TRPV5 (2.7-fold)  and calbindin-D28K (1.5-fold) signal in ORX mice when  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Characterization of AR localization in kidney. Confocal laser microscopy of 
double-labeled mouse kidney sections using guinea pig anti-TRPV5 (TRPV5, upper left 
panel) and rabbit anti-AR antibodies (AR, upper middle panel). Differential interference 
contrast (DIC, upper right panel) and overlay (lower panel) are also presented.  
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compared to sham-operated mice (Figure 7). Furthermore, treatment of ORX mice with 
testosterone led to a significant decline in TRPV5 and calbindin-D28K signals (Figure 7). 
  
Effect of DHT on transcellular Ca2+ transport in rabbit kidney CNT and CCD 
primary cell cultures 
The effect of androgen on renal Ca2+ handling in the ORX mice may be facilitated by the 
possible interference of other organs (e.g. bone) or hormones (calciotropic, estrogen). 
Therefore, the effect of androgen on TRPV5-mediated Ca2+ transport was studied in an 
isolated renal cell system. Primary cultures of rabbit CNT/CCD cells were grown to 
confluence on permeable supports. The cells were treated with DHT or vehicle, and the rate 
of transepithelial Ca2+ transport was determined. Application of 10 nM DHT to the 
polarized confluent cell monolayers for 24 h significantly inhibited the net apical-to-
basolateral transport of Ca2+ by 37 ± 5 % (Figure 8).  
 
DISCUSSION 
 
The present study is to our knowledge the first to delineate the effect of androgens on renal 
handling of Ca2+ and TRPV5-mediated active Ca2+ transport. We find that testosterone 
contributes significantly to the sex differences observed in renal Ca2+ handling. This 
conclusion is based on the following observations: First, male mice have a greater urinary 
Ca2+ excretion compared to females,  a  feature  accompanied  by a reduced renal expression 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Differences in urinary Ca2+ excretion of Sham-operated, ORX and ORX+T mice. 
(A) 24 h urine Ca2+ excretion and (B) Ca2+/Cr ratio were determined in Sham-operated, ORX 
and ORX+T mice. Data are presented as means ± S.E.M. Cr, creatinine.  * p < 0.05 male vs. 
female mice. n = 8 samples per group. 
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of Ca2+ transport proteins. Second, androgen-deficient ORX mice show a significant 
decline in the urinary excretion of Ca2+, which normalizes after testosterone replacement. 
Similar data was obtained when evaluating the fractional excretion of Ca2+, suggesting that 
the testosterone-induced increase of urinary Ca2+ excretion is due to inhibition of tubular 
Ca2+ reabsorption. Forth, the mRNA and protein abundance of renal Ca2+ transporters was 
up-regulated in ORX mice, while the expression of renal Ca2+ transporters was suppressed 
by resupplying these mice with testosterone. Fifth, the serum 1,25(OH)2D3, PTH, and 
estrogen levels did not differ between the sham-operated, ORX and ORX+T mice, 
suggesting that androgens may primarily affect the transcription of the renal Ca2+ 
transporters, rather than having an indirect effect via calciotropic hormones or estrogen. 
Finally, the direct effect of androgens was substantiated by the inhibition of transcellular 
Ca2+ transport after DHT treatment in isolated rabbit kidney CNT/CCD primary cell 
cultures.  
     Our observation that male mice show a greater urinary Ca2+ excretion than females is in 
agreement with previous clinical studies evaluating sex differences in humans 1, 2. In 
addition, orchidectomy induced hypocalciuria in male mice, thus resembling a female-like 
phenotype. Moreover, testosterone supplementation of ORX mice caused a normalization 
of their urinary Ca2+ excretion, accompanying a decreased expression of renal TRPV5 and 
calbindin-D28K. Previous studies evaluating the effect of estrogen on renal Ca2+ handling, 
demonstrated that the hormone exerts a direct effect on renal Ca2+ reabsorption via up-
regulation of TRPV5 and calbindin-D28K 3. Thus, both testosterone and estrogen have 
opposing regulatory properties in terms of renal expression of Ca2+ transporters. Similar sex 
differences have been found for the regulation of the thiazide-sensitive sodium-chloride 
cotransporter (NCC) that is expressed in the DCT. Chen et al. 19 demonstrated that the 
density of  NCC  (quantified  by  binding  [3H]metolazone  to  NCC)  was  two-fold higher  in 
Figure 6. Effects of ORX and testosterone treatment on renal mRNA expression of Ca2+ 
transporters. (A) Renal mRNA expression of TRPV5 and calbindin-D28K in sham-operated, 
ORX and ORX+T mice were analyzed by quantitative real-time RT-PCR analysis, expressed 
as the ratio of HPRT and depicted as percentage of sham-operated mice. (B) Immunoblots of 
protein samples (10 μg each) from homogenates of kidney tissue of sham-operated, ORX and 
ORX+T mice were labeled with antibodies against calbindin-D28K or β-actin. (C) Expression 
of calbindin-D28K protein was quantified by computer-assisted densitometry analysis and 
presented as the ratio to β-actin expression levels, in relative percentages compared with 
sham-operated mice. Data are presented as means ± S.E.M. Sham, sham-operated mice; 
ORX, orchidectomized mice; ORX+T, orchidectomized mice treated with Sustanon 250 
subcutaneously (250 mg/kg/week) for 2 weeks. * p < 0.05 vs. sham-operated mice. # p < 0.05 
vs. ORX mice. n = 8 samples per group. 
► 
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female than in male rats. Furthermore, ORX resulted in an up to 84 % increase in 
metolazone binding sites in males, whereas ovariectomy decreased the density by 
maximally 31 % in females 19.  
     In the present study no difference in the serum 1,25(OH)2D3 and PTH concentrations 
were detected between sham-operated, ORX, and ORX+T mice, suggesting that the up-
regulation of TRPV5 in ORX mice is not mediated by these calciotropic hormones. 
bbbbbbb 
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Conversely, androgens have previously been suggested to affect Ca2+ homeostasis by 
altering the regulation of calciotropic hormones. Some discrepancy has been reported in the 
literature; in a study by Nyomba et al. 20, the serum concentration of 1,25(OH)2D3 was 
shown to  decrease after  ORX  in male rats, while testosterone replacement therapy restored   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Immunohistochemical staining of renal Ca2+ transporters in sham-operated, ORX 
and ORX+T mice. (A) Representative images of immunohistochemical staining of TRPV5 
and calbindin-D28K in kidney cortex of sham-operated, ORX and ORX+T mice. (B) Semi-
quantification of renal TRPV5 and calbindin-D28K protein abundance was performed by 
computerized analysis of immunohistochemical images. Data were calculated as IOD 
(arbitrary units), depicted as percentage of sham-operated mice, and presented as means ± 
S.E.M. Sham, sham-operated mice; ORX, orchidectomized mice, ORX+T, orchidectomized 
mice treated with Sustanon 250 subcutaneously (250 mg/kg/week) for 2 weeks. * p < 0.05 vs. 
sham-operated mice. # p < 0.05 vs. ORX mice. n = 8 samples per group. 
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serum 1,25(OH)2D3 to normal levels. In agreement with our data, a study by Hope et al. 21, 
reported that ORX performed in male rats could not be associated with any changes in 
active 1,25(OH)2D3 levels. Possible explanations for these discrepancies are currently 
unclear and may not exclude a contribution of 1,25(OH)2D3 to overall Ca2+ handling by 
androgens. 
     Here, we showed that the AR is present in TRPV5-expressing cells, which is in line with 
earlier results demonstrating the presence of the AR in the distal part of the nephron 22. In 
general, the binding of androgens to the AR results in a conformational change and 
dimerization of the AR 23, 24. The AR dimer interacts with androgen-response elements 
(AREs)  and  the  subsequent  recruitment  of transcription  factors  in  the  nucleus  leads  to 
regulation of specific gene transcription 24. Potential AREs (nucleotide sequence: 
GGTACAnnnTGTTCT) within the putative promotor sequence of TRPV5 can be identified 
via the PromoterInspector database (http://www.genomatix.de). Such analysis reveals two 
AREs located within the first 5-kb fragment upstream of the transcriptional start site of 
mouse TRPV5 (genBankTM accession number NM_001007572), at positions 3629-3611 
and 3895-3877 bp. Moreover, the AREs are conserved in rat and human. These data further 
suggest that transcriptional activity affected by the AR is possibly involved in the 
molecular mechanism leading to reduced TRPV5 and calbindin-D28K mRNA transcripts 
after testosterone treatment. However, at present the physiological significance of these 
AREs and their role in suppressing expression of the proteins involved in active Ca2+ 
transport remains unclarified.  
     In this study, we aimed to evaluate the primary effect of androgens on renal Ca2+ 
handling. The inhibitory effect of testosterone on renal Ca2+ reabsorption seems at variance 
with the increased Ca2+ excretion found in elderly men with androgen deficiency, which is 
thought to be associated with male osteoporosis during aging 25-27. However, the short-term 
renal effects of androgen deficiency presented here should be separated from the long-term 
consequences of andropause in terms of bone remodeling. This issue was appropriately 
addressed in a study of Mauras et al. 13. They studied young men who were made 
hypogonadal for different time periods by injection of a gonadotropin-releasing hormone 
agonist. The contribution of Ca2+ released from bone to urine losses was shown to remain 
unchanged for 4 weeks, but, thereafter, significantly increased upon 10 weeks after 
induction of hypogonadism. In our experiments, we studied the effects of androgen 
deficiency in mice within the time frame of 2 weeks, to avoid the possible interference of 
Ca2+ released from bone. We could clearly delineate a change in intrarenal Ca2+ transport. 
Furthermore, we substantiated our in vivo results by experiments in isolated rabbit kidney 
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CNT/CCD primary cell cultures. These cells express endogenous TRPV5 and calbindin-
D28K, and are a consistent model to investigate active transepithelial Ca2+ transport ex vivo 
11. Here, we found that incubation with the non-aromatizable androgen DHT (10 nM, which 
is in line with a physiological concentration of testosterone) for 24 h resulted in a marked 
inhibition of apical-to-basolateral Ca2+ transport. This finding further supports the 
inhibitory role of androgen on the regulation of renal active Ca2+ reabsorption in vivo. 
     In conclusion, this study provides evidence that androgens contribute to sex differences 
observed in renal Ca2+ handling via inhibition of TRPV5 and calbindin-D28K expression. 
Furthermore, this effect is independent of calciotropic hormones or estrogen.  
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Figure 8.  Effect of DHT on net apical to basolateral Ca2+ transport in primary cultures of 
rabbit CNT/CCD cells. Transepithelial Ca2+ transport across confluent monolayers was 
measured in the absence or presence of 10 nM DHT. At the end of the 90 minutes incubation 
period apical medium was collected to determine the amount of Ca2+ transport across the 
monolayer. Transepithelial Ca2+ transport is expressed as percentage of vehicle-treated cells 
(set to 100 %) ± S.E.M. Data from 2 independent experiments (n = 6) was combined. * p < 
0.001. 
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Chapter 6 
SUMMARY 
 
A recently described novel controllable method to regulate protein expression is based on 
a mutated FK506-binding protein-12 (mtFKBP) that is unstable and rapidly degraded in 
mammalian cells. This instability can be conferred to other proteins directly fused to 
mtFKBP. Binding of a synthetic cell-permeant ligand (Shield-1) to mtFKBP reverses the 
instability, allowing conditional expression of mtFKBP-fused proteins. We adapted this 
strategy to study multimeric plasma membrane proteins using the ion channel TRPV5 as 
model protein. mtFKBP-TRPV5 forms functional ion channels and its expression can be 
controlled in a time- and dose-dependent fashion using Shield-1. Moreover, in the presence 
of Shield-1, mtFKBP-TRPV5 formed heteromultimeric channels with untagged TRPV5, 
which were co-degraded upon washout of Shield-1 - providing a strategy to study 
multimeric plasma membrane protein complexes without the need to destabilize all 
individual subunits.  
 
INTRODUCTION  
 
Studying the biological function of ion channels generally implies the perturbation of 
protein function using a variety of approaches, including gene elimination (knock-out), 
RNA interference, over-expression of (dominant) negative mutant proteins or use of small 
molecule inhibitors. The timescale, specificity and required experimental skills of these 
strategies differ largely. A strategy that encompasses the specificity of genetic approaches 
with the speed and reversibility of small molecules was recently described by Banaszynski 
and colleagues 1. The key feature of their technique is the use of a mutant FK506-binding 
protein-12 (FKBP12F36V/L106P, hereafter referred to as mtFKBP), that is unstable and 
prompts the protein to proteasomal degradation. However, instability of the protein is 
reversed by binding of a specific cell-permeant high affinity ligand (a synthetic small 
molecule termed Shield-1) that can interact with the destabilized protein, thereby rescuing 
it from degradation (as illustrated in Figure 1A). By fusion of mtFKBP to a protein of 
interest, this instability is conferred to the fusion protein, while addition of Shield-1 
stabilizes the entire fusion protein (Figure 1B). The main advantages of this technique are 
(i) a tunable protein stabilization; expression level is tightly controlled by the concentration 
of Shield-1 in the culture medium, (ii) reversibility; Shield-1 washout rapidly results in 
fusion protein destabilization and degradation, and (iii) specificity; Shield-1 only binds to 
FKBP12 carrying the F36V mutation and does not elicit any transcriptional effects in cells 
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2. Previously, Banaszynski et al. demonstrated that this approach can be used on a variety 
of target proteins, as mtFKBP fusion rendered instability to yellow fluorescent protein 
(YFP), several kinases (e.g. CDK1), small GTPases (e.g. Rac1), transcription factors (e.g. 
CREB) and CD8α, a glycoprotein carrying a single membrane-spanning domain 1. Here, 
we investigated whether this approach is effective for ion channels and if it is applicable to 
study heteromultimeric protein complexes using mtFKBP-tagged subunits. 
     As a model ion channel we used the epithelial Ca2+ channel Transient Receptor Potential 
Vanilloid-subtype 5 (TRPV5), which belongs to the TRP superfamily of ion channels. 
TRPV5 forms the apical entry gate for Ca2+ which is the rate-limiting step in active 
transepithelial Ca2+ transport 3, 4. TRPV5 channels consist of four identical subunits, 
forming a single central pore 5. Each subunit has six transmembrane domains, with the pore 
lining region located between transmembrane domain five and six, and large intracellular a 
separate TRPV (vanilloid) subfamily of TRP channels. Of all the members of the TRPV 
subfamily, TRPV5 can only form a multimeric complex with TRPV6, its closest family 
bbb 
 
 
 
Figure 1. Concept of conditional protein stabilization by Shield-1. (A) mtFKBP is an unstable 
cytosolic protein that is rapidly degraded by the proteasome (1), unless protected by the 
specific cell-permeant ligand Shield-1 (2) that binds the mtFKBP-destabilization domain and 
stabilizes the protein (3). mtFKBP protein stability is reversibly affected by the presence or 
absence of Shield-1 (4). (B) mtFKBP confers protein instability to any protein of interest by 
fusion of this tag. 
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 member that plays a pivotal role in intestinal Ca2+ absorption 7, 8. TRPV5 channel activity 
is characterized by selective Ca2+ currents that rapidly decrease, indicative for Ca2+-
dependent inactivation, and a specific (inward rectifying) ion current-voltage (I/V) profile. 
The latter is reflected by large currents at negative membrane potential and negligible 
currents at positive membrane potential 9. In the present study, we fused mtFKBP to the 
amino-terminal domain of TRPV5 (mtFKBP-TRPV5) and investigated its destabilizing 
effect on TRPV5 expression and activity. Addition of the mtFKBP protein to TRPV5 
resulted in a large destabilization of the channel, with tunable and rapidly reversible 
stabilization upon addition of Shield-1, demonstrating the applicability of this method to 
ion channels. Importantly, in the presence of Shield-1, mtFKBP-TRPV5 formed 
heteromultimeric channels with untagged TRPV5, which were co-degraded upon washout 
of Shield-1. This suggests that this approach can be used to study multimeric protein 
complexes operating at the plasma membrane without the need to destabilize all individual 
subunits using mtFKBP fusion. 
 
MATERIALS AND METHODS  
 
Molecular biology 
FKBP12F36V/L106P-YFP in pBMN was kindly provided by Dr. T. Wandless (Department of 
Molecular Pharmacology, Stanford University, Stanford, CA, USA). TRPV5 was sub-
cloned without start-codon into the eukaryotic expression vector pCB7 by PCR (forward 
primer 5’-GGGGTACCGGGGCCTGTCCACCCAAG-3’ and reverse primer 5’-CGGGATCCTCAGAA 
ATGGTAGACTTCCTC-3’) using HA-TRPV5 in pCB6 10 as template. mtFKBP was fused to 
the amino-terminal tail of TRPV5 in pCB7 by PCR (forward primer 5’-GAAGATCTGCCACC 
ATGGGAGTGCAGGTGGAAAC-3’ and reverse primer 5’-GGGGTCCTTCCGGTTTTAGAAGCTCCAC 
-3’) using the pBMN construct as template. HA-TRPV6 was sub-cloned into the pCB6 
eukaryotic expression vector by PCR (forward primer 5’-CTAGCTAGCGCCACCATGTACCCAT 
ACGACGTGCC-3’ and reverse primer 5’-GGGACCGGTTCAGATCTGGTACTCCCAGC-3’) using 
HA-TRPV6 10 in pTLN as template. TRPV4 in pCAGGSM2-IRES-GFP was kindly 
provided by Dr B. Nilius, Laboratory of ion channel research, KU Leuven, Belgium. All 
constructs were verified by sequence analysis. 
 
Cell culture and ligand treatment 
Human embryonic kidney-293 (HEK293) were grown in DMEM (Bio Whittaker) 
containing 10 % FCS, 4 mM L-glutamine, 0.1 % (w/v) NaHCO3, 0.1 mM non essential 
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amino acids (Invitrogen, Carlsbad, USA) and 10 μg/ml ciproxin at 37 °C in a humidity-
controlled incubator with 5 % (v/v) CO2 in air. HEK293 cells stably expressing TRPV5 
were cultured using the medium described above with addition of 400 μg/ml G418. 
Following overnight transfection, medium was replaced with vehicle-treated or drug-
applied medium as indicated for the individual experiments. The destabilizing ligand 
Shield-1 (final concentration of 1 μM - generously provided by Dr. T. Wandless) and 
vehicle (ethanol absolute) were applied directly into the medium for 24 h before an assay 
was performed, unless indicated otherwise. 
 
Drugs and antibodies  
Drugs: MG132 (dissolved in DMSO: 474790, Calbiochem, EMD Biosciences, La Jolla, 
CA, USA), Chloroquine (dissolved in sterile H2O: C6628, Sigma-Aldrich, St. Louis, MO, 
USA), Cycloheximide (dissolved in ethanol absolute: C-6255, Sigma-Aldrich), Shield-1 
(dissolved in ethanol absolute). Antibodies: guinea pig anti-TRPV5 (1:3000), rabbit anti-
eGFP (1:5000), rabbit anti-TRPV4 (1:5000), mouse anti-FKBP12 (1:2500, 554091, BD 
Pharmingen, BD Biosciences, NJ, USA), mouse anti-HA (1:5000, 2367, Cell signaling 
technology, Danvers, MA, USA), sheep anti-mouse IgG-PO (1:10000, 515-035-003, 
Jackson Immuno Research Europe), goat anti-rabbit IgG-PO (1:10000, A-4914, Sigma-
Aldrich), goat anti-quinea pig IgG-PO (1:10000, A7289, Sigma-Aldrich). 
 
Cell surface biotinylation and protein quantification 
HEK293 cells were transfected and treated as indicated in the individual experiments and 
subjected to cell surface biotinylation as described previously 11. Cells were lysed in 50 
mM Tris-HCl pH 8.0 containing 5 mM EGTA, 100 mM KCl, 1 mM MgCl2, 0.2 % (v/v) 
Triton-X100, 0.2 % (v/v) NP40 and a protease inhibitor cocktail (0.10 mg/ml leupeptin, 
0.05 mg/ml pepstatin-A, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 5 mg/ml 
aprotinin). Biotinylated proteins were eluted with SDS-PAGE loading buffer and analyzed 
by immunoblotting. Quantification of protein expression was acquired by the use of pixel 
density (volume analysis) scanning with a Biorad GS 690 Imaging Densitometer and 
computed calculation (Biorad Molecular Analyst Software, version 1.5; Biorad Molecular 
Bioscience Group, Hercules, CA, USA). Protein expression levels are depicted as arbitrary 
units (A.U.) or as relative protein expression (%). 
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Figure 2. The Shield-1-dependent protein stabilization method applied to TRPV5. (A) 
mtFKBP-TRPV5 and mtFKBP-YFP protein expression in total cell lysates of mtFKBP-
TRPV5-, mtFKBP-YFP- or mock-transfected HEK293 cells treated with 1 μM Shield-1 or 
vehicle for 24 h. (B) dose-response effect of Shield-1 on cell surface expression of mtFKBP-
TRPV5. HEK293 cells were transfected with mtFKBP-TRPV5 or mock and treated with 
different doses of Shield-1 for 24 h. Cell surface resident proteins were biotinylated and 
biotinylated mtFKBP-TRPV5 was detected by immunoblot (“plasma membrane”, top panel). 
Samples of the lysed cells (“total cell lysates”, lower panel) were immunoblotted in parallel 
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to visualize total amount of expressed mtFKBP-TRPV5. As negative controls, mock cells 
were used and for mtFKBP-TRPV5-transfected cells biotin was omitted from the procedure 
(indicated as “w/o biotin”). (C) time course of Shield-1-mediated stabilization of mtFKBP- 
TRPV5 cell surface expression. Transfected HEK293 cells were incubated with Shield-1 (1 
µM) for different durations. At the indicated time points biotinylation was performed as 
described in (B). (D) mtFKBP-TRPV5 protein degradation kinetics. Transfected HEK293 
cells were incubated with Shield-1 (1 µM) for 24 h. Subsequently, Shield-1 was washed-out 
and rapid mtFKBP-TRPV5 protein degradation in total cell lysates was observed using 
immunoblotting (top panel). mtFKBP-TRPV5 protein expression levels were computed to 
arbitrary units (A.U.) using an imaging densitometer (n = 3) and protein decay was plotted 
against time (solid line in graph) within its 95 % confidence intervals (dotted lines). (E) 
transfected HEK293 cells were incubated with Shield-1 (1 µM) for 24 h. Subsequently, cells 
were washed with media and either treated with MG132 (20 µM), chloroquine (200 µM), 
Shield-1 (1 µM) or vehicle, as indicated, for 4 h. mtFKBP-TRPV5 protein expression was 
visualized by immunoblotting using anti-TRPV5 antibodies. The increased mtFKBP-TRPV5 
expression in the presence of MG132 suggests proteasomal degradation of mtFKBP-TRPV5.  
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Electrophysiology and 45Ca2+ uptake assay 
Patch-clamp experiments using two voltage protocols were performed as described 
previously 9. Averaged Na+ current densities were calculated from the current at -80 mV. 
The averaged Ca2+ current densities were acquired by calculating the maximum current 
resulting from the voltage step to –100 mV from a holding potential of +70 mV. For the 
45Ca2+ uptake assay, HEK293 cells stably expressing TRPV5 were transfected with 
mtFKBP-YFP or empty vector (mock) and treated with 1 µM Shield-1 for 24 h before 
starting the assay as described 12. In one of the conditions tested, during washing and 
uptake, 10 μM ruthenium red (which blocks the TRPV5 channels) was supplemented to 
determine the fraction of TRPV5-mediated 45Ca2+ influx. 
 
mtFKBP-TRPV5 heteromultimerization assays 
In the first assay, mtFKBP-TRPV5 was co-transfected with wild-type (HA-tagged) TRPV5 
(rabbit), HA-TRPV6 (mouse), TRPV4 (mouse), or with empty vector (mock) in HEK293 
cells and treated with Shield-1 (1 µM) for 24 h. Then, cells were washed with PBS and 
subsequently further cultured for 18 hours (~ 7 times t½) in medium containing 1 µM 
Shield-1 or vehicle. During the last 4 h, all samples were treated with 50 µM 
cycloheximide to block protein synthesis. Next, cell surface biotinylation was performed 
(as described above), and protein expression was determined by immunoblotting using anti-
HA (for wild-type TRPV5), anti-TRPV6, anti-TRPV4, and anti-FKBP12 and anti-TRPV5 
(both to detect mtFKBP-TRPV5) antibodies. In the second assay, to study mtFKBP-tagged 
heteromultimeric protein complex assembly using Shield-1, mtFKBP-TRPV5 was co-
transfected with wild-type (HA-tagged) TRPV5 in HEK293 cells and treated with 1 µM 
Shield-1 or vehicle for 2 days. Then, cells were subjected to cell surface biotinylation and 
protein expression was determined by immunoblotting using anti-HA antibodies. 
Statistical analysis 
In all experiments, the data are expressed as mean ± S.E.M. Overall statistical significance 
was determined by analysis of variance. In case of significance, individual groups were 
compared using a Student’s t test. P values < 0.05 were considered significant. 
 
RESULTS 
 
The FKBP12 destabilizing domain confers Shield-1-dependent stability to TRPV5 
To investigate whether fusion of mtFKBP confers Shield-1-dependent stability to 
multimeric ion channels, we fused mtFKBP to the amino-terminal  domain of TRPV5 and 
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tested its heterologous expression in the presence or absence of Shield-1. In this series of 
experiments, HEK293 cells were transfected with mtFKBP-TRPV5 or empty vector 
(mock), or with mtFKBP-fused yellow-fluorescent protein (mtFKBP-YFP) as a control 
protein. Cells were treated with Shield-1 or vehicle for 24 h before lysis, and protein 
expression was investigated by immunoblotting. Fusion of the mtFKBP destabilizing 
domain to either TRPV5 or YFP decreased protein expression when Shield-1 was omitted 
from the medium, whereas in the presence of Shield-1 both TRPV5 and YFP were well 
expressed (Figure 2A). The level of mtFKBP-TRPV5 expression was dependent on the 
concentration of Shield-1 in the medium, with maximal expression at 1 µM (Figure 2B). 
Importantly, a concentration-dependent stabilization using Shield-1 was also observed for 
plasma membrane resident mtFKBP-TRPV5, which was isolated upon cell surface 
biotinylation. Similar to the total lysate, maximal cell surface abundance of mtFKBP-
TRPV5 was observed when 1 µM of Shield-1 was applied to the medium for 24 h (Figure 
2B). Ligand-induced stabilization was fast, with a significantly increased mtFKBP-TRPV5 
signal within 1 h after addition of Shield-1. Also the mtFKBP-TRPV5 expression at the 
plasma membrane showed rapid increase upon addition of Shield-1, although this signal 
further increased in time. Maximal expression was detected at 24 h (Figure 2C) and then 
remained virtually at a stable level (data not shown). To determine whether stabilization of 
mtFKBP-TRPV5 expression by Shield-1 was reversible, transfected cells with mtFKBP-
TRPV5 were treated with 1 µM Shield-1 for 24 h, then the ligand was washed-out, and 
subsequently the mtFKBP-TRPV5 signal was detected at different time points. mtFKBP-
TRPV5 protein levels were quickly reduced with a half life (t½) of 2.53 ± 0.59 h (Figure 
2D). The mtFKBP-TRPV5 degradation was significantly inhibited by addition of the 
proteasome inhibitor MG132 (20 µM) after washout of Shield-1, whereas addition of the 
lysosome inhibitor chloroquine (200 µM) had virtually no effect (Figure 2E).  
 
mtFKBP-TRPV5 forms a functional ion channel in the presence of Shield-1 
The consequences of mtFKBP fusion and addition of Shield-1 on the activity of TRPV5 
was determined using whole-cell patch-clamp analysis. Expression of wild-type TRPV5 
resulted in a readily measurable Na+ current at negative membrane potentials, which was 
absent in mock-transfected cells. At more positive membrane potentials, this current was 
largely diminished (Figure 3A). Such an inwardly rectifying I/V curve is indicative for 
TRPV5. Fusion of the mtFKBP destabilization domain to the amino-terminus of TRPV5 
nearly diminished this current. However, addition of 1 µM Shield-1 in the culture medium 
for 24 h  resulted in a absolute  restoration of the current,  with the typical I/V relationship of  
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Figure 3. mtFKBP-TRPV5 forms a Shield-1-dependent functional ion channel. HEK293 
cells were transfected as indicated and either treated with 1 µM Shield-1 or vehicle for 24 h 
before whole-cell patch clamp analysis. (A and B) depicted are the current-voltage (I/V) 
relations measured using a voltage ramp protocol (from -100 to + 100mV) in medium without 
added divalent ions (DVF). Average Na+ current densities at -80 mV in DVF solution are 561 
± 58 pA/pF (n = 16) for Shield-1-stabilized mtFKBP-TRPV5-tranfected cells compared to 75 
± 12 pA/pF (n = 14) for the vehicle-treated - and 545 ± 47 pA/pF (n = 20) compared to 19 ± 6 
pA/pF (n = 5) for TRPV5- or mock-transfected cells, respectively. (C and D) averaged Ca2+ 
currents of the different conditions measured using a voltage step to -100 mV from a holding 
potential of + 70 mV with 10 mM Ca2+ in the extracellular solution. Ca2+ currents are 
significantly increased in wild-type TRPV5 and Shield-1-stabilized mtFKBP-TRPV5, 
compared to mock- and vehicle-treated mtFKBP-TRPV5-transfected cells, respectively. 
Averaged densities of the maximum Ca2+ peak currents measured are 724 ± 72 pA/pF (n = 
13) for Shield-1-stabilized mtFKBP-TRPV5-tranfected cells compared to 146 ± 61 pA/pF (n 
= 11) for the vehicle-treated - and 503 ± 44 pA/pF (n = 19) compared to 23 ± 11 pA/pF (n = 
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4) for TRPV5- or mock-transfected cells, respectively. (E) (mtFKBP-)TRPV5 protein 
expression in one of the experiments representative for the patch clamp analysis. * and # 
indicate significant difference to control situations (p < 0.0001).  
 
TRPV5 (Figure 3A) and with an amplitude comparable to the wild-type current (Figure 
3B). Furthermore, wild-type TRPV5 displayed rapid inactivation when Ca2+ is present in 
the medium, which was due to a rise in the intracellular Ca2+ concentration in the vicinity 
of the channel (Figure 3C) 13. This typical Ca2+ current was largely abolished upon fusion 
of mtFKBP to TRPV5 (Figure 3C,D). Addition of Shield-1 to the mtFKBP-TRPV5 
transfected cells completely rescued the TRPV5-mediated Ca2+-currents (Figure 3D).  
     Previously, it was shown that FKBP52 inhibits TRPV5 by direct interaction 14. To 
exclude the possibility that the FKBP12-derived destabilizing domain has a similar effect 
on (wild-type) TRPV5 activity, mtFKBP-YFP or empty vector (mock) were transiently 
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transfected into HEK293 cells stably expressing TRPV5 (HEK293-TRPV5) and incubated 
with 1 µM Shield-1 for 24 h. Importantly, the ruthenium red-sensitive, TRPV5-mediated 
Ca2+-uptake was not affected by FKBP12 over-expression as was determined using a 45Ca2+ 
influx assay (data not shown).  
 
Specific co-degradation of wild-type TRPV5 and TRPV6 upon destabilization of 
mtFKBP-TRPV5 
As TRPV5 channels are constituted by four subunits, we investigated whether 
destabilization of mtFKBP-fused TRPV5 subunits results in destabilization of the entire 
channel-forming complex, including untagged subunits. In this experiment, mtFKBP-
TRPV5 was co-expressed with untagged TRPV5 in the presence of Shield-1 for 24 h. 
Subsequently, Shield-1 was washed-out and the expression of untagged TRPV5 was 
monitored 18 hours (~ 7 times t½) thereafter. mtFKBP-TRPV5 expression was significantly 
reduced in the plasma membrane fraction upon washout of Shield-1, as determined by cell 
surface biotinylation. Importantly, the expression of untagged TRPV5 in the plasma 
membrane fraction was also reduced (-51 ± 7 %; Figure 4A,D), indicating co-degradation 
with destabilized mtFKBP-TRPV5. Omission of biotin, used as a control for the specific 
isolation for cell surface proteins, resulted in complete loss of TRPV5 signal, 
demonstrating the specificity of the neutravidin for biotin. Next, we assessed whether the 
co-degradation effect can be used to determine whether proteins are present in a hetero-
oligomeric complex with mtFKBP-tagged subunits. In this set of experiments, mtFKBP-
TRPV5 was co-expressed with TRPV6 that was previously identified to form 
heterotetramers with TRPV5 7, 8. Similar to the results obtained using wild-type TRPV5, 
TRPV6 showed significant co-degradation with mtFKBP-TRPV5 upon washout of Shield-
1 (-58 ± 5 %; Figure 4B,D). Importantly, plasma membrane expression of TRPV4, which 
does not form heteromultimers with mtFKBP-TRPV5 8, 15, was not significantly affected by 
mtFKBP-TRPV5 degradation when Shield-1 was removed (-14 ± 8 %; Figure 4C,D), 
demonstrating the specificity of the procedure.  
     In a following set of experiments we investigated whether the long-term pre-incubation 
with Shield-1 was necessary for assembly of mtFKBP-tagged subunits into 
heteromultimeric protein complexes. Untagged TRPV5 and mtFKBP-TRPV5 were co-
expressed in HEK293 cells and either treated with Shield-1 or vehicle for 2 days. Cell 
surface biotinylation assays were performed and the amount of untagged TRPV5, 
expressed at the plasma membrane, was analyzed by immunoblotting and pixel scanning 
densitometry. Vehicle-treated cells co-expressing untagged TRPV5 and mtFKBP-TRPV5 
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displayed 57 ± 16 % of untagged TRPV5 protein at the cell surface, compared to the 
transfected cells treated with Shield-1 (Figure 4E,F), indicating that long-term pretreatment 
with Shield-1 is not required to allow for degradation of heteromultimeric complexes 
containing mtFKBP-tagged subunits. 
 
DISCUSSION 
 
In the present study, we established a method to control expression, cell surface abundance 
and activity of TRPV5. Importantly, this protein stabilization method enabled control of the 
expression of multimeric protein complexes of which only a subset of the subunits is 
tagged with the mtFKBP destabilization domain. Together, this provided a novel 
application of Shield-1, which might be extrapolated to ion channels in general or to other 
multimeric protein complexes. The suitability of the Shield-1-mediated stabilization 
method to regulate TRPV5 (multimeric) protein expression and activity was demonstrated 
by the following observations: First, plasma membrane and total cellular expression of 
mtFKBP-TRPV5 can be regulated in a dose- and time-depending fashion using Shield-1. 
Second, mtFKBP-TRPV5 is a Shield-1-dependent functional ion channel with similar 
(electrophysiological) characteristics as wild-type TRPV5. Third, mtFKBP-tagged TRPV5 
subunits assemble into heteromultimeric TRPV ion channels together with wild-type 
TRPV5 or TRPV6 subunits, thereby creating Shield-1-dependent multimeric protein 
complexes. 
     In the study of Banaszynski et al. it was shown that fusion of FKBP12 carrying two 
point mutations (F36V/L106P) can destabilize cytoplasmic proteins, nuclear proteins and 
the transmembrane protein CD8α 1. This method has recently been successfully applied in 
apicomplexan parasites, where analysis of gene function is limited by the absence of 
reverse genetic tools that allow easy and rapid modulation of protein levels 16. Herm-Götz 
and colleagues fused the mtFKBP destabilizing domain to different proteins and elucidated 
the essential function of Rab11A during invasion of the host cell and for intracellular 
propagation of the parasite 16. In the present study we describe the use of this destabilizing 
domain method to conditionally regulate expression and function of the plasma membrane-
expressed ion channel TRPV5. We showed that fusion of the mtFKBP destabilizing 
domain results in rapid degradation of TRPV5 via the proteasome in the absence of Shield-
1. Although the measured half-life of mtFKBP-TRPV5 upon Shield-1 washout was already 
very short, novel protein synthesis during this interval could partially obscure an even 
faster  rate  of  degradation.  Furthermore,  mtFKBP-TRPV5  cell  surface  abundance and/or  
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Figure 4. Degradation of mtFKBP-TRPV5 hetero-oligomers. HEK293 cells were transfected 
with empty vector (mock), or co-transfected with mtFKBP-TRPV5 and HA-TRPV5, HA-
TRPV6, or TRPV4, and subsequently the heteromultimerization assay as described in the 
materials and methods was performed. Biotinylations of TRPV5, TRPV6, TRPV4 and 
controls were performed and analyzed as described in Figure 2B and the materials and 
methods. Degradation of cell surface-expressed mtFKBP-TRPV5, initiated by the 
replacement of the stabilizing ligand Shield-1 by vehicle (A-C: “plasma membrane”, lower 
panels), significantly decreased plasma membrane expression of untagged TRPV5 by 51 ± 7 
% (A: “plasma membrane”, top panel, and D) and TRPV6 by 58 ± 5 % (B: “plasma 
bbbbbbbbb 
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membrane”, top panel, and D), but not that of TRPV4 (14 ± 8 %; C: “plasma membrane”, top 
panel, and D). Samples of the lysed cells (A-C: “total cell lysates”) were immunobpanel, and 
D). Samples of the lysed cells (A-C: “total cell lysates”) were immunoblotted in parallel to 
visualize the total amount of expressed proteins. For each condition (n = 6 from 3 
independent experiments) representative blots are shown. In a following set of experiments, 
HEK293 cells were mock-transfected or co-transfected with HA-TRPV5 and mtFKBP-
TRPV5 and either treated with Shield-1 or vehicle for 2 days. Subsequently, biotinylation of 
TRPV5 was performed and cell surface protein expression was analyzed (E, n = 3) and 
plotted (F, expression of the Shield-1-treated condition is 100 %). This series of experiments 
indicates that heteromultimeric channels expressed at the plasma membrane are degraded 
when Shield-1 is removed (D) and that heteromultimers with the mtFKBP-tagged subunit 
protein are transiently formed in  the absence of Shield-1 (F). * indicates significant 
difference (D, p < 0.001; E, p < 0.05), “w/o biotin” indicates that for these samples biotin was 
omitted from the procedure, and “HA, TRPV4, TRPV5, TRPV6, FKBP12” indicate the 
corresponding antibodies that were used for immunoblotting. 
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channel activity increased to control levels in a time- and dose-dependent fashion upon 
application of Shield-1. Together, this provides the first example of the use of Shield-1 to 
control the expression and activity of an ion channel in a rapid, reversible and tunable 
fashion. In addition, the effect of destabilization of mtFKBP-TRPV5 after Shield-1 
washout on the degradation of untagged TRPV5 and TRPV6 indicates that not all subunits 
need to be mtFKBP-tagged to regulate plasma membrane expression of these multimeric 
ion channels (see also the model in Figure 5). TRPV5 can form homotetramers and 
heterotetramers with TRPV6 in vitro and in vivo - as shown by pull-down assays, co-
immunoprecipitations and life cell imaging of ‘Förster resonance energy transfer’ (FRET) 
using transfected cells 7, 8. In contrast, TRPV4 only forms homomeric channels and does 
not interact with other TRPV family members 8, 15. Therefore, the specificity of the 
degradation of wild-type TRPV5 and TRPV6 by the incorporation of mtFKBP-TRPV5 
subunits is demonstrated as TRPV4 expression was not affected by mtFKBP-TRPV5 
degradation after Shield-1 washout.  
     Although destabilization of the TRPV5 complex in the total cell lysate was incomplete, 
plasma membrane resident mtFKBP-TRPV5/TRPV5 heteromultimers displayed significant 
degradation upon Shield-1 washout. Interestingly, similar destabilization of mtFKBP-
TRPV5/TRPV5 heteromultimers was also demonstrated without pre-incubation with 
Shield-1, providing evidence that the stabilizing ligand is not necessary for assembly of the 
mtFKBP-tagged multimeric ion channel. Likely, the heteromultimers are continuously 
assembled in the endoplasmic reticulum, and subsequently rapidly degraded by the 
proteasome when Shield-1 is not present. These findings demonstrate that mtFKBP-fusion 
provides destabilization of protein complexes containing untagged proteins in addition to 
the mtFKBP-tagged subunits. Based on the application of Shield-1 on a broad variety of 
proteins, we expect that this approach can be extrapolated to other multimeric protein 
complexes. In particular, ion channels that require the assembly of two distinct subunits for 
localization at the plasma membrane would be suitable for tunable functional expression 
using a mtFKBP-tagged isoform of one of the subunits. For example, KATP channels, 
octameric K+ channels, which consists of four inward rectifying potassium (KIR) subunits 
and four sulphonylurea receptor (SUR) subunits, are targeted to the plasma membrane, 
whereas the isolated KIR or SUR subunits do not exit the endoplasmic reticulum 17. When 
one of these subunits is fused to mtFKBP, this would ensure that all KATP complexes 
arriving at the plasma membrane are mtFKBP-tagged, enabling efficient destabilization 
upon Shield-1 washout. Similarly, ion channel complexes that acquire protein stability only 
upon heteromultimeric assembly would provide good tunable Shield-1-mediated control 
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upon mtFKBP-tagging of only one subunit. An example would be the chloride channel-7 
(ClC-7) protein, which is expressed poorly (< 10 %) unless associated with osteopetrosis-
associated transmembrane protein-1 (Ostm1) for maximum stability and function 18. Fusion 
of mtFKBP to Ostm1 would ensure the presence of the tag in a large majority of the formed 
ClC-7/Osmt1 complexes. Possibly, mtFKBP-tagged subunits could provide tunable control 
of expression and function over a wide variety of heteromeric multiprotein complexes, 
including plasma membrane transporters or even cytosolic or nuclear protein complexes, as 
long  as they are accessible to proteasomal degradation.  Similarly, it remains to be explored 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Heteromultimeric protein complex degradation by removal of Shield-1. In the 
presence of Shield-1, mtFKBP-fusion proteins can be incorporated into protein complexes 
that also contain untagged subunits (top panel). By subsequent removal of Shield-1 from the 
culture medium, complete protein complexes containing mtFKBP-fused subunits will be 
degraded (lower panel), resulting in degradation of both the tagged and untagged subunits. 
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whether transient interactions in a protein complex allow for complex degradation upon 
Shield-1 washout and the number of subunits needed to be mtFKBP-tagged to result in 
degradation of the complex.  
     Two possible pitfalls in the application of mtFKBP-fusion to ion channel proteins were 
addressed in our study. The first was whether addition of the mtFKBP tag changed the 
channel properties in the Shield-1 stabilized state. mtFKBP-TRPV5 currents were not 
altered by the tag, which is in line with previous results using GFP-fused TRPV5 12. The 
second was whether the expression of the FKBP12-derived destabilizing domain in cells 
affected TRPV5 activity. The main rationale for this was an earlier study where we showed 
that the FKBP12-related family member FKBP52 (synonym of Hsp56) actively inhibited 
the TRPV5-mediated Ca2+ influx via its peptidyl-prolyl cis-trans isomerase (PPIase) 
activity 14. However, over-expression of mtFKBP-YFP (after stabilization using Shield-1) 
by itself did not affect TRPV5-mediated Ca2+ influx, indicating that FKBP52 and FKBP12 
work via distinct mechanisms. This control might be essential for ion channels that bind 
FKBP12, including TRPC ion channels 19 and the ryanodine receptor 20.  
     In conclusion, this study shows the application of the small molecule ligand Shield-1 in 
the tunable and reversible control of TRPV5 expression. This is the first demonstration of 
the application of this novel method to study ion channels that operate at the plasma 
membrane. Importantly, our findings indicate that not all subunits of hetero-oligomers need 
to be mtFKBP-tagged to regulate protein expression and seems therefore valuable for the 
investigation of multimeric protein functioning.   
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Chapter 7 
SUMMARY 
 
To provide a cell model for studying specifically the regulation of Ca2+ entry by the 
epithelial calcium channel Transient Receptor Potential Vanilloid subtype-5 (TRPV5), 
green fluorescent protein (GFP)-tagged TRPV5 was expressed stably in Madin-Darby 
canine kidney type-I (MDCK) cells. The localization of GFP-TRPV5 in this cell line 
showed an intracellular granular distribution. Ca2+ uptake in GFP-TRPV5-MDCK cells 
cultured on plastic supports was threefold higher than in non-transfected cells. Moreover, 
apical Ca2+
 
uptake in GFP-TRPV5-MDCK cells cultured on permeable supports was 
eightfold higher than basolateral Ca2+
 
uptake, indicating that GFP-TRPV5 is expressed 
predominantly in the apical membrane. Patch-clamp analysis showed the presence of 
typical electrophysiological features of GFP-TRPV5, such as inwardly rectifying currents, 
inhibition by divalent cations and Ca2+-dependent inactivation. Moreover, the TRPV5 
inhibitor ruthenium red completely inhibited Ca2+
 
uptake in GFP-TRPV5-MDCK cells, 
whereas Ca2+
 
uptake in non-transfected cells was not inhibited. The characterized GFP-
TRPV5-MDCK cell line was used to assess the regulation of TRPV5. The protein kinase C 
activator phorbol 12-myristate 13-acetate and the cAMP-elevating compounds forskolin/3-
isobutyl-1methylxanthine, 8-Br-cAMP and PGE2 stimulated TRPV5 activity in GFP-
TRPV5-MDCK cells by 121 ± 7, 79 ± 5, 55 ± 4 and 61 ± 7 %, respectively. These 
compounds did not affect Ca2+
 
uptake in non-transfected cells. In conclusion, the GFP-
TRPV5-MDCK cell line provides a model to specifically study the regulation of TRPV5 
activity.  
 
INTRODUCTION  
 
Active reabsorption of Ca2+ occurs in the distal convoluted tubule (DCT) and the 
connecting tubule (CNT) of the kidney. Reabsorption by these nephron segments accounts 
for 10–20 % of total renal Ca2+
 
reabsorption. The Transient Receptor Potential Vanilloid 
subtype-5 (TRPV5) channel plays a key role in this Ca2+
 
transport, as knock-out mice 
lacking this channel experience severe hypercalciuria caused by diminished active Ca2+
 
reabsorption within the early part of the DCT/CNT 1. TRPV5 is present in the apical 
membrane of these tubular cells, where it is constitutively active. To adapt to changes in 
Ca2+
 
balance, active renal Ca2+
 
reabsorption is under control of hormones such as 
parathyroid hormone (PTH), arginine vasopressin (AVP), prostaglandin E2 (PGE2), 
calcitonin, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and estrogen 2-6. Estrogen, PTH and 
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1,25(OH)2D3 regulate TRPV5 at the level of transcription 4, 7, 8. Besides transcriptional 
control, short-term control mechanisms may also influence Ca2+
 
reabsorption.  
     As it is difficult to investigate transcellular Ca2+
 
transport in vivo, most studies have 
been performed in isolated perfused tubules or in cell cultures. For instance, Ca2+
 
transport 
by primary cultures of the rabbit DCT/CNT is activated by apical adenosine and basolateral 
PGE2 and AVP 5, 9, 10. In isolated perfused tubules PTH also has a non-transcriptional 
stimulatory effect on Ca2+
 
reabsorption and a role for cAMP in this effect has been 
postulated 3. To provide an in vitro cell model for studying Ca2+
 
transport, we have recently 
described a murine renal DCT cell line (mpkDCT) that approaches the endogenous 
physiological state of DCT in mice. Consistent with findings in other studies, Ca2+
 
transport 
by mpkDCT cells is stimulated by cAMP-elevating compounds and by deamino-Cys1-D-
Arg8-vasopressin (dDAVP)  11. However, as Ca2+
 
reabsorption comprises a sequence of 
processes involving apical Ca2+
 
entry via TRPV5 12, translocation of Ca2+
 
through the 
cytosol by calbindins 13, 14 and extrusion over the basolateral membrane by the Na+/Ca2+
 
exchanger (NCX) and plasma membrane Ca2+ ATPase (PMCA) 12, 15, a general effect on 
Ca2+
 
transport does not provide detailed mechanistic information about which individual 
processes are affected.  
     To gain insight into the regulation of apical Ca2+
 
entry through TRPV5, a Madin-Darby 
canine kidney type-I (MDCK) cell line was generated that expresses green fluorescent 
protein (GFP)-tagged TRPV5 stably. The generation and characterization of this cell line 
are described in this study and the signaling pathways affecting TRPV5-mediated Ca2+
 
entry addressed using this cell system.  
 
MATERIALS AND METHODS  
 
Constructs  
The open reading frame from rabbit TRPV5 (GENBANK sequence number AJ133128) 
was sub-cloned as a PvuII-BamH1 fragment into the pCINeo/IRES-GFP vector as 
described previously 16. To generate a N-terminal GFP-tagged TRPV5 construct, rabbit 
TRPV5 was cloned into the pEGFP-C1 vector (Clontech, Palo Alto, CA, USA) by PCR 
(forward primer 5’-TCCGGACGGGGGGGGATGGGGGCCTGTCCACCC-3’; reverse primer 5’-CCG 
GTGGATCCTGATCAG-3’).  
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Transient transfection of HEK293 cells with TRPV5 and GFP-TRPV5 and Western 
blot analysis  
To compare the electrophysiological properties of untagged and N-terminus-GFP-tagged 
TRPV5, both proteins were expressed heterologously in human embryonic kidney 
(HEK293) cells. HEK293 cells were grown in DMEM (Bio Whittaker Europe, Vervier, 
Belgium) containing 10 % (v/v) fetal calf serum (PAA, Linz, Austria), 13 mM NaHCO3, 2 
mM L-glutamine and 10 µg/ml ciproxin (Bayer, Mijdrecht, The Netherlands) at 37 °C in a 
humidity-controlled incubator with 5 % CO2. The cells were transfected transiently with 
TRPV5-pCINeo/IRES-GFP or GFP-TRPV5 using Lipofectamin 2000 (Invitrogen Life 
Technologies, Breda, The Netherlands) according to the manufacturers’ instructions. After 
24-48 h, cells (0.1 cm2
 
confluent) were treated with Laemmli sample buﬀer and subjected 
to SDS-PAGE and Western blotting. TRPV5 was detected with guinea-pig anti-TRPV5 17 
and peroxidase-coupled goat-anti-guinea-pig (Sigma, St. Louis, MO, USA). For 
electrophysiological analysis, transfected cells were identified visually by their green 
appearance, as described previously 16.  
 
Electrophysiology  
Electrophysiological methods for measuring Na+ and Ca2+ currents carried by TRPV5 have 
been described in detail previously 16. Patch-clamp experiments were performed on single 
cells in the whole-cell configuration (24-48 h after transfection for HEK293 cells 
transiently expressing TRPV5 and 2 h after seeding for GFP-TRPV5-MDCK cells), using 
an EPC-9 patch-clamp amplifier (HEKA, Lambrecht, Germany). Patch pipettes had DC 
resistances of 2-4 MΩ when filled with intracellular solution. A ramp protocol, consisting 
of linear voltage ramps from +100 mV to -100 mV within 450 ms, was applied every 2 s 
from a holding potential of +20 mV. Current densities, expressed per unit membrane 
capacitance, were calculated from the current at -80 and +90 mV during ramp protocols. 
The internal (pipette) solution contained (mM): 20 CsCl, 100 Cs-aspartate, 1 MgCl2, 10 
BAPTA, 4 Na2ATP and 10 HEPES/CsOH, pH 7.2. The external solution contained: 150 
mM NaCl, 6 mM CsCl, 1 mM MgCl2, 10 mM HEPES/NaOH (pH 7.4) and 10 mM glucose. 
To inhibit monovalent cation currents, 150 mM NaCl was replaced with an equimolar 
amount of N-methyl-D-glucamine-Cl (NMDG-Cl). Permeation of Ca2+
 
was measured in 
divalent (ion)-free solution (DVF) consisting of the NMDG-Cl-containing external solution 
with 10 mM Ca2+
 
but without the addition of other divalent cations. To completely abolish 
the effect of divalent cations on Ca2+
 
permeation, a buffer was used with the same 
composition as DVF but containing 100 µM EDTA to remove trace amounts of divalent 
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cations. All experiments were performed at room temperature.  
 
Generation of a MDCK cell line stably expressing GFP-TRPV5 
MDCK type-I cells 18 were grown in DMEM containing 5 % (v/v) fetal calf serum 
(HyClone, Logan, Utah, USA), 13 mM NaHCO3, 2 mM L-glutamine and 10 µg/ml ciproxin 
(Bayer) at 37 °C in a humidity-controlled incubator with 5 % CO2. For stable transfection 
of MDCK cells, 25 µg circular DNA was transfected using the calcium phosphate 
precipitation technique 19. At 24 h after transfection, the cells were trypsinized, divided 
over Petri dishes and cultured in medium containing 800 µg/ml G418 (Life Technologies 
Europe). Between 10 and 14 days after transfection, individual colonies were selected by 
means of cloning rings and expanded.  
 
Western blot detection of GFP-TRPV5 from GFP-TRPV5-MDCK cells 
GFP-TRPV5-MDCK cells and non-transfected MDCK cells were washed twice with PBS 
and subsequently lysed for 1 h on ice in lysis buﬀer containing: 135 mM NaCl, 20 mM 
TRIS (pH 7.4), 5 mM EDTA, 0.5 % NP-40 and 0.1 % Triton X-100. The lysate was 
centrifuged at 16,000 g for 1 h at 4 °C to pellet undissolved proteins and treated with 
Laemmli buffer for 30 min at 37 °C. A lysate volume equivalent to 0.2 cm2
 
cells was 
subjected to SDS-PAGE and Western blotting. GFP-TRPV5 was detected with rabbit-anti-
GFP 20 and peroxidase-coupled goat-anti-rabbit (Sigma).  
 
GFP-TRPV5 localization by confocal laser scanning microscopy 
GFP-TRPV5-MDCK cells were seeded at a density of 1.5·105 cells/cm2 on 0.33 cm2 
polycarbonate filters (Costar, Corning Europe, Badhoevedorp, The Netherlands) and grown 
to confluence for 3 days. Cells were washed twice with ice-cold PBS supplemented with 
0.1 mM CaCl2 and 1 mM MgCl2 and were fixed in PBS containing 3 % (w/v) 
paraformaldehyde for 30 min on ice. After washing twice with PBS, filters were cut out and 
mounted on glass slides with Vectashield (Vector Labs, Burlingame, CA, USA). Images 
were obtained with a Bio-Rad confocal laser scanning microscope (MRC-1024, Bio-Rad, 
Richmond, CA, USA) using a 60x oil-immersion objective.  
 
45Ca2+
 
uptake 
Cells were seeded in 24-well plates at a density of 3·105 cells/cm2 and cultured to 
confluency for 2 days. Cells were washed twice with Krebs-Henseleit buffer (KHB) 
containing 110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 20 mM HEPES, 10 mM sodium 
 137
Chapter 7 
acetate, 2 mM NaH2PO4, 4 mM L-lactate, 10 mM D-glucose and 1 mM L-alanine, adjusted 
to pH 7.4 using 1 M TRIS. After incubating for 1 h in KHB, this buffer was removed and 
replaced by KHB with 100 nM phorbol 12-myristate 13-acetate (PMA, Sigma), 10 µM 
forskolin (Sigma) and 100 µM 3-isobutyl-1-methylxanthine (IBMX, Sigma), 100 µM 8-Br-
cAMP (Sigma), 100 nM PGE2 (Sigma) or 10 µM ruthenium red (Fluka, St. Louis, MO, 
USA). Cells were preincubated for 15 min, after which the preincubation buﬀer was 
exchanged for 45Ca2+
 
uptake buffer, which consisted of KHB supplemented with 0.1 mM 
CaCl2, 2 mM NaH2PO4, 10 µM felodipine, 10 µM verapamil, 1 mM BaCl2 and 1 µCi 
45CaCl2/ml. After incubating for 15 min, cells were washed 3 times with ice-cold stop 
buffer consisting of KHB without NaH2PO4 supplemented with 0.5 mM CaCl2 and 1.5 mM 
LaCl3. Subsequently, cells were lysed in 0.1 % (w/v) SDS and radioactivity of the lysate 
was measured using a liquid scintillation counter.  
 
Apical and basolateral 45Ca2+
 
uptake in GFP-TRPV5-MDCK cells  
Cells were seeded on Transwell permeable supports (Corning, N.Y., USA) at a density of 
3·105
 
cells/cm2. Confluent monolayers were obtained 3 days post seeding. Transepithelial 
electrical resistance (TEER) was measured using an epithelial voltohmmeter (Millicell-D, 
Millipore, Denmark). Each cell monolayer exhibited a TEER > 1,330 Ω.cm2
 
prior to use in 
45Ca2+
 
uptake experiments. The apical and basolateral side of the filter was rinsed twice 
with KHB buffer. After 1 h incubation in KHB buffer this was exchanged for 45Ca2+-uptake 
buffer, either at the apical or the basolateral side. After incubating for 15 min, cells were 
washed 3 times with ice-cold stop buffer consisting of KHB without NaH2PO4 
supplemented with 0.5 mM CaCl2 and 1.5 mM LaCl3. Subsequently, cells were lysed in  
0.1 % (w/v) SDS and radioactivity of the lysate was measured using a liquid scintillation 
counter.  
 
Statistics 
Data are reported as means ± S.E. The significance of differences between means was 
determined using Student’s t-test. P < 0.05 was considered significant.  
 
RESULTS 
 
Western blot and electrophysiological analysis of GFP-TRPV5 heterologously 
expressed in HEK293 cells 
The aim of the study was to generate a cell line that expresses TRPV5 stably in order to 
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study the regulation of this channel. Expression of a GFP-tagged protein is preferred as it 
facilitates localization studies. The first question that must be addressed is whether the GFP 
tag influences TRPV5 channel properties. Untagged TRPV5 and N-terminus-tagged GFP-
TRPV5 were expressed heterologously in HEK293 cells. Western blot analysis showed a 
major 60 kDa band for untagged TRPV5 (Figure 1A) and a major 90 kDa band for GFP-
TRPV5 (Figure 1B). An additional band with a higher molecular weight was also observed 
for both proteins, possibly representing a post-translationally modified form. The 
bbbbbbbbb 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Western blot and electrophysiological analysis of the Transient Receptor Potential 
Vanilloid-subtype 5 (TRPV5) channel and the green fluorescent protein-tagged TRPV5 
(GFP-TRPV5). TRPV5 and GFP-TRPV5 were expressed heterologously in HEK293 cells. 
Western blot analysis was performed for non-transfected cells (NT), TRPV5- (A, upper 
panel) and GFP-TRPV5-transfected cells (B, upper panel). Electrophysiological properties of 
TRPV5 (A, lower panel) and GFP-TRPV5 (B, lower panel) were determined by patch-clamp 
analysis. Ionic currents (I) were determined during voltage (V) ramps in the absence of 
divalent cations [divalent ion-free (DVF) and EDTA], in the presence of N-methyl-D-
glucamine (NMDG) and in the presence of 10 mM Ca2+ (Ca). 
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current/voltage (I/V) curves in Figure 1 show inwardly rectifying currents through TRPV5 
and GFP-TRPV5. In a buffer containing Na+
 
without divalent ions (DVF and EDTA) 
inwardly rectifying currents were only carried by sodium. These currents could be blocked 
by replacing Na+
 
with NMDG+
 
(NMDG). The currents carried by 10 mM Ca2+
 
are much 
smaller than those carried by 150 mM Na+. TRPV5 and GFP-TRPV5 conducted Na+
 
and 
Ca2+
 
currents with a similar amplitude. These results indicate that the GFP tag does not 
influence the electrophysiological properties of TRPV5.  
 
Generation of a MDCK cell line stably expressing TRPV5 
To generate a polarized kidney epithelial cell line that expresses TRPV5 stably, MDCK 
type-I cells were transfected with GFP-TRPV5. The GFP tag allowed direct screening of 
TRPV5-positive clones on basis of GFP fluorescence. A clone, all cells of which were 
GFP-positive, was selected for the experiments described in this study and named “GFP-
TRPV5-MDCK”. To assess the localization of GFP-TRPV5, cells were grown to 
confluency on permeable filter supports, fixed and examined using confocal laser scanning 
microscopy. As shown in Figure 2A, TRPV5 was present mainly in intracellular granular 
structures. A similar localization pattern was also observed in the partially GFP-TRPV5-
positive clones (not shown). In an attempt to identify physiological triggers that induce 
trafficking of TRPV5 to the plasma membrane, filters were incubated (apically) for 10 and 
45 min with 8-Br-cAMP (100 µM), 8-Br-cGMP (100 µM), forskolin (10 µM), PMA (100 
nM) and the vasopressin-2 (V2) receptor agonist dDAVP (10 nM, basolateral) and the 
localization of TRPV5 studied by confocal laser scanning microscopy. Treatment with 
these compounds did not induce a change in localization of GFP-TRPV5 (not shown). 
Western blot analysis of GFP-TRPV5-MDCK cells showed a major protein band at 90 
kDa, which corresponds with the expected size of the tagged channel (60 kDa TRPV5 plus 
26 kDa GFP) (Figure 2B). Besides the 90 kDa protein an additional band with higher 
molecular weight was detected. This band might represent the complex glycosylated form 
of TRPV5 that has been reported previously 21.  
 
Increased Ca2+
 
uptake in GFP-TRPV5-MDCK cells 
To determine the presence of functional TRPV5 channels in the apical membrane, GFP-
TRPV5-MDCK cells and non-transfected MDCK cells were cultured to confluency in 24-
well plates. Ca2+
 
uptake, calculated as picomoles/106
 
cells, was determined at different 
times as described in Materials and methods. To prevent non-specific uptake through 
endogenous voltage-operated Ca2+
 
channels, the 45Ca2+
 
uptake buffer contained the 
inhibitors  felodipine  (10 µM)  and verapamil  (10 µM).  BaCl2  (1 mM)  was added to block 
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Figure 2. Localization and Western blot analysis of TRPV5 in GFP-TRPV5-MDCK cells. A 
MDCK cell line stably expressing GFP-TRPV5 was generated. (A) GFP-TRPV5 localization 
in cells cultured on filters was determined by confocal laser scanning microscopy. (B) 
Expression of GFP-TRPV5 was analysed by Western blotting. Non-transfected MDCK cells 
(NT) served as negative control (x, y, z axes). 
potassium channels and so prevent changes in membrane potential. Figure 3 shows that 
Ca2+
 
uptake at 5 min was 4.4 ± 0.2-fold higher in GFP-TRPV5-MDCK cells than in non-
transfected cells. This difference persisted for the duration of the observation period and 
represents TRPV5 activity. These data point to the presence of functional TRPV5 channels 
in the apical membrane of GFP-TRPV5-MDCK cells.  
 
Ca2+
 
is taken up via apical, ruthenium red-sensitive channels in GFP-TRPV5-
MDCK cells 
Previous studies have shown that ruthenium red inhibits TRPV5 activity with an IC50 of 
121 ± 13 nM 22. Ruthenium red sensitivity of Ca2+
 
currents might, therefore, indicate the 
presence of TRPV5 activity. Ca2+ uptake in GFP-TRPV5-MDCK was 356 ± 17 % higher 
than in non-transfected cells (Figure 4A). Ruthenium red (10 µM) did not affect Ca2+
 
uptake 
in non-transfected MDCK cells, whereas it decreased Ca2+
 
uptake in GFP-TRPV5-MDCK 
cells to the level observed in non-transfected cells. 
     To determine whether Ca2+
 
uptake in GFP-TRPV5-MDCK cells is mediated via 
channels in the apical or the basolateral membrane, cells were cultured on permeable 
supports until confluent monolayers were obtained with a TEER of >1,330 Ω.cm2, a value 
comparable with the TEER of non-transfected MDCK monolayers 18. Cells were then 
exposed to an apical or basolateral buffer containing 45Ca2+. After 15 min cells were 
washed and lysed and the uptake of 45Ca2+
 
determined. Ca2+
 
uptake via the apical membrane 
was 8.0 ± 1.9-fold higher than that via the basolateral membrane (Figure 4B) and was 
inhibited by ruthenium red (not shown). These data indicate that the increased Ca2+
 
uptake 
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in GFP-TRPV5-MDCK cells is mediated predominantly via ruthenium red-sensitive Ca2+
 
channels in the apical membrane. 
  
TRPV5 characteristics of ion currents in GFP-TRPV5-MDCK 
Several electrophysiological properties have been identified that are characteristic of 
TRPV5. The presence of these typical properties in GFP-TRPV5-MDCK cells was studied. 
The I/V diagram in Figure 5A shows the inwardly rectifying TRPV5 current. In the 
presence of EDTA and in DVF solution, currents were carried by Na+
 
and were abolished 
by replacing Na+
 
with NMDG+. Ca2+
 
currents in the presence of 10 mM Ca2+
 
were much 
smaller than monovalent currents. 
     Increased cytosolic Ca2+
 
levels are known to inactivate TRPV5 channels. Inactivation by 
Ca2+
 
and recovery from inactivation was further studied by measuring the activation time 
course of the inwards currents at -80 mV during a ramp protocol similar to that used in the 
experiments shown in Figure 5A. Control currents were measured in DVF and EDTA 
solutions (Figure 5B). Currents were completely absent when Na+
 
was replaced by 
NMDG+. Addition of 10 mM Ca2+
 
resulted in a peak current that declined in subsequent 
ramps. Replacement of the solution containing NMDG and Ca2+
 
by DVF resulted in a slow 
but full recovery to the control level. These experiments show clearly that the characteristic 
TRPV5 properties, such as inwardly rectifying currents, large monovalent cation currents 
in the absence of divalent cations and channel inactivation by Ca2+, are present in the GFP-
b 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Ca2+ uptake in non-transfected MDCK cells and GFP-TRPV5-MDCK cells. GFP-
TRPV5-MDCK cells (closed circles) and non-transfected MDCK cells (open circles) were 
seeded in 24-well plates and the Ca2+ uptake/106 cells determined at the times shown. The 
Ca2+ uptake by non-transfected cells at 5 min was regarded as 100%. Means ± S.E. (n = 3). 
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TRPV5-MDCK cell line.  
 
Regulation of TRPV5-mediated Ca
2+ 
uptake 
The data presented thus far show that GFP-TRPV5MDCK cells express functional TRPV5 
channels. This cell line can now be used as a model for unraveling the regulation of 
TRPV5-mediated Ca2+
 
entry. PKC and cAMP are thought to be potential signaling 
molecules involved in the regulation of TRPV5 activity 3, 9, 23. We therefore examined the 
effects of the PKC activator PMA (100 nM), the adenylyl cyclase activator forskolin (10 
µM) in combination with the phosphodiesterase inhibitor IBMX (100 µM), 8-Br-cAMP 
(100 µM) and the stimulatory G protein (Gs)-activating prostaglandin PGE2 (100 nM) on 
Ca2+ uptake in the GFP-TRPV5-MDCK cells (Figure 6). A 15 min preincubation with 
PMA increased Ca2+
 
uptake by 121 ± 7 % (p < 0.05) compared with untreated GFP-
TRPV5-MDCK cells. Preincubation with forskolin/IBMX increased Ca2+
 
uptake by 79 ± 5 
b 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Increased Ca2+ uptake in GFP-TRPV5-MDCK cells occurs mainly via the apical 
membrane and is inhibited by ruthenium red. (A) GFP-TRPV5-MDCK cells and non-
transfected cells were seeded in 24-well plates, preincubated with ruthenium red (10 µM) for 
15 min, incubated with 45Ca2+ for 15 min and the Ca2+ uptake/106 cells determined. Ca2+ 
uptake of non-transfected (control) MDCK cells without preincubation with ruthenium red 
was 21 ± 1 pmol/106 cells and was regarded as 100 %. The uptake by non-transfected MDCK 
cells (closed bars) and GFP-TRPV5-MDCK cells (open bars) is referred to this value. Means 
± S.E. (n = 3). *p < 0.05 vs. control. (B) GFP-TRPV5-MDCK cells were seeded on permeable 
supports and cultured for 3 days to form tight layers of polarized cells [transepithelial 
electrical resistance (TEER) > 1,330 Ω.cm2]. After incubation for 15 min with 45Ca2+ buffer 
either at the apical or basolateral membrane, the supports were washed and Ca2+ uptake/106 
cells determined. Means ± S.E. (n = 8). *p < 0.05 vs. apical Ca2+ uptake. 
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% (p < 0.05). A similar stimulation was achieved with 8-Br-cAMP and PGE2, which 
increased Ca2+
 
uptake by 55 ± 4 % and 61 ± 7 %, (p < 0.05), respectively. None of the 
tested compounds affected Ca2+
 
uptake in non-transfected cells. From these experiments, it 
can be concluded that PKC-activating and cAMP-elevating agents specifically activate 
TRPV5-mediated Ca2+
 
uptake in GFP-TRPV5-MDCK cells.  
 
DISCUSSION 
 
In this study, we describe the generation and characterization of an MDCK cell line that 
stably expresses GFP-TRPV5. Western blot analysis showed a major 90 kDa protein and an 
additional band with higher molecular weight that probably represents the complex 
glycosylated form of TRPV5 21. Functional TRPV5 channels are expressed in the plasma 
membrane as Ca2+
 
uptake in GFP-TRPV5-MDCK cells was increased significantly 
compared with parental non-transfected MDCK cells, and TRPV5-specific 
electrophysiological properties could be demonstrated in GFP-TRPV5-MDCK cells. 
Moreover, ruthenium red inhibited this increased Ca2+
 
uptake completely, whereas it had no 
effect on non-transfected cells. Exposure of GFP-TRPV5-MDCK cells to apically or 
basolaterally added 45Ca2+
 
showed substantial Ca2+
 
uptake across the apical membrane only. 
This points to a primary apical localization of Ca2+
 
channels, which is consistent with the 
physiological localization of this channel in the apical membrane of DCT cells.  
     The intracellular localization pattern of TRPV5 in GFP-TRPV5-MDCK cells contrasts 
with the predominantly apical localization found in DCT2, but closely resembles the 
localization of TRPV5 at the end of CNT, where exclusively cytoplasmic staining is 
observed 24. Intracellular localization is not restricted particularly to Ca2+
 
channels, since 
the epithelial Na+
 
channel is also localized mainly intracellularly, with only 1 % of the 
channels present in the apical membrane 25. It would be interesting to identify the 
physiological triggers that can direct a large portion of intracellular TRPV5 to the plasma 
membrane. This may provide more insight into membrane trafficking mechanisms. 
However, the compounds tested in this study (8-Br-cAMP, 8-Br-cGMP, forskolin, PMA, 
dDAVP) did not affect TRPV5 localization visibly (data not shown). This indicates that 
either shuttling of channels to the membrane is not induced by these compounds, or that the 
subset of channels routed to the membrane is too small to detect using confocal laser 
scanning microscopy. Alternatively, trafficking of TRPV5 channels to the plasma 
membrane might be sub-optimal due to the absence of certain regulatory factors in MDCK 
cells  such as serum  and  glucocorticoid-inducible  kinase-1 (SGK1)  and Na/H exchanger- 
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Figure 5. Electrophysiological properties of GFP-TRPV5-MDCK cells. (A) The I/V 
relationships were determined in response to a voltage ramp in the absence of divalent cations 
(DVF and EDTA), in the presence of NMDG and in the presence of 10 mM Ca2+. (B) 
Development of the inwards current at -80 mV during ramps as described in Materials and 
methods after applying different solutions. 
 
regulating factor-2 (NHERF2) 26. However, localization studies in primary rabbit 
DCT/CNT cells have shown also that a large fraction of endogenous TRPV5 channels is 
localized intracellularly (unpublished data).  
     Ca2+
 
reabsorption has been shown to be stimulated by PTH, AVP, PGE2, calcitonin, 
1,25(OH)2D3 and estrogen 2-6. While 1,25(OH)2D3, PTH and estrogen stimulate Ca2+
 
reabsorption via an increase of TRPV5 transcription 4, 7, 8 the other compounds may activate 
short-term stimulatory pathways. For example, Ca2+
 
reabsorption by rabbit DCT/CNT 
primary cultures is activated by short incubations with apical adenosine, PGE2 and AVP 5, 9, 
10. As these compounds raise cAMP via Gs-coupled receptors, and the stimulatory effect 
can be mimicked by membrane-permeable cAMP analogues and forskolin in isolated 
perfused nephron tubules 3, a role for cAMP in stimulation of Ca2+
 
reabsorption has been 
suggested. However, other studies have suggested a major role for (atypical) PKC, as the 
PKC inhibitor chelerythrine inhibits stimulatory effects of several cAMP-elevating 
hormones 3, 23.  
     The mechanisms regulating renal Ca2+
 
reabsorption have been studied extensively. 
Transepithelial Ca2+
 
transport can be divided into three processes: Ca2+
 
entry at the apical 
side, intracellular Ca2+
 
translocation and extrusion at the basolateral side. Effects on trans-
epithelial Ca2+
 
transport thus do not provide detailed information on the specific process 
influenced. Unravelling the regulatory mechanisms of TRPV5 has long been hampered by 
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the lack of a cell model. Recently, we described a mpkDCT cell line that approaches the 
endogenous physiological state of DCT. In this cell line, forskolin stimulates ruthenium-red 
sensitive Ca2+
 
transport from the apical to basolateral side whereas PMA has no effect 11. 
However, as mpkDCT cells express both TRPV5 and TRPV6, it is not possible to 
distinguish between stimulatory effects of forskolin on the modulation of TRPV5 or 
TRPV6 activity. To study the short-term modulation of TRPV5 activity specifically, we 
developed the GFP-TRPV5-MDCK cell line described in this study. The effect of the 
TRPV5-inhibiting compound ruthenium red on Ca2+
 
uptake was investigated 22. Ca2+
 
uptake 
in GFP-TRPV5-MDCK cells was ruthenium red sensitive, whereas Ca2+
 
uptake in non-
transfected MDCK cells was not affected by this compound. This shows that TRPV5-
mediated Ca2+
 
entry can be studied specifically in the GFP-TRPV5-MDCK cell line with 
non-transfected cells as a negative control.  
     Using this cell model, we showed that Ca2+
 
uptake in GFP-TRPV5-MDCK cells is 
stimulated by cAMP-elevating compounds such as forskolin/IBMX, 8-Br-cAMP and PGE2. 
As these compounds did not affect basal Ca2+
 
uptake of non-transfected cells, this points to 
a specific stimulatory effect on TRPV5-mediated Ca2+
 
uptake. These results are consistent 
with findings of previous studies. However, whether this effect is mediated by atypical 
PKC isoforms, as previously found in rabbit primary DCT/CNT cultures 23, remains to be 
bb 
 
 
 
 
 
 
 
 
 
Figure 6. Effect of PMA and cAMP-elevating compounds on Ca2+ uptake in GFP-TRPV5-
MDCK cells and non-transfected MDCK cells. Cells were preincubated with PMA (100 nM), 
forskolin/IBMX (10 µM/100 µM), 8-Br-cAMP (100 µM) or PGE2 (100 nM) for 15 min, 
followed by incubation with Ca2+ for 15 min. Ca2+ uptake in non-transfected cells (open bars) 
and GFP-TRPV5-MDCK cells (closed bars) was measured. Ca2+ uptake in non-stimulated 
non-transfected cells (17 ± 1 pmol/106 cells) was regarded as 100 % and all values are 
referred to this. Means ± S.E. (n = 4). *p < 0.05 vs. control. 
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determined. A mechanism involving an atypical PKC isoform might be present in the GFP-
TRPV5-MDCK cell line, as MDCK cells express PKCζ 27. TRPV5 contains one putative 
PKA phosphorylation site which could be involved in a direct PKA-mediated stimulation 
28. However, as this site is not species-conserved a modulatory action of PKA via channel 
phosphorylation is unlikely. It has been shown that cAMP-elevating agents that induce 
PKA activity in renal Ca2+-transporting cells also activate PKC. Moreover, their 
stimulatory effect on Ca2+
 
transport could be inhibited with the PKC inhibitor chelerythrine, 
suggesting that PKC mediates the stimulatory effect 23.  
     The finding that the PKC activator PMA stimulated TRPV5 activity twofold is in line 
with these results. However, in primary cultures of rabbit DCT/CNT phorbol ester-
insensitive PKC isoforms appeared to be involved in stimulation of Ca2+
 
transport whereas 
phorbol-ester sensitive isoforms inhibited Ca2+
 
transport 23, 29. The differences in PKC-
mediated effects might be due to stimulation of PMCA or NCX by PKC 30, 31, which may 
enhance Ca2+
 
transport in primary cultures, but are not involved in TRPV5-mediated Ca2+
 
uptake in GFP-TRPV5-MDCK cells. Moreover, the latter studies were conducted in rabbit 
DCT/CNT primary cultures, which not only express TRPV5 but also TRPV6 24, 32. In this 
respect, it would be interesting to determine whether TRPV5 and TRPV6 are regulated 
differently. The stimulatory effect of PMA on TRPV5 activity in the GFP-TRPV5-MDCK 
cells might involve direct phosphorylation by PKC, as TRPV5 possesses three conserved 
putative PKC phosphorylation sites in both the N- and C-termini 28. Alternatively, a co-
factor could be phosphorylated that subsequently exerts its effect on TRPV5.  
     Taken together, the GFP-TRPV5-MDCK cell line developed and characterized in this 
study provides a new cell model for studying TRPV5 regulation specifically. Using this cell 
line, we showed that cAMP elevation and PKC activation stimulate TRPV5-mediated Ca2+
 
entry across the apical membrane. These findings will enable further studies with the aim of 
unravelling the mechanisms of TRPV5 activation.  
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Chapter 8 
INTRODUCTION 
 
Control of the plasma Ca2+ concentration is of vital importance for many physiological 
processes in the body, ranging from intracellular signaling events to the formation of bone. 
Ca2+ is absorbed from the diet - the only external Ca2+ source for the body - and wasted via 
urine or faeces. In the body, different organs, including the gastro-intestinal (GI) tract, 
kidney and bone, contribute in concert to maintain the extracellular Ca2+ concentration 
([Ca2+]e) at a constant level (Figure 1) 1, 2.   
     The bulk of Ca2+ is transported across the intestinal’ or kidney’s epithelial tissue in a 
passive paracellular fashion, while the active - transcellular - component is of major 
significance because it determines the net amount of total Ca2+ (re)absorption 3, 4. 
Transcellular Ca2+ transport occurs in three sequential steps: (1st) Ca2+ enters the polarized 
cell at its luminal membrane, facing the diet or pro-urine, via the epithelial Ca2+ channels 
TRPV5 and/or TRPV6; (2nd) In the cell, Ca2+ is sequestered by specialized Ca2+-binding 
proteins, calbindin-D28K or -D9K, and translocates to the basolateral membrane, where (3rd) 
it is extruded into the bloodstream via the Na+/Ca2+-exchanger and/or the plasma membrane 
Ca2+-ATPase-1b (PMCA1b) 2. This active transport of Ca2+ is under the strict control of 
Figure 1. Overview of the human gastro-intestinal tract and other tissues predominantly 
involved in maintenance of body Ca2+ homeostasis.  
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systemic (calciotropic) hormonal factors 1, 5, or regulated locally at different sites 
throughout the epithelial cell. The calciotropic hormones are predominantly involved in the 
initiation of gene transcription of TRPV5, TRPV6 and some of their protein partners, such 
as the calbindins 1, 2, 6-9. In addition, fast non-genomic effects directly affecting cellular Ca2+ 
entry via TRPV5 and TRPV6 have been reported. For instance - as described in the general 
introduction to this thesis (Chapter 1) - parathyroid hormone (PTH) not only increases 
expression of the Ca2+ channels, it also activates protein kinases A and C, which in turn 
stimulate transepithelial Ca2+ transport 10-12. At another level, molecular chaperones of 
TRPV5 and TRPV6 have been shown to control the intracellular trafficking and recycling 
of the channels towards and from the plasma membrane, thus contributing (indirectly) to 
the amount of Ca2+ that can enter the cell 13. Perhaps most essential is the regulation of 
TRPV5 and TRPV6 directly at the luminal cell surface, their functional domain, because 
regulation directly at the entry gate of Ca2+ allows immediate response to fluctuations in the 
Ca2+ concentration. In this respect, the local intra- and extracellular milieus are key 
determinants of channel regulation. For instance, the negative feedback response of Ca2+ in 
close vicinity of the intracellular channel mouth leads to fast inactivation of the channel 1, 2, 
whereas changes in the intra- or extracellular pH either increases (in case of an alkaline 
environment) or decreases (acidic milieu) channel activity 14-18. In many situations, 
auxiliary proteins of the epithelial Ca2+ channels are involved in this fast, short-term, 
regulation of Ca2+ entry. As mentioned, of particular importance are proteins that regulate 
TRPV5 and TRPV6 directly at the plasma membrane. A number of partner proteins, such 
as the S100A10-annexin-2 protein complex 19, Rab11A 20, and the Ca2+-sensors 80K-H 21, 
calmodulin 22 and calbindin 23, were recently identified as critical components modulating 
Ca2+ entry via TRPV5 and/or TRPV6. The characterization of these chaperones provided 
important insights in our understanding of the molecular pathways regulating the epithelial 
Ca2+ channels.  
     This thesis describes the identification and characterization of two associated proteins 
that regulate TRPV6 activity. Chapters 2 and 3 introduce Regulator of G-protein Signaling-
2 (RGS2) and Nipsnap1, respectively, as interacting partners that specifically inhibit 
TRPV6 activity directly at the cell surface. However, next to the functions of these two 
binding proteins, other molecular pathways involving distant auxiliary proteins can affect 
cell surface expression and activity of the Ca2+ channels. For that reason, a G-protein-
coupled receptor- (GPCR-)operated mechanism that controls the duration of TRPV5 
channels at the plasma membrane by sensing the local [Ca2+]e was described in Chapter 4. 
In addition, the hormonal regulation of TRPV5 expression and activity by androgens was 
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described for orchidectomized mice in Chapter 5. Importantly, the proteins and regulatory 
mechanisms of these molecular pathways were delineated by a comprehensive approach 
including (co-)localization in native tissues, (electro)physiological ion channel analysis and 
cell surface expression in appropriate cell models. To acquire more insight into the basis of 
plasma membrane regulation of the epithelial Ca2+ channels, two different in vitro tools 
were designed. First, a polarized cell line that expresses green fluorescent-labeled TRPV5 
was generated to characterize its cellular localization and activation. Second, the 
construction of a tunable TRPV5 protein expression system enabled the dynamics of 
protein complex formation to be studied. These tools were described in Chapters 6 and 7.  
 
REGULATION OF THE EPITHELIAL CA2+ CHANNELS PRESENT AT THE CELL 
SURFACE BY PROTEIN INTERACTIONS 
 
TRPV5 and TRPV6 are constitutively active at physiological membrane potentials and 
intracellular Ca2+ concentrations ([Ca2+]i) 24. Regulation of the open probability of the 
channels may be mediated via mechanisms that either block or open the pore by structural 
rearrangements (e.g. via protein binding) or ionic blockage/release, or by endocytosis/ 
trafficking of channels from or towards the cell surface. In the next section the role of 
protein interactions with the channels (as illustrated in Figure 2) will be discussed.  
    
RGS2 and Nipsnap1 inhibit TRPV6 
 
One way to gain more insight into regulation of TRPV5 and TRPV6 is to identify putative 
Figure 2. Regulation of the epithelial Ca2+ 
channels at the cell surface by interaction 
with auxiliary proteins. RGS2, Nipsnap1 and 
calmodulin have been shown to interact with 
both TRPV5 and TRPV6, but are considered 
to specifically control TRPV6 activity. 
Whether these regulatory functions result 
from blocking or opening of the channels’ 
pores, or from structural rearrangements of 
the pore regions remains elusive. BSPRY, 
FKBP52, and 80K-H bind to both channels, 
but their different regulatory functions were 
studied for TRPV5 only. See text for details.  
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regulatory binding proteins of the Ca2+ channels. The corresponding screening methods are 
often based on biochemical protein-protein interaction studies, but novel, bioinformatical, 
approaches are applied to date as well.  
 
Identification and selection of candidates  
The first technique that we applied was the yeast-two-hybrid protein interaction-
identification method, described in Chapter 2. The strategy was as follows: the amino-
terminal domain of TRPV6 was used as a bait molecule and screened for interactions with 
protein products derived from DNA sequences that were obtained from a mouse kidney 
cDNA library. DNA was purified from yeasts of the initial positive identifications and re-
screened in a second yeast-two-hybrid using the bait. From the 
resulting list of binding proteins candidates were either selected 
on interesting properties described in literature, or by the lack of 
any information. DNA sequences of selected candidates were 
annotated and full length transcripts were isolated from mouse 
kidney lysates. These obtained DNA constructs were used for 
further studying. 
 
Bait:  
A known protein used to 
identify new binding 
partners in the yeast-two-
hybrid protein-interaction 
screening technique.       The second method that we employed was a bioinformatical 
strategy, described in Chapter 3. To find potential interaction 
partners for TRPV5 and TRPV6 with this computerized 
technique, the genes that were within the same gene co-expression 
network were examined. Expression data from multiple species 
was included to increase reliability of the predictions that could be 
made about functional interactions between the proteins 25. 
However, there are many ways in which the expression data 
between species can be combined and one should be cautious with 
selecting a certain procedure. For instance, by averaging co-
expression data across paralogous genes and across species 
sensitivity will be lost 25. Thus, many of the biologically relevant 
interactions will not be present among the highest conserved co-
expressed gene pairs. Therefore, we selected the maximum level 
of co-expression, both per pair of orthologous groups within each 
species and between the species, and grouped them according to 
the ‘euKaryotic cluster of Orthologous Genes (KOG)’ 
classification 26, 27. The KOGs that showed highest co-expression 
 
Orthologues:  
Genes in different species 
that evolved from a 
common ancestral gene 
by speciation. Normally, 
orthologues retain the 
same function in the 
course of evolution.  
 
Paralogues: 
Genes related by 
duplication within a 
genome. While 
orthologues retain the 
same function in the 
course of evolution, 
paralogues often evolve 
new functions, even if 
these are related to the 
original one. 
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with the KOG of TRPV5 and TRPV6 were ranked and manually examined for potential 
TRPV5/6-interacting proteins. Full-length transcripts of the selected putative TRPV5 
and/or TRPV6 regulatory genes were obtained and further examined using an experimental 
approach. 
 
TRPV6 channel inhibition by RGS2 
RGS2 is a member of the RGS family of proteins that terminate signaling of heterotrimeric 
GPCRs, by accelerating the GTPase activity of active Gα subunits 28. RGS2 was selected as 
a candidate protein because of the possibility that it influences a putative GPCR-induced 
intracellular pathway regulating TRPV5 and/or TRPV6. Such a GPCR involved may by 
activated by (calciotropic) hormones or changes in [Ca2+]. In addition, over 25 different 
RGS proteins have been identified to date and their effector functions have been revealed to 
extend beyond negative regulation of GPCR signaling. It was demonstrated that RGS 
proteins not only act as effector antagonists (binding to either the effector protein or the Gα 
subunit to prevent an operative physical interaction), but that they can also interact with a 
wide variety of auxiliary proteins such as calmodulin, spinophilin (SPL), Homer 2, and the 
14-3-3 adaptor protein 29-31. These auxiliary proteins can influence the subcellular 
localization, stability and function of the RGS proteins. Therefore, RGS2 might just as well 
regulate TRPV5 and/or TRPV6 by its direct interaction. Importantly, the phenotype of 
RGS2 knock-out (RGS2-/-) mice implicated a role for RGS2 in hypertension 32, thus 
suggesting a possible function of this protein in regulating ion transport. 
     In Chapter 2 we showed that RGS2 interacts with the amino-terminal domain of 
TRPV6. Moreover, we collected evidence that RGS2 is specifically involved in the 
regulation of TRPV6 while not affecting its closest homologue 
TRPV5. To investigate the role of RGS2 in TRPV6 regulation, a 
combined approach including biochemical and functional assays 
was applied. First, GST-Pull down studies demonstrated binding 
of the amino-terminal domain of RGS2 to the amino-terminus of 
TRPV6 in the presence or absence of Ca2+. To date, this is the first 
regulatory protein that acts on the amino-terminal tail of TRPV6. 
Second, electrophysiological data showed a TRPV6-specific 
inhibition of Na+ and Ca2+ currents in human embryonic kidney-
293 (HEK293) cells co-expressing TRPV6 and RGS2. The 
activity of TRPV5 was not affected by RGS2. In addition, 
inhibition of TRPV6 was not observed for the deletion mutant ΔN-
 
Homologue:  
An organ or structure that 
is similar in structure and 
evolutionary origin, 
though not necessarily in 
function (vs ‘analogue’: 
similar in function to one 
in another kind of 
organism, but is of 
dissimilar evolutionary 
origin). 
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RGS2 (lacking the amino-terminal domain). Interestingly, ΔN-RGS2 does not interact with 
TRPV6. The amino-terminal domain of RGS2 is an important regulatory domain that, 
together with the “RGS-box” amino acid sequence, is necessary for interactions with RGS2 
effector proteins, GPCRs, and/or auxiliary proteins such as SPL 33-36. Third, using a cell 
surface biotinylation method, we showed that RGS2 does not retrieve TRPV6 from the 
plasma membrane of HEK293 cells co-expressing TRPV6 and RGS2. Together with the 
finding that RGS2 inhibits both Ca2+ and Na+ currents, these results suggest that RGS2 
needs to be recruited to the plasma membrane to affect the gating properties of the channel 
directly at the cell surface. In this respect, it has previously been demonstrated that G-
proteins recruit RGS proteins to the plasma membrane 37, and also SPL has been shown to 
fulfill such a function 35. SPL is a scavenger of RGS2, enhances the binding between RGS2 
and its GPCR, and increases the inhibitory effect of Ca2+-activated Cl- currents in parotid 
cells 35. While anticipating that SPL would increase the inhibitory effect of RGS2 on 
TRPV6-mediated Ca2+ and Na+ currents when a GPCR was involved in this pathway, the 
GST pull-down assay with the RGS2-interacting scaffold protein SPL did not reveal a 
stimulatory effect on RGS2 binding to TRPV6. In agreement, electrophysiological 
recordings of TRPV6 in HEK293 cells co-expressing SPL showed currents that were 
identical to those of TRPV6 alone. Together, these latter findings suggest a regulatory 
effect of RGS2 on TRPV6 activity that is independent of a GPCR. The actual mechanism 
of TRPV6 inhibition by RGS2 remains to be investigated; however, these results suggest 
that activity of TRP channels may be directly controlled by interacting proteins at the cell 
surface.   
     As concluded from the cell surface biotinylation experiments, TRPV6 activity is likely 
regulated by RGS2 directly at the plasma membrane. Thus, inhibition of TRPV6 is not a 
result of endocystosis of the channel. In this respect, the open state of TRPV6 may be 
affected by structural rearrangements of the channel, or by blockage of the pore region, 
following the binding of RGS2. Whether a structural 
rearrangement within the pore takes place or not, might be 
investigated by methods such as cystein substitution of the amino 
acids in the pore region. Such a method has been proven 
successful to - at least partly - elucidate the pH sensitivity of the 
epithelial Ca2+ channel, where intra- or extracellular protons 
narrow the pore via structural rearrangements 18. Otherwise, 
measuring the open probability of TRPV6 - by recording its single 
channel activity - may clarify whether RGS2 modifies the open 
 
RGS box:  
A domain of about 120 
amino acids that is a 
hallmark of RGS family 
members, involved in the 
binding of RGS proteins 
to Gα subunits. 
 157
Chapter 8 
state of the Ca2+ channel.  
 
Nipsnap1 inhibits the epithelial Ca2+ channel TRPV6 
Bioinformatics was applied as a tool to create a phylogenetic profile of TRPV5 and 
TRPV6 within the TRP superfamily. This profile was based on gene and protein database 
searches including co-expression, co-occurrence, gene fusion/fission, experimental data, 
and was designed to help us predicting genes that are possibly involved in transcellular 
Ca2+ transport as chaperones or as regulators of TRPV5 and/or TRPV6 activity. A number 
of genes that co-express with TRPV5 and TRPV6 were identified using this method, and 
by studying the candidates for a putative role in - for example - (ion) transport functioning, 
trafficking, or scaffolding, we selected the Nipsnap protein family to study in more detail 
by an experimental approach (as described in Chapter 3).  
     The Nipsnap proteins are well conserved during evolution, 
ranging from worm to man (Nipsnap1), but their physiological 
function is unknown 38, 39. The putative regulatory role of 
Nipsnap1 towards TRPV5 and TRPV6 activity was investigated 
by studying tissue distribution, biophysical properties of Nipsnap1 
and functional interactions with TRPV5 and TRPV6.  
 
Phylogenetic: 
Evolutionary relatedness 
of genes. A phylogenetic 
profile is the 
phylogenetic distribution 
of an orthologous group. 
By comparing 
phylogenetic profiles, 
putative biological 
interactions can be 
predicted. 
 
     The physical interactions between these proteins were 
established via GST pull-down and co-precipitation assays. 
Thereafter, we generated specific antibodies against Nipsnap1 to 
investigate (co-)localization of Nipsnap1 and TRPV5 or TRPV6 in 
different mouse tissues. Immunohistochemical labeling revealed 
that Nipsnap1 is present in the inner medulary collecting ducts 
(IMCD) of mouse kidney, as indicated by the co-localization of 
Nipsnap1 and Aquaporin-2 (AQP2), a marker protein for the 
collecting ducts. TRPV6, but not TRPV5, is present in the IMCD 
segment of the nephron. Moreover, Nipsnap1 did not localize 
together with TRPV5 that is expressed in the distal convoluted 
tubules (DCT) of the kidney cortex. Nipsnap1 expression in other 
tissues was investigated by reverse transcriptase (RT) polymerase 
chain reaction (PCR). The tissue panel indicated that Nipsnap1 is 
ubiquitously expressed, including the Ca2+-transporting tissues 
(e.g. intestine, bone, kidney), but not in spleen. In addition, semi-
quantitative RT-PCR showed that Nipsnap1 has higher expression 
Co-occurrence:  
Proteins with a similar 
distribution across 
species have a high 
tendency to functionally 
interact. 
 
Gene fusion/fission: Two 
adjacent genes fuse into a 
single gene (fusion), or a 
single gene splits into 
two genes (fission). 
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in colon compared to duodenum. Together, the localization and expression data made us 
decide to study the physiological effect of Nipsnap1 on TRPV6 only. 
     We identified the exact binding domains of Nipsnap1 within the TRPV6 amino acid 
coding sequence. Detailed analysis of the interaction domain revealed that Nipsnap1 binds 
to the TRPV6 amino-terminus (TRPV683-118) and carboxyl-terminus (TRPV6577-607) 
suggesting that Nipsnap1 is part of a mechanism involving multiple interaction sites. The 
carboxyl-terminal domain at position 603-607 in TRPV6 corresponds to the amino acid 
sequence MLERK. This MLERK domain is present in TRPV5 as well and it is conserved 
throughout evolution 20, underlining the potential importance of this particular stretch of 
amino acid residues. Interestingly, the MLERK domain has previously been demonstrated 
to be critical for TRPV5 and TRPV6 activity (by binding of interacting partners 80K-H, 
NHERF4 and Rab11A) 20, 21, 40, and for channel multimerization 41. In general, it suggests 
that this region is either a critical element for the general folding of the carboxyl-terminus 
of TRPV5 and TRPV6, or that several of the associated proteins recognize motifs within 
this particular region. Nipsnap1-mediated regulation of TRPV6 activity might be a dynamic 
result of several associated proteins that affect TRPV6 activity by antagonizing or 
synergizing each other via competitive association with the channel. In this situation, the 
occupancy of the binding sites would depend on the relative concentration and affinity of 
the proteins that, during over-expression of Nipsnap1, are in favor for Nipsnap1. Such a 
mechanism of ion channel regulation by competitive association for target sites might be 
feasible since it has also been defined for G-protein beta gamma subunit- (Gβγ-)dependent 
regulation of voltage-operated Ca2+ channels 42 43-46.  
     To identify the physiological relevance of Nipsnap1 and 
TRPV6 interaction, we applied whole cell patch-clamp analysis on 
HEK293 cells co-expressing Nipsnap1 and TRPV6. These data 
revealed an abolishment of Na+ and Ca2+ currents conducted 
through TRPV6 in HEK293 cells co-expressing Nipsnap1. 
Particularly, by applying purified Nipsnap1 protein into the cell 
via the patch pipette we could confirm the inhibitory effect of 
Nipsnap1 on TRPV6 activity in a more direct fashion compared to 
the generally used situation of protein over-expression in cells.  
 
Polycistronic operon:  
In bacterial DNA, the 
whole of an operator, 
promoter and one (mono) 
or more (poly) structural 
genes (cistrons) coding 
for one messenger RNA. 
 
SNAP25:  
A t-SNARE protein that 
is involved in lipid bi-
layer fusion by docking a 
vesicle to its target 
membrane. 
     Finally, using a cell surface biotinylation method, we showed 
that Nipsnap1 did not affect the cell surface expression of TRPV6 
at the plasma membrane of HEK293 cells co-expressing Nipsnap1 
and TRPV6. This latter finding indicates that Nipsnap1 probably 
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controls TRPV6 activity directly at the cell surface, independently from endocytosis or 
trafficking of the channel.  
     Considering the hypothesis that the Nipsnap1 proteins are involved in vesicular 
trafficking, which was based on the localization of the Nipsnap1 DNA coding sequence 
within a polycistronic operon encoding 4-nitrophenylphosphatase and SNAP25-like 
proteins 38, 47, our data challenges this assumption. In addition, as TRPV6 cell surface 
expression was not modified by Nipsnap1, it is unlikely that associated proteins such as 
S100A10-annexin-2 and Rab11A - that affect trafficking and recycling of the channel 19, 20 - 
are involved in the Nipsnap1-mediated inhibition of Ca2+ entry. Although it remains to be 
established whether the interaction of Nipsnap1 and TRPV6 induces structural 
rearrangements of the channel or that it affects the channels’ open probability by blocking 
the pore, these findings also support the idea that activity of TRP channels may be directly 
controlled by interacting proteins at the cell surface.   
 
Other proteins involved in TRPV5 and TRPV6 regulation at the cell surface by 
physical interaction  
 
As shown in the studies for RGS2 and Nipsnap1, the cell surface biotinylation method 
proved to be a powerful tool to investigate plasma membrane abundance of proteins. Using 
this method we could demonstrate that additional auxiliary proteins of TRPV5 and TRPV6 
regulate the cell surface abundance of the channels. For example, as described in Chapter 1, 
the first physiological role of the TRPV5- and TRPV6-interacting protein “B-box and 
SPRY-domain containing protein” (BSPRY) was identified as a direct negative regulator of 
the channels, involving inhibitory signaling cascades that control activity of the Ca2+ 
channels at the cell surface 48.  
     In addition, the Ca2+-sensing proteins 80K-H and calmodulin 
were demonstrated to bind Ca2+ via their EF-hand structures and 
to interact with TRPV5 and TRPV6 21, 22. Whereas calmodulin 
specifically bound TRPV5 and TRPV6 in a Ca2+-dependent 
fashion, 80K-H did not discriminate between the presence or 
absence of Ca2+ for the interaction. Importantly, by applying patch 
clamp recordings and the cell surface biotinylation method, it was 
demonstrated that 80K-H regulates the Ca2+-dependent inhibitory 
feedback mechanism of TRPV5 independently from its presence at 
the plasma membrane 21. Therefore, like in the cases of RGS2 and 
 
EF-hand:  
An about 30 amino-acid 
domain - consisting of an 
α-helix (E), a loop, and a 
second α-helix (F) – that 
can bind a Ca2+ ion in the 
loop region. EF-hand 
proteins contain 2 to 12 
copies of the EF-hand 
domain. 
 160
General discussion 
Nipsnap1, it was suggested that 80K-H regulates channel activity directly at the cell 
surface. Although calmodulin interacted with both TRPV5 and TRPV6, its physiological 
function seemed, however, to be restricted to the control of TRPV6 channel activity 22. This 
is a remarkable finding given the high homology between TRPV5 and TRPV6, and the 
similar binding characteristics of calmodulin to both channels. Although cell surface 
expression data is lacking for the calmodulin effect on TRPV6 activity, patch clamp 
analysis showed that calmodulin significantly affected the Ca2+-dependent inactivation of 
the channel 22, 49, suggesting a working mechanism similar to that of 80K-H on TRPV5 
activity.  
     Furthermore, the FK506-binding protein-52 (FKBP52, an enzyme that plays an 
important role in the translocation of steroid receptors to the nucleus 50), has previously 
been shown to interact with TRPV5 (among other members of the TRP superfamily) and to 
regulate its activity 51. FKBP52 reduces TRPV5-mediated Na+ and Ca2+ currents via its 
catalytic property 51 and it is therefore suggested that FKBP52 decreases the number of 
functional channels at the plasma membrane. However, information whether the plasma 
membrane abundance of TRPV5 channels is changed by the co-expression with FKBP52 is 
lacking at present. 
     Finally, the aforementioned auxiliary proteins of TRPV5 and TRPV6 are hypothesized 
to directly regulate channel activity at the cell surface. However, the tethering of the 
channels at the plasma membrane may be regulated primarily by the scaffolding proteins 
Na+/H+ exchanger regulatory factors- (NHERFs-)2 and -4 40, 52, 53. These proteins are 
expressed at the plasma membrane, interact with the epithelial Ca2+ channels at different 
sites of their carboxyl-terminal domains 40, 54, and may assist the S100A10-Annexin-2 
protein complex in channel delivery towards the cell surface. Trafficking of TRPV5 and 
TRPV6 will be discussed in one of the sections described below. 
 
REGULATION OF TRPV5 AND TRPV6 CELL SURFACE CHANNEL ABUNDANCE 
 
The previous paragraphs described the importance of TRPV5- and TRPV6-associated 
proteins in regulating the open or closed states of the channels at the cell surface. Another 
mean of controlling cellular Ca2+ influx via TRPV5 and TRPV6 is by changing the total 
number of channels present at the plasma membrane. Lowering the number of channels 
may be acquired by endocytosis, whereas increasing the total amount might be achieved via 
insertion of channels and/or by delaying the half-life of the typical retrieval of the channels 
present at the cell surface 55-57.  
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Local extracellular factors that regulate the cell surface abundance of the 
channels 
 
Activation of the Ca2+-sensing and Bradykinin-2 receptors in the kidney stimulate 
TRPV5 activity 
In Chapter 4 of this thesis we described the role of the extracellular Ca2+-sensing receptor 
(CaR) that is co-expressed with TRPV5 in the DCT segment of the kidney nephron. 
Changes in free [Ca2+]e are sensed by the CaR. Depending on the [Ca2+]e, the CaR initiates 
or blocks signaling cascades that release different calciotropic hormones affecting Ca2+ 
(re)absorption 58. Next to the main expression site of the CaR in the chief cells of the 
parathyroid glands, the receptor is also expressed in other tissues implied in regulating 
body Ca2+ homeostasis (i.e. intestine, kidney and bone) 59-61. In the kidney, CaR protein 
expression is prominently observed in proximal tubules, thick ascending limbs (TAL) of 
Henle’s loop, and (medullary) collecting tubules 62, 63. Although the role of the CaR in TAL 
has been clearly demonstrated 63-65, the functional importance of the receptor expressed in 
DCT and connecting tubules (CNT), where active Ca2+ reabsorption takes place, remained 
elusive. The DCT/CNT account for ~15 % of total renal Ca2+ reabsorption and are 
generally considered as sites fine-tuning sites the urinary Ca2+ excretion 2. As described, in 
the apical compartment of the DCT/CNT, TRPV5 is the gatekeeper for active Ca2+ 
reabsorption. In the present study, we demonstrated that activation of the CaR stimulates 
TRPV5 activity by a combined experimental approach including immunohistochemical 
labeling of TRPV5 and the CaR, [Ca2+]i measurements, and patch-clamp recordings. Our 
conclusion is based on the following findings: First, CaR and TRPV5 co-localize at the 
luminal membrane of DCT/CNT. Second, both Ca2+ and Na+ currents mediated by TRPV5 
were stimulated after CaR sensitization by neomycin or L-Phenylalanine. Third, CaR 
stimulation influences specifically TRPV5, since the currents of its closest relative, 
TRPV6, were unaffected. Forth, obstruction of the CaR signaling pathway using a 
dominant negative mutant of the CaR normalized the amplitude of the TRPV5-mediated 
current to their non-stimulated values. Fifth, the stimulatory effect of CaR activation on 
TRPV5-mediated currents was mediated via the phospholipase C (PLC)/protein kinase C 
(PKC) signaling pathway and required two conserved PKC phosphorylation sites 
(Ser(S)299 and S654) in TRPV5. Sixth, the down-stream signaling cascade that was 
activated by the CaR was mediated via phorbol 12-myristate 13-acetate (PMA)-insensitive 
PKC isoforms. Taken together, we postulate a functional role for the apical CaR in DCT 
and CNT segments of the kidney, where TRPV5 is predominantly present.  
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     Interestingly, it was previously shown that in Madin-Darby 
canine kidney (MDCK) cells (that serve as an in vitro cell model 
for the distal part of the nephron) activation of the basolaterally 
expressed CaR inhibits Ca2+ transport via decreasing the activity 
of the plasma membrane Ca2+-ATPase (PMCA) 66. These findings 
need to be confirmed in vivo but suggest that PMCA activity is 
down-regulated upon sensing hypercalcemia by the CaR. Our 
experiments, however, points to a hypercalciuria-induced activity 
of the luminal expressed CaR. Therefore, these findings reveal two 
distinct regulatory roles of the CaR in DCT, depending on its 
cellular localization; a balance between these processes may allow 
a precise control of final urinary Ca2+ excretion.  
Auto-/paracrine factor:  
(also termed ‘growth and 
differentiation factor’) 
A protein that is 
synthesized and excreted 
by a cell and that 
stimulates itself 
(autocrine), or that 
diffuses over a small 
distance to induce 
changes in neighboring 
cells (paracrine). 
 
 
     Importantly, we previously showed that activation of the 
bradykinin receptor subtype 2 (B2R) GPCR, by the serine protease tissue kallikrein (TK), 
increases TRPV5-mediated Ca2+ reabsorption 56. Whereas the CaR is activated by 
increasing [Ca2+]e in the pro-urine, TK acts from the CNT compartment 67 as an auto-
/paracrine factor to regulate active Ca2+ reabsorption. Notably, the mechanism by which 
the CaR and TK enhance transcellular Ca2+ transport in the DCT/CNT seem identical (as 
illustrated in Figure 3|1). TK activates a PLC/PKC pathway that phosphorylates TRPV5 at 
positions S299 and S654 and subsequently leads to increased channel abundance and 
activity at the cell surface 56. In addition, a delay of TRPV5 channel retrieval from the 
plasma membrane contributed significantly to this effect. Moreover, it was only recently 
demonstrated that phosphorylation of TRPV5 at positions S299 and S654 inhibits caveolin-
1-dependent endocytosis of the channel, thus increasing the cell surface abundance of 
TRPV5 68.  
     Together, these results attest the existence of local feedback mechanisms that could 
rapidly adapt renal Ca2+ reabsorption mediated by increased TRPV5 cell surface expression 
and activity. Whereas TK is a protease that activates the B2R to enhance TRPV5 activity, 
the CaR regulates TRPV5 activity independently of hormonal regulation by sensing 
increased Ca2+ levels in the pro-urine. 
 
The β-glucuronidase klotho stimulates TRPV5 and TRPV6 activity 
Klotho, a hormone exhibiting β-glucuronidase activity, has been proposed to play an 
essential role in long levity by affecting body Ca2+ and phosphate (Pi) homeostasis 57, 69-71. 
The enzyme removes terminal sialic acid residues from the sugar trees of the epithelial Ca2+ 
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channels, thus enabling the binding of galectin-1 to the exposed underlying disaccharides. 
The coupling of galectin-1 entraps TRPV5 and TRPV6 in the plasma membrane by 
inhibiting endocytosis (depicted in Figure 3|2), leading to accumulation of the channels at 
the cell surface 72. Surprisingly, almost the complete N-glycan of the channels remains 
intact during this process, whereas it was demonstrated earlier that removal of the complete 
sugar tree results in the identical effect of channel entrapment 57. Despite this discrepancy, 
klotho specifically modulates Ca2+ influx via TRPV5 and TRPV6, as no stimulatory effects 
were observed for the homologous channels TRPV4 and TRPM6 73.     
 
Intracellular mechanisms that regulate cell surface channel abundance 
 
In addition to the PLC/PKC signaling pathways that lead to phosphorylation of TRPV5 and 
subsequently increase the plasma membrane channel abundance by delaying its 
endocytosis, another intracellular mechanism by which the number of channels at the cell 
surface can be temporarily increased is by a delivery process termed ‘kiss and linger’ 
(Figure 4). In this process, channel-containing vesicles form transient openings with the 
plasma membrane and thereby expose the channels present in the vesicle to the 
extracellular compartment. This is a minute process that acts as if the channels were 
actually inserted into the plasma membrane. When the transient opening between the 
vesicle and the plasma membrane closes, the vesicle remains tethered to the cell surface, 
but the channels cannot contribute any longer to the influx of Ca2+.  This mechanism of 
temporarily increasing the number of channels at the cell surface was recently 
demonstrated for TRPV5 (see illustration in Figure 3|3), by total internal reflection 
fluorescence (TIRF) evanescent-field life cell microscopy 14. The process was initiated by 
changing the extracellular pH. Upon alkalization of the extracellular milieu, an increase in 
TRPV5 localization towards the plasma membrane was observed, accompanied by 
enhanced 45Ca2+ influx 14. Vice versa, upon extracellular acidification, TRPV5-containing 
vesicles were closed or recruited, with a simultaneous drop in 45Ca2+ influx. Importantly, it 
was previously shown that TRPV5 contains two pH-sensing amino acid residues that 
change the conformational structure of the TRPV5 pore region upon sensing protons 18. 
However, this structural rearrangement does not take place within the pH range of 6.0-8.5. 
Changes of the pH within this range significantly affect TRPV5 activity, and, therefore, the 
‘kiss and linger’ process may be the ultimate manner to regulate the pH-dependent activity 
of TRPV5 in the kidney.  
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DELIVERY OF TRPV5 AND TRPV6 CHANNELS AT THE CELL SURFACE 
(TRAFFICKING) 
 
Trafficking of TRPV5 and TRPV6 towards the plasma membrane may be achieved by 
transporting newly synthesized channels to the cell surface, or by recycling of channels 
after endocytosis. A crucial component in the correct facilitated transport of the channels 
towards the plasma membrane has been demonstrated for the S100A10-Annexin 2 protein 
complex that interacts with a short peptide sequence (VATTV, i.e. positions 597-601 in 
TRPV5, or 598-602 in TRPV6) within the channels’ carboxyl-terminal domain 19. This 
mechanism of channel delivery at the cell surface may be 
facilitated by the scaffolding proteins NHERF2 and -4, which are 
expressed at the plasma membrane 40. In this respect, NHERF2 
(together with serum- and glucocorticoid-dependent kinase 
isoform SGK1) specifically enhances TRPV5-mediated Ca2+ 
influx via increased cell surface abundance of the channel, and 
does not affect TRPV6 52, 53. Once the channels are expressed at 
the cell surface they are subject to a dynamic range of processes 
that affect their activity, as is evident from the sections described 
above. Inactive channels are internalized via dynamin- and 
clathrin-dependent activities (Figure 3|4) 55. Following the 
retrieval from the cell surface, the channels enter a Ca2+-controlled 
and Rab11A-dependent recycling compartment 20, 55, from where 
they can be inserted into the plasma membrane again. Importantly, 
it is suggested that a large endosomal pool of the channels is 
present to replenish the internalized fraction, because blocking 
protein synthesis for several hours did not affect Ca2+ influx 55.    
 
Dynamin:  
A large GTPase involved 
in endocytosis by the 
scission of newly formed 
vesicles from parent 
(plasma, golgi) 
membranes. 
 
Clathrin:  
A fibrous protein that 
(with the aid of assembly 
proteins) polymerizes 
into a lattice-like network 
at specific regions on the 
cytosolic side of the 
plasma membrane, 
thereby forming a 
clathrin-coated pit, which 
buds off to form a 
vesicle.  
 
Endosome:  
A sorting versicle with an 
acidic internal pH in 
which bound ligands 
dissociate from their 
membrane-bound 
receptor proteins 
     Recently, two sub-types of the ‘With-No-Lysine (K)’ (WNK) 
family of serine/threonine protein kinases have been implicated in 
the secretory process of TRPV5 and TRPV6 to enhance cell 
surface expression and Ca2+ influx when expressed in Xenopus 
laevis oocytes 74, 75. WNK3 was demonstrated to enhance both 
TRPV5 and TRPV6 activity via its kinase domain 74, whereas 
WNK4 specifically regulates TRPV5-mediated Ca2+ influx via a 
role in the secretory pathway that involves the complex N-
glycosylation of the channel (Figure 3|4) 76.  
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IN VITRO TOOLS TO GAIN MORE INSIGHT INTO THE REGULATION OF TRPV5 
AND TRPV6 AT THE CELL SURFACE  
 
Evident from the previous paragraphs is that regulation of TRPV5 and TRPV6 at the cell 
surface is an important and complex interplay of different processes that control the plasma 
membrane channel abundance, or that directly regulate the open or closed state of the 
channels present at the cell surface. The evidence to support these conclusions was 
acquired utilizing a comprehensive range of experimental techniques such as 
immunohistochemistry, protein-protein binding identification, patch clamp recordings of 
channel activity, mutagenesis, siRNA, and etcetera. Together, this shows that applying 
efficient and valid techniques to study TRPV5 and TRPV6 regulation are a prerequisite to 
obtain progress in our knowledge. The following paragraphs describe two valuable tools 
that helped us to further unravel the basis of epithelial Ca2+ channel regulation at the 
plasma membrane.    
 
Homo- and heteromultimeric assembly of the epithelial Ca2+ channels 
 
TRPV5 and TRPV6 are assembled into a multimeric protein complex that consists of four 
individual subunits, surrounding a central pore, and forming one functional ion channel 
complex. Two domains in the amino-terminal tail (position 69-82, first ankyrin repeat) and 
carboxyl-terminal tail (602-606, MLERK coding sequence) are crucial for channel subunit 
assembly and the subsequent trafficking of the channel towards the cell surface 41. TRPV5 
Figure 4. ‘Kiss and linger’ process of vesicular transport. TRPV5-containing vesicles are 
tethered to the plasma membrane and form transient openings with the extracellular 
compartment. After closing, vesicles relocate back to the cytosol.  
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and TRPV6 are co-expressed in several tissues 2, which allows oligomerization of the 
distinct subunits in vivo, and consequently, regulation of the relative expression levels of 
TRPV5/6 may be a mechanism to fine-tune the Ca2+ transport kinetics in these tissues. 
Therefore, the tetrameric stoichiometry of TRPV5 and TRPV6 using concatemeric 
TRPV5/6 constructs was examined previously (by applying cross-
linking studies, co-immunoprecipitations, ‘Förster resonance 
energy transfer’ (FRET) light microscopy, and molecular mass 
determination of TRPV5/6 complexes using sucrose gradient 
sedimentation) and it was shown that TRPV5 and TRPV6 can 
form homo- and heterotetrameric channel complexes in vitro 77, 78. 
Furthermore, patch clamp analysis revealed that by having a 
different number of TRPV5 and TRPV6 subunits in such a 
concatemer the resulting channel complex displays a phenotype 
resembling mixed properties of TRPV5 and TRPV6 77.  
 
FRET:  
A technique in 
fluorescence microscopy. 
For FRET to occur, two 
fluorochromes must be 
within a defined distance 
of one another (typically 
<10 nm) and have their 
dipoles correctly 
oriented. Under these 
conditions, when one 
fluorochrome (donor) is 
excited, its excited-state 
energy can be transferred 
to the second 
fluorochrome (acceptor) 
via a nonradiative 
transfer. To monitor 
intramolecular FRET, the 
donor is excited and the 
intensity ratio of the 
donor and acceptor 
emissions is calculated. 
Because the 
stoichiometry of the two 
probes is always 1:1, the 
amount of direct 
excitation of the acceptor 
and donor emission 
bleedthrough is constant. 
Therefore, any change in 
the resulting emission 
ratio will reflect changes 
in the level of FRET. 
     To get a step closer to a possible in vivo situation of fine-tuning 
Ca2+ influx by expression of heterotetrameric channels at the cell 
surface, it is crucial that we can identify TRPV5/6 homo- or 
heterotetrameric channel assembly from single TRPV5 and 
TRPV6 transcripts rather than using the concatemeric constructs 
described previously. By designing an experimental setup to study 
channel assembly, we combined this purpose with the generation 
of an inducible protein expression system to regulate TRPV5 
abundance in time, which is described in Chapter 6 of this thesis. 
The method we applied to study channel assembly of TRPV5 in 
living cells was extrapolated from a recently published technique 
having the ability to reversibly regulate protein expression in time, 
based on the interaction of small molecules 79. By labeling TRPV5 
with the small molecule FKBP12F36V,L106P, thus creating an 
unstable fusion protein (mtFKBP-TRPV5), mtFKBP-TRPV5 was 
prompted for degradation. However, when applying the cell-
permeant synthetic molecule termed Shield-1, mtFKBP-TRPV5 
was rescued from degradation. Shield-1 binds to FKBP12F36V,L106P 
at its mutated region and thereby stabilizes the (fusion-)protein. 
Using Shield-1, we showed that expression of mtFKBP-TRPV5 
could be regulated dose-dependently, in time, and that this 
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expression was reversible when Shield-1 was removed. Furthermore, the degradation of 
mtFKBP-TRPV5 was identified to be mediated via the proteasome, as indicated by the 
‘rescue effect’ of MG132 (an inhibitor of the proteasome) as a substitute for Shield-1, 
whereas chloroquine (an inhibitor of the lysosome) did not inhibit mtFKBP-TRPV5 
degradation. Subsequently, TRPV channel stochiometry was studied by co-transfecting 
mtFKBP-TRPV5 with wild-type TRPV5, TRPV6, or with TRPV4. In the presence of 
Shield-1 mtFKBP-TRPV5 formed heteromultimers with wild-type TRPV5 and with its 
closest relative, TRPV6, but not with TRPV4. This was shown by the dominant-negative 
effect of mtFKBP-TRPV5 in the degradation of co-transfected wild-type TRPV5 and 
TRPV6 when Shield-1 was omitted from the medium 24 hours after transfection/channel 
assembly. Interestingly, this dominant-negative effect could also be demonstrated more 
directly by omitting Shield-1 from the complete procedure. Importantly, TRPV4 expression 
was not affected by mtFKBP-TRPV5 when Shield-1 was removed, revealing the specificity 
of TRPV5 and TRPV6 heteromultimerization. Together, these results further demonstrated 
that TRPV5 and TRPV6 may specifically assemble into heterotetrameric channel 
complexes in vivo.  
     By the here established functionality of this tunable protein expression method in 
studying TRPV5 and TRPV6 regulation, also mtFKBP–fusion proteins of TRPV5- and/or 
TRPV6-associated proteins could be constructed in future. These would provide efficient 
methods to investigate - in time - the effect of these auxiliary proteins on TRPV5/6 channel 
activity in living cells. 
 
Generation of a polarized cell line stably expressing green-fluorescent TRPV5 
 
By generating a TRPV5-expressing polarized cell line, which is described in Chapter 7, we 
aimed to acquire an in vitro cell model mimicking the in vivo DCT/CNT situation. 
Therefore, we stably expressed green-fluorescent protein- (GFP-)TRPV5 in MDCK-type 1 
cells, in order to investigate its expression and Ca2+ entry. The localization of GFP-TRPV5 
in this cell line displayed an intracellular granular distribution. Ca2+ uptake in GFP-TRPV5-
MDCK cells cultured on permeable supports was threefold higher than in non-transfected 
cells. Moreover, apical Ca2+
 
uptake in GFP-TRPV5-MDCK cells cultured on permeable 
supports was eightfold higher than basolateral Ca2+
 
uptake, indicating that GFP-TRPV5 is 
expressed predominantly in the apical membrane, which is in line with its in vivo 
localization. Patch-clamp analysis showed the presence of typical electrophysiological 
features of TRPV5, such as inwardly rectifying currents, inhibition by divalent cations and 
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the Ca2+-dependent inactivation. Moreover, the TRPV5 inhibitor ruthenium red completely 
inhibited Ca2+
 
uptake in GFP-TRPV5-MDCK cells, whereas Ca2+
 
uptake in non-transfected 
cells was not affected.  
     After establishing this kidney cell model with TRPV5 expressed at the apical cell 
surface, we used this characterized cell line to assess the regulation of TRPV5. For this 
purpose we tested different compounds that have previously been shown to stimulate 
TRPV5 activity in ex vivo primary cultures of rabbit DCT/CNT cells 12, 80, or that were 
suggested to stimulate TRPV5-mediated Ca2+ influx 81, 82. In this respect, the PKC activator 
PMA and the cAMP-elevating compounds forskolin/3-isobutyl-1-methylxanthine, 8-
bromo-cAMP and Prostaglandin-E2 were tested and revealed to stimulate TRPV5 activity 
in the GFP-TRPV5-MDCK cells. Importantly, these compounds did not affect Ca2+
 
uptake 
in non-transfected control cells. Taken together, this GFP-TRPV5-MDCK polarized cell 
line provides an excellent model to specifically study the regulation of TRPV5 activity.  
 
IN VIVO PHYSIOLOGICAL RELEVANCE AND FUTURE PERSPECTIVES 
 
The first paragraph of the introduction to this thesis (Chapter 1) described the important 
clinical relevance of maintaining correct body Ca2+ homeostasis and therewith the essential 
role of studying the regulation of transepithelial Ca2+ transport in Ca2+-(re)absorptive 
epithelia. In this respect, different processes involved in TRPV5- and TRPV6-mediated 
Ca2+ transport (i.e. regulation of transcription, channel assembly, trafficking, or channel 
activity) were described above. The various regulatory factors that affect these processes 
are summarized in Table 1. Importantly, however, in this final section of my thesis I would 
like to discuss our experimental findings in a broader context by extrapolating this data 
towards several in vivo (mice) models that are nowadays available. This should bring our 
cell biological data a step closer to the clinic.  
 
Active Ca2+ (re)absorption: from cell physiology to organism 
 
RGS2 and Nipsnap1  
Described in Chapters 2 and 3, RGS2 and Nipsnap1 are potent inhibitors of TRPV6-
mediated Ca2+ transport. By studying RGS2-deficient mice, RGS2 has now been implicated 
in a diverse range of physiological processes including hypertension 32, 83-86, immunity 87, 
anxiety 87 and neuronal synaptic activity 88. In our study, RGS2 inhibited Ca2+ influx via 
TRPV6. In respect to Ca2+ absorption, TRPV6 is mainly functionally expressed in the 
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duodenum 2, 89, 90, and so we investigated the mRNA expression of TRPV6 in RGS2-/- mice. 
These knock-out mice showed a markedly larger diameter of the duodenum and a 
significantly increased TRPV6 mRNA expression, compared to control littermates 
(unpublished findings). This would implicate that in wild-type mice TRPV6 expression is 
attenuated by RGS2, which makes sense if RGS2 and TRPV6 are assembled into, or 
expressed as, a protein complex that is transported to the cell surface. TRPV6 and RGS2 
inter 
Table 1. Regulatory factors of TRPV5 and TRPV6 described in this thesis. “+”, “–“, or “=” 
indicate stimulation, inhibition, or no effect, respectively. ND means not determined. See text 
for more details regarding each factor. 
 
Regulatory factor TRPV5 TRPV6 Affected process 
[Ca2+]i - - Unknown 
1,25(OH)2D3 + + Transcription 
80K-H + ND Channel activity 
Acidosis - ND Transcription/channel 
activity/trafficking 
Androgen - ND Transcription 
BSPRY + ND Unknown 
Calmodulin = + Channel activity 
CaR + = Channel activity/trafficking 
Dietary Ca2+ + + Transcription 
Estrogen + + Transcription 
FKBP52 - ND Channel activity 
Klotho + + Trafficking 
NHERF2/SGK1 + ND Unknown 
NHERF4 = = Unknown 
Nipsnap1 - - Channel activity 
PTH + = Transcription 
Rab11A + + Trafficking 
RGS2 = - Channel activity 
S100A10-Annexin 2 + + Trafficking 
Tissue Kallikrein + ND Channel activity/trafficking 
WNK3 + + Trafficking 
WNK4 + ND Trafficking 
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interact via their amino-terminal domains, however, experimental evidence for the 
existence of such a protein complex at the plasma membrane is lacking. In addition, since 
TRPV6-/- mice are now available 91 (see following paragraph), it would be interesting to 
investigate whether RGS2 expression is affected in these mice.  
     The inhibition of TRPV6 activity by Nipsnap1 demonstrated the first physiological 
implication of this auxiliary protein. At present, Nipsnap1-deficient or over-expressing 
mice are not available to study its in vivo relevance in a more direct fashion. However, it 
would be tempting to investigate whether Nipsnap1 plays a significant role in the 
(patho)physiology of TRPV6-/- mice. 
 
TRPV6-/-, calbindin-D9K-/-, and the double knock-out mice 
TRPV6 is located in the luminal brush border of enterocyte epithelial cells present in the 
GI tract. Within the GI tract, TRPV6 is mainly localized to the duodenum 89, where it is the 
postulated rate-limiting factor of transepithelial Ca2+ transport. A cancer cell line derived 
from human colon (Caco-2) that mimics a mature enterocyte phenotype after 
differentiation, demonstrated that endogenous TRPV6 and calbindin-D9K expression was 
dependent on the presence of the active metabolite of vitamin D: 1,25-dihydroxy-vitamin 
D3 (1,25(OH)2D3) 92-94. Moreover, in mice and man, the duodenal expression of TRPV6 is 
1,25(OH)2D3-dependent, and both properties decrease with age 95, 96 - which can explain (at 
least in part) the decreased intestinal absorption of Ca2+ in elderly woman. The in vivo 
function of TRPV6 was ultimately demonstrated by the generation of TRPV6-/- mice 91. 
These mice were viable, but suffered from a 60 % decreased intestinal Ca2+ absorption. In 
addition, they showed abnormal bone formation, renal Ca2+ wasting, impaired weight gain, 
lower fertility, and decreased maternal-fetal Ca2+ transport 91, 97. Together, this implies that 
TRPV6 not only fulfills essential roles in Ca2+-transporting epithelia, but also in other 
tissues. The processes in which TRPV6 is involved in these latter tissues remains to be 
explored, but importantly, also a functional role for TRPV6 in Ca2+ reabsorption in the 
kidney remains to be demonstrated. In kidney, TRPV6 may form heterotetrameric channels 
together with TRPV5, thus contributing to the active reabsorption of Ca2+.  
     Surprisingly, a number of recent genetic studies are challenging the currently proposed 
three-step process of transcellular Ca2+ transport in enterocytes. This ‘general process’ 
involves the entry of Ca2+ via TRPV6, diffusion of intracellular Ca2+ to the basolateral cell 
compartment by binding to calbindin-D9K, and extrusion of Ca2+ into the bloodstream via 
PMCA1b. It was expected that calbindin-D9K-/- mice would be impaired in this transcellular 
pathway of Ca2+ transport, and would therefore suffer from decreased intestinal Ca2+ 
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Figure 5. Tight junctions and their pore-like structures by claudins. In the tight junction of 
two neighboring cells membranes form a continuous seal: claudin strands adhere with each 
other in the paracellular space, thereby forming charge- and size-selective aqueous pores. 
absorption. However, those mice were not different from wild-type mice in phenotype and 
serum Ca2+ levels 98. Moreover, calbindin-D9K-/- mice were able to absorb dietary Ca2+ in 
response to 1,25(OH)2D3, indicating that calbindin-D9K is not essential for 1,25(OH)2D3-
dependent intestinal Ca2+ absorption. Whereas it could be reasoned that other EF-hand 
proteins may take over the role of calbindin-D9K in the enterocytes of these knock-out mice 
(as long as they are 1,25(OH)2D3 controlled), it is more likely that a different 1,25(OH)2D3-
dependent pathway of intestinal Ca2+ absorption contributes to the 
normalized serum Ca2+ levels. The rationale for this assumption is 
that TRPV6/calbindin-D9K double knock-out mice were also still 
able to increase duodenal Ca2+ transport after 1,25(OH)2D3 
supplementation 99. Because compensatory or reciprocal 
mechanisms by TRPV5 (in kidney), TRPV6 (in calbindin-D9K-/- 
mice), calbindin-D28K, or PMCA1b were not significantly altered 
in the TRPV6-/-, calbindin-D9K-/-, and TRPV6-/-|calbindin-D9K-/- 
mice, a 1,25(OH)2D3-dependent effect on paracellular Ca2+ 
transport may point to an explanation for these observations. For 
instance, it was generally considered that paracellular Ca2+ fluxes, 
mediated via tight junctions (Figure 5), were mainly 
concentration- and electrical gradient-dependent processes that 
 
Tight junction:  
Region of the cell 
surface, of variable size, 
and situated just below 
the apical border where 
the membranes of 
adjacent cells are fused to 
form a continuous seal; 
serves as a selective 
barrier to small molecules 
and as a total barrier to 
large molecules.  
 173
Chapter 8 
were not specifically regulated; however, different lines of recent evidence might change 
this assumption: (a) in Caco-2 cells a dose-dependent 1,25(OH)2D3-mediated increase in 
transepithelial electrical resistance, accompanied by a significant raise in paracellular Ca2+ 
transport, was demonstrated - possibly by affecting the assembly and/or permeability of the 
tight junctions 100; (b) a mutated subunit in renal tight junctions caused impaired 
paracellular Mg2+ reabsorption in humans, and resulted in severe urinary Mg2+ wasting and 
hypomagnesaemia 101; (c) claudins (i.e. structural components of the tight junction 102) were 
demonstrated to create pore-like structures in the paracellular space that are ion size and 
charge selective 103 - and, importantly, the expression of some claudin isoforms (present in 
and between enterocytes) was shown to be regulated by 1,25(OH)2D3 104. Together, these 
findings imply an important function for tight junctions in 1,25(OH)2D3-dependent 
regulation of paracellular Ca2+ transport, and thus may account for the 1,25(OH)2D3-
activated Ca2+ absorption in TRPV6-/- and/or calbindin-D9K-/- mice. To determine whether - 
and which - claudins might be involved in this process would be a tempting but challenging 
project, because of the large number of claudin isoforms and the variety in claudin 
structural arrangements.  
 
TRPV5-/-, TRPV5-/-/calbindin-D28K-/-, klotho-/-, and FGF23 knock-out mice  
The generation of TRPV5-/- mice demonstrated the physiological importance of TRPV5 as 
gatekeeper of epithelial transcellular Ca2+ transport. These knock-out mice suffer from 
severe hypercalciuria, polyuria, acidification of urine and reduced bone thickness 105, as 
described in Chapter 1. In addition, compensatory mechanisms such as hyperabsorption of 
dietary Ca2+ in the intestine was observed in these mice 105, resulting from hypervitaminosis 
D 106. The polyuria and acidification of urine likely prevent urinary tract stone formation 
that could be caused by the severe hypercalciuria. In contrast, however, the TRPV5-/- mice 
are also characterized by hyperphosphaturia 105, which, in turn, would lead to an increased 
risk of Ca2+-Pi precipitation. The mechanism responsible for the urinary loss of Pi in the 
TRPV5-/- mice is presently unknown.  
     The gatekeeper function of TRPV5 was further demonstrated by calbindin-D28K-/- and 
TRPV5-/-|calbindin-D28K-/- double knock-out mice. Renal Ca2+ wasting in TRPV5-/- mice is 
about 4 times higher than in calbindin-D28K-/- animals 107. In addition, the Ca2+ wasting by 
the double knock-out mice was not aggravated in respect to the TRPV5-/- mice 107. 
Moreover, other renal, intestinal, and serum parameters (e.g. mRNA expression of Ca2+-
transport proteins, serum 1,25(OH)2D3 and PTH levels) were not different between the 
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calbindin-D28K-/- and TRPV5-/-|calbindin-D28K-/- mice 107, suggesting that TRPV5, and not 
calbindin-D28K, is the rate-limiting step in active renal Ca2+ reabsorption.  
     Interestingly, many of the characteristics of TRPV5-/- mice were also observed in klotho-
/- and fibroblast growth factor-23 (FGF23) knock-out mice (e.g. hypercalciuria, 
hypervitaminosis D, hyperphosphatemia, and reduced bone mineral density) 70, 108, 109. 
Whereas klotho has been implicated in the regulation of the Ca2+ balance, FGF23 plays a 
role in Pi homeostasis as a phosphatonin 108, 110-112. FGF23 is secreted from osteoblasts and 
binds and activates FGF receptors 113, 114. An overlap in klotho and FGF23 signaling was 
demonstrated by the observation that klotho forms a complex with these FGF receptors 115, 
116. Thus, the concerted action of klotho and FGF23 contributes to the regulation of renal Pi 
handling, whereas the synergistic effect of klotho on TRPV5 activity contributes to the 
regulation of renal Ca2+ reabsorption.  
     These different knock-out mice are valuable models that help to further delineate 
essential aspects of (renal) Ca2+ and Pi homeostasis. It would be interesting to evaluate the 
(lack of) kidney stone formation in these mice models. For certain, also the CaR will play 
an important role therein. 
 
CaR-/-, CaR-/-/PTH-/-, and TK knock-out mice  
Plasma [Ca2+] is sensed by the CaR in the parathyroid glands and affects the hormonal 
regulation of Ca2+ re(absorption). In addition, the CaR fulfills important local functions in 
the kidney: (i) in TAL, activation of the CaR inhibits paracellular Ca2+ reabsorption that is 
driven by the lumen-positive, transepithelial potential gradient generated by the apical Na+-
K+-2Cl- co-transporter combined with the recycling of K+ into the tubular lumen via the 
renal outer medulla K+ channel 65, 117, 118; (ii) activation of the CaR in the collecting ducts 
modulates NaCl and water transport, and assists the TAL in regulating divalent mineral 
reabsorption and urine concentration 63-65, thereby minimizing the risk of urinary tract stone 
formation; (iii) activation of CaR in DCT/CNT activates TRPV5 and stimulates 
reabsorption of Ca2+ (described in Chapter 4). 
     Genetic ablation of the CaR in mice results in severe hyperparathyroidism and 
hypercalcemia, leading to fast post-neonatal dead 119. When these mice were cross-bred 
with PTH-/- mice, generating homozygous CaR-/-|PTH-/- mice, no severe phenotype was 
observed 120. Surprisingly, however, CaR-/-|PTH-/- mice have increased TRPV5 and TRPV6 
mRNA expression in kidney and intestine, compared to control littermates 120, suggesting 
an in vivo role for the CaR in wild-type mice by regulating Ca2+ homeostasis independently 
of PTH secretion.  
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     Interestingly, our hypothesis of a functional role of the CaR in DCT/CNT points to an 
increase of TRPV5 expression at the plasma membrane to explain the enhanced Ca2+ entry 
in HEK293 cells co-expressing the CaR and TRPV5. In addition, activity of the epithelial 
Ca2+ channel remains unchanged when the CaR is not activated, or not present. 
Surprisingly, also the CaR-/-|PTH-/- mice display increased expression of the Ca2+ channels. 
PTH is important for the formation of 1,25(OH)2D3, but serum 1,25(OH)2D3 levels were 
not published for the CaR-/-|PTH-/- mice, nor for PTH-/- mice. In parathyroidectomized rats, 
however, 1,25(OH)2D3 levels are only slightly reduced 121. Therefore, a compensatory 
mechanism involving 1,25(OH)2D3 or expression of the vitamin D receptor (independent of 
PTH) may eventually lead to stimulation of gene transcription of TRPV5 and TRPV6 (and 
related Ca2+ transport proteins) in the CaR-/-|PTH-/- mice, whereas in our current study the 
local effect of CaR activation was investigated without the influence of calciotropic 
hormones. Generation of a kidney/tissue-specific CaR or TRPV5 knock-out mouse would 
both be valuable tools to unravel the precise mechanism by which the CaR regulates 
TRPV5 in vivo. 
     Genetic ablation of TK in mice resulted in a robust hypercalciuria 122 that was 
comparable to the urinary Ca2+ wasting in TRPV5-/- mice. It was proposed that TK could be 
a physiologic regulator of renal Ca2+ transport, however acting independent of its kinin-
forming properties 122. Thereafter, the signaling pathway of TK controlling TRPV5 activity 
was delineated 56, and shown to be similar to that of the CaR 2nd messenger pathway 
described in Chapter 4.  
 
(Fe)male sex hormones: estrogen and androgen 
A role for estrogen in Ca2+ homeostasis was demonstrated by estrogen therapy in 
postmenopausal women that suffer from decreased Ca2+ absorption, leading to 
osteoporosis. The therapy corrects the decline in 1,25(OH)2D3-dependent active Ca2+ 
absorption, as indicated by studies using estrogen receptor-α (ERα) knock-out mice 123, and 
ovariectomized (OVX) rats 124, 125 or women 126. However, the 1,25(OH)2D3-dependency of 
this effect is controversial and may be dependent on the studied model. In addition, one 
should also be careful with the concept that ERα is the main target for estrogen (because in 
human intestine the β-subtype is the principal ER 127). Of other importance is that using 
OVX animals does not eliminate the formation of estrogens by aromatization of adrenal 
androgens 128. Estrogen can regulate the expression of active Ca2+ transport proteins 123, 125; 
however, a recent study using human colonic cells suggests that estrogen also has a fast 
stimulatory effect on TRPV6 activity, independent of its response on transcription of the 
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channel 129. Although further studies are needed to clarify the mechanisms triggered by 
estrogen, all cases show that estrogen increases Ca2+ absorption and thus demonstrate the 
importance of estrogens in the regulation of body Ca2+ homeostasis. 
     While estrogens can regulate active Ca2+ transport, detailed information about the 
function of androgens in this context is lacking. For instance, androgen deficiency may 
result in a negative Ca2+ balance via long-term effects that increase bone demineralization, 
but a direct role in renal Ca2+ handling may also be present. Therefore we investigated 
whether androgen affected renal active Ca2+ reabsorption by regulation of the expression of 
TRPV5 and calbindin-D28K, in an effort to elucidate the sex differences in renal Ca2+ 
handling. As described in Chapter 5, we demonstrated that male mice excrete significantly 
more Ca2+ in their urine compared to female mice, and that this increased excretion was 
accompanied by reduced renal expression of the Ca2+ transporters. In addition, 
orchidectomized mice (ORX mice), which we used as a model for the androgen deficiency 
status, excreted less Ca2+ than sham-operated controls. Urinary Ca2+ excretion restored to 
control levels when the ORX mice were treated with testosterone. Consistently, loss of 
androgen resulted in augmentation of both renal mRNA and protein abundance of TRPV5 
and calbindin-D28K, which in turn was suppressed by treatment with testosterone. 
Importantly, no significant differences in serum estrogen, parathyroid hormone or 
1,25(OH)2D3 levels were observed between control, ORX and testosterone-treated ORX 
mice. The negative effect of androgen on renal Ca2+ reabsorption could be substantiated in 
an ex vivo model of primary cells of rabbit CNT/cortical collecting ducts, in which 
incubation of the androgen dihydrotestosterone inhibited transcellular Ca2+ transport. 
Moreover, the experiments using this ex vivo model exclude possible contributions of bone 
turnover or androgen aromatization to estrogen. In conclusion, our study demonstrates that 
androgen is negatively involved in renal Ca2+ reabsorption via the attenuation of TRPV5 
and calbindin-D28K, an effect independent of calciotropic hormones or estrogen.  
 
Concluding notes 
 
Here, I have described the phenotypes of various (knock-out) animals - suffering from 
deregulated body Ca2+ levels - to underline the essence of Ca2+ homeostasis. Discussing the 
effects of, for example, 1,25(OH)2D3-supplementation, high or low Ca2+ diets, or 
glucocorticoid treatment in animals or patients was beyond the scope of this thesis. 
However, the animal models here described helped to explain the molecular mechanisms 
that are responsible for regulation of Ca2+ absorption and reabsorption in healthy and 
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diseased individuals. In this respect, understanding the fundamental cellular regulation of 
TRPV5 and TRPV6 channel abundance and activity at the plasma membrane is of vital 
importance. Regulation of TRPV5 and TRPV6 at the cell surface by direct physical 
interaction was, for instance, demonstrated by the channel–associated proteins RGS2 and 
Nipsnap1. Although single channel electrophysiological recordings or cystein scanning 
studies are needed to elucidate the precise mechanism(s) by which these chaperone proteins 
work, other valuable tools to identify the basis of cell surface regulation of TRPV5 and 
TRPV6 were utilized in the studies described in Chapters 6 and 7 of this thesis. 
Furthermore, the effect of androgens on TRPV5 expression is likely mediated via binding 
of the hormone to androgen receptors expressed in the DCT, and therefore, together with 
the CaR, these are – potentially pharmacological – extracellular targets that affect the 
cellular abundance of the channel. However, in that respect, kidney cell type-specific 
markers should be identified to guarantee the proper targeting of those receptors. In 
addition to the predominant biochemical methods to identify cell surface expression of 
TRPV5 and TRPV6, advanced microscopic techniques may further identify the precise 
regulation of the channels at the plasma membrane. For example, TIRF microscopy would 
be a valuable tool to study the effects of auxiliary proteins on TRPV5 and TRPV6 channel 
expression at the plasma membrane, next to the cell surface biotinylation method. This 
former technique has been proven successful by demonstrating the effects of extracellular 
pH and the role of calbindin-D28K in TRPV5 cell surface channel regulation 14, 23. 
Furthermore, by using the Fura2 Ca2+ indicator, the effects of TRPV5 and TRPV6 on total 
intracellular free Ca2+ can be studied, thus providing information about inactivation of the 
channels expressed at the cell surface. The findings described in this thesis, together with 
these exciting future prospects, may ultimately lead to a more complete understanding of 
the molecular and cellular mechanisms behind cell surface regulation of the epithelial Ca2+ 
channels and their contribution to the daily maintenance of the body Ca2+ balance. 
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Chapter 9 
Calcium ions (Ca2+) are very important for many physiological functions in the body, 
including intracellular signaling processes, neuronal excitability, muscle contraction and 
bone formation. For all these processes it is essential that the concentration of Ca2+ is 
maintained at a constant level in the plasma of the body’s circulation. Disturbances in the 
plasma Ca2+ concentration ([Ca2+]e) may result in clinical symptoms such as decreased 
bone mineral density (osteoporosis) when [Ca2+]e is persistently too low, or the formation 
of kidney stones when [Ca2+]e is too high. 
     In healthy individuals [Ca2+]e is regulated by a homeostatic mechanism that tightly 
controls the concerted actions of intestinal Ca2+ absorption, renal Ca2+ excretion and 
reabsorption, and exchange of Ca2+ to and from bone. An important step of the Ca2+ 
exchange in these organs is the transport across epithelial cell layers. The bulk of Ca2+ is 
transported in a passive paracellular fashion. However, to maintain [Ca2+]e at a constant 
level, the body is also equipped with an active Ca2+ transport mechanism that is of major 
significance because it determines the net amount of total Ca2+ (re)absorption. Active, 
transcellular, transport of Ca2+ takes place predominantly in the proximal part of the small 
intestine (duodenum) and in the distal convoluted tubules (DCT) and connecting tubules 
(CNT) of the kidney. The process of transcellular Ca2+ transport occurs in three sequential 
steps: Ca2+ enters the polarized cell at its luminal membrane, facing the diet or pro-urine, 
via the epithelial Ca2+ channels Transient Receptor Potential Vanilloid-subtype 5 (TRPV5) 
and/or TRPV6. In the cell, Ca2+ is sequestered by specialized Ca2+-binding proteins, 
calbindin-D28K or -D9K that maintain the intracellular Ca2+ concentration at low non-toxic 
levels, and translocates to the basolateral membrane. Subsequently, Ca2+ is extruded into 
the bloodstream via the Na+/Ca2+-exchanger and/or the plasma membrane Ca2+-ATPase-1b. 
     Transepithelial Ca2+ transport is under the strict control of systemic calciotropic 
hormones, such as the parathyroid hormone (PTH) and 1,25-dihydroxy-vitamin D3, but also 
regulated by various extra- and intracellular factors. These factors can influence the 
transport as well as the internalization and recycling of the channels towards and from their 
functional domain, the plasma membrane. Regulation of the channels at the cell surface is, 
perhaps, the most important because it allows immediate response of the body to 
fluctuations in [Ca2+]e. To understand how the Ca2+ balance in the body is maintained, it is 
essential to acquire more insight in the plasma membrane regulation (expression and 
activity) of TRPV5 and TRPV6. 
     The characterization of several Ca2+ channel-associated proteins, as described in Chapter 
1, already provided important insights in regulation of the channels. However, particularly 
the regulation of TRPV6 at the cell surface by associated proteins (molecular chaperones) 
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remained unclear. Therefore, it was important to identify chaperones that specifically 
regulate TRPV6 activity at the cell surface. The studies described in Chapters 2 and 3 
reveal two different chaperones (Regulator of G-protein signaling-2 (RGS2) and Nipsnap1) 
that bind to TRPV6 and regulate the activity of the channel at the plasma membrane. 
RGS2, described in Chapter 2, was selected from a yeast-two-hybrid protein-protein 
interaction screening method, wherein proteins that bind to the amino-terminal domain of 
TRPV6 were identified. By using the patch clamp technique to measure channel activity in 
the presence or absence of RGS2 it is shown that RGS2 inhibits the conductance of 
TRPV6. The amino-terminal tail (N-tail) of RGS2 is responsible for this effect. The RGS2 
N-tail, together with the RGS-box (an amino acid sequence present in all RGS family 
members) was previously shown to be important for the binding to, and the inhibition of, 
G-protein-coupled receptors (GPCRs). In addition, the scaffold protein spinophilin had 
been identified as a crucial factor in the interaction between RGS2 and the GPCR. 
However, spinophilin does not influence the effect of RGS2 towards TRPV6, and 
therefore, it is unlikely that a GPCR is involved in the regulation of TRPV6 by RGS2. 
Importantly, RGS2 inhibits TRPV6 activity directly at the plasma membrane, as 
demonstrated by the unchanged plasma membrane expression of TRPV6 by RGS2. 
Therefore, these findings suggest that TRP channels can be regulated at the cell surface. 
     Nipsnap1 was selected by an alternative identification method, such as described in 
Chapter 3. A bioinformatical search strategy using protein databases available on the 
internet was applied. A functional role for Nipsnap1 was not described in literature. 
However, it is suggested that this protein might fulfill a role in intracellular (vesicular) 
transport. Of special interest is that Nipsnap1 interacts to both TRPV6 and its closest 
homologue, TRPV5, but its physiological relevance seems to be restricted to TRPV6. This 
is based on the finding that Nipsnap1 and TRPV5 do not co-localize in the DCT and CNT. 
Moreover, Nipsnap1 is expressed together with TRPV6 in the duodenum and colon. In 
addition, the inhibitory effect of Nipsnap1 on channel activity is much larger for TRPV6 
than for TRPV5. Infusion of recombinant Nipsnap1 protein into TRPV6-expressing cells 
revealed that Nipsnap1 inhibits the channel within a short time. Importantly, the inhibitory 
effect of Nipsnap1 does not affect the plasma membrane localization of TRPV6. Together, 
our results suggest that Nipsnap1 inhibits TRPV6 activity directly at the cell surface and 
that Nipsnap1 is not involved in intracellular transport. Furthermore, this study describes 
the first physiological function of Nipsnap1. 
     Next to the functions of these two binding proteins that regulate the activity of TRPV6 
at the cell surface, other molecular pathways involving distant auxiliary proteins may affect 
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cell surface expression and thus activity of the Ca2+ channels. In Chapters 4 and 5 is 
described how possible receptor-operated mechanisms can regulate the expression and 
activity of TRPV5. The experiments in Chapter 4 demonstrate that the extracellular Ca2+-
sensing receptor (CaR), which is expressed together with TRPV5 at the luminal membrane 
of DCT and CNT, initiates an intracellular signaling pathway that increases TRPV5 activity 
by protein kinase C- (PKC-)dependent phosphorylation of the channel. In more detail, an 
atypical isoform of PKC is primarily responsible for the stimulatory effect. Moreover, this 
response is specific for TRPV5, as these phosphorylation domains are not present in 
TRPV6, and neither does TRPV6 show a response to activation of the CaR. Interestingly, 
earlier studies had demonstrated that tissue kallikrein (TK) stimulates a similar GPCR and 
thereby activates an identical intracellular signaling pathway involving the same PKC 
domains in TRPV5. As a result, the influx of Ca2+ is stimulated because TK inhibits the 
internalization of TRPV5 from the cell surface and thus increases the abundance of the 
channel at the plasma membrane. In addition, a matching pathway is shown for the PTH 
subtype-1 GPCR. These identical phosphorylation mechanisms suggest that TRPV5 
activity is stimulated by one and the same PKC-dependent intracellular signaling pathway, 
but initiated by different activators; i.e. the extracellular Ca2+ concentration or hormones.  
     In Chapter 5 is described how androgens increase urine Ca2+ wasting in male mice. 
Testosterone can bind to the androgen receptor that is expressed in the kidney, exactly 
where TRPV5 is present. Loss of androgen increases the expression of the active Ca2+ 
transporters, which is evident from measuring the Ca2+ excretion and the expression levels 
of TRPV5 and calbindin-D28K in castrated and control-operated male mice. In turn, 
treatment of the castrated animals with testosterone decreases the expression of TRPV5 and 
calbindin-D28K. Importantly, castration had no effect on the serum levels of calciotropic 
hormones or estrogen within the two weeks time frame of the study. In addition, 
dihydrotestosterone, which cannot be converted to estrogen by aromatization, inhibits 
transcellular Ca2+ transport in primary cultures of rabbit CNT and cortical collecting duct 
cells, and thus confirms the in vivo observations. Together, these findings show that 
androgen has a direct inhibitory effect on the expression of proteins involved in active Ca2+ 
transport in the kidney, and explain the sex differences in urinary Ca2+ wasting. 
     To gain more insight in the molecular basis of the plasma membrane regulation of the 
Ca2+ channels, two in vitro tools were developed, as described in Chapters 6 and 7. Firstly, 
the heteromultimeric assembly and expression of TRPV5 at the cell surface was 
investigated by applying a protein expression system using Shield-1. The experiments 
described in Chapter 6 demonstrate that the expression of TRPV5 can be regulated by 
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Shield-1 after fusion of a mutated FKBP12 (mtFKBP) protein to TRPV5. mtFKBP-TRPV5 
is degraded in the cell unless protected by a dose-dependent concentration of Shield-1. 
After providing evidence that the channel characteristics of mtFKBP-TRPV5 and wild-type 
TRPV5 were similar, the assembly of the channels was studied. TRP channels are 
composed of four individual subunits. To investigate TRPV5 channel assembly, subunits of 
mtFKBP-TRPV5 and wild-type TRPV5 were expressed in cells in the presence of Shield-1. 
Next, Shield-1 was omitted and the cell surface expression of wild-type TRPV5 was 
determined by using biotin. Those experiments reveal that the amount of wild-type TRPV5 
decreases by the degradation of mtFKBP-TRPV5. These findings not only show that 
heteromultimeric TRPV5 channels are formed, but also indicate that it is not necessary to 
tag all individual subunits of the protein complex with mtFKBP for its Shield-1-dependent 
expression. 
     Secondly, a polarized kidney cell line in which fluorescent TRPV5 (GFP-TRPV5) is 
stably expressed was developed, as described in Chapter 7. Initially, the channel 
characteristics of GFP-TRPV5 were demonstrated to be similar to wild-type TRPV5. 
Subsequently, the cellular localization and activation of GFP-TRPV5 was investigated. 
GFP-TRPV5 shows a predominant intracellular granular distribution. However, measuring 
the influx of radioactive-labeled Ca2+ in these cells indicates that a significant amount of 
GFP-TRPV5 is functionally present at the cell surface. The influx of Ca2+ is eight-fold 
higher at the luminal side of these polarized cells compared to the basolateral uptake, and 
three-fold higher than the influx of Ca2+ in control cells. Subsequently, the regulation of 
(GFP-)TRPV5 was studied. Different TRPV5-activating compounds were shown to 
increase GFP-TRPV5 activity, while no response of these compounds on the influx of Ca2+ 
was measured in control cells. Together, these experiments demonstrate that the polarized 
GFP-TRPV5 cell line provides a good model to study the regulation of TRPV5 activity.  
     The findings described and discussed in this thesis (Chapters 1-8) contribute to a better 
understanding of the physiology and molecular basis of TRPV5 and TRPV6 regulation at 
the cell surface. In addition, the CaR and the androgen receptor may be potential 
pharmacological targets that could influence the daily maintenance of the Ca2+ balance. 
However, kidney cell type-specific markers should then be identified to guarantee correct 
receptor targeting. The cell physiological challenges in the near future will be to identify 
the exact molecular mechanisms involved in channel (in)activation directly at the cell 
surface. For this purpose, the use of advanced (fluorescence) microscopic techniques may 
be the path to follow. 
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Chapter 9 
Calcium is een belangrijk ion voor diverse fysiologische processen in het lichaam. Het 
speelt bijvoorbeeld een rol als signaalmolecuul bij de contractie van spieren en bij de 
geleiding van zenuwprikkels, maar is ook de belangrijkste bouwstof van botten. Voor het in 
stand houden van deze processen is het van belang dat de concentratie calcium in het 
bloedplasma constant blijft. Verstoringen in deze hoeveelheid extracellulair calcium 
kunnen leiden tot aandoeningen, zoals botafbraak (osteoporose) ter compensatie voor een te 
lage calcium concentratie, of de vorming van nierstenen bij een te hoge concentratie van 
calcium in het bloed.  
     In een gezond lichaam wordt de calciumconcentratie in het bloed op een constante 
waarde gehouden door een samenspel van drie organen; namelijk, in de darm wordt 
calcium opgenomen vanuit de voeding, met bot vindt uitwisseling plaats en in de nieren 
wordt calcium uitgescheiden via de urine of juist heropgenomen uit de voorurine. Een 
belangrijk onderdeel van de uitwisseling van calcium in deze organen is het transport over 
epitheel cellagen. Het grootste gedeelte van het calciumtransport vindt plaats via een 
passief, paracellulair proces (i.e. transport van calcium tussen cellen door). Echter, voor de 
fijnafstemming van de calciumconcentratie in het bloed heeft het lichaam een actief en 
gereguleerd proces van calciumtransport. Dit actieve (transcellulaire) transport van calcium 
vindt plaats in de epitheliale cellen van voornamelijk het proximale deel van de dunne darm 
(twaalfvingerige darm), en het distale convoluut (DCT) en de verbindingsbuizen (CNT) 
van de nier. Het transcellulair transport van calcium kan worden onderverdeeld in drie 
opeenvolgende stappen: Allereerst komt calcium de cel binnen (influx) aan de luminale 
zijde (waar het voedsel of de voorurine zich bevindt) via de epitheliale calciumkanalen 
TRPV5 en TRPV6. Vervolgens wordt het getransporteerd naar de bloedzijde (basolaterale 
zijde) van de cel door gespecialiseerde calciumbindende eiwitten, zogenaamde calbindines 
(calbindine-D28K en calbindine-D9K), die ervoor zorgen dat de vrije intracellulaire 
calciumconcentratie laag en niet-toxisch blijft. Tenslotte wordt calcium over de 
basolaterale membraan getransporteerd door twee energieverbruikende mechanismen, een 
natrium/calcium-uitwisselaar (NCX1) en een ATP-afhankelijke calciumpomp (PMCA1b).  
     Het actieve transport van calcium wordt systemisch gereguleerd door calciotrope 
hormonen, zoals het parathyroidhormoon (PTH) en 1,25-dihydroxy-vitamine D3, maar ook 
op celniveau met behulp van extra- en intracellulaire factoren. Deze factoren kunnen het 
transport, alsmede de internalisatie en recycling van de calciumkanalen naar en vanaf hun 
functionele domein, de plasmamembraan, beïnvloeden. Regulatie van de kanalen aan het 
celoppervlak is waarschijnlijk het allerbelangrijkst omdat dit het lichaam in staat stelt snel 
en efficiënt te reageren op fluctuaties in de calciumconcentratie in het bloed. Om het proces 
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van een evenwichtige calciumbalans in het lichaam beter te begrijpen is het van essentieel 
belang kennis over de regulatie (expressie en activiteit) van TRPV5 en TRPV6 aan het 
celoppervlak te verkrijgen. 
     De karakterisatie van een aantal TRPV5- en TRPV6-geassocieerde eiwitten, zoals 
beschreven in Hoofdstuk 1, heeft belangrijke inzichten gegeven in de regulatie van deze 
kanalen. Toch bleef voor de regulatie van voornamelijk TRPV6 aan het celoppervlak door 
geassocieerde eiwitten nog veel onduidelijk. Het is daarom belangrijk om te onderzoeken 
of er geassocieerde eiwitten zijn die specifiek de activiteit van TRPV6 aan het celoppervlak 
beïnvloeden. De studies beschreven in Hoofdstukken 2 en 3 tonen aan dat twee 
verschillende eiwitten (Regulator of G-protein signaling-2 (RGS2) en Nipsnap1), die 
binden aan TRPV6, de activiteit remmen van kanalen die zich aan het oppervlak van de cel 
bevinden. RGS2, beschreven in Hoofdstuk 2, werd geïdentificeerd in een yeast-two-hybrid 
eiwit-eiwit-interactie methode waarbij eiwitten die binden aan de aminoterminus van 
TRPV6 werden opgepikt. Door met de patch clamp techniek de kanaalactiviteit te meten in 
de aan- en afwezigheid van RGS2 is duidelijk geworden dat RGS2 de activiteit van TRPV6 
inhibeert. De aminoterminus van RGS2 is verantwoordelijk voor dit effect. Reeds eerder is 
aangetoond dat de aminoterminus (samen met de zogenaamde RGS-box, een 
aminozuurvolgorde die voorkomt in alle familieleden van de RGS eiwitten) een belangrijk 
aminozuurdomein is voor de binding aan, en de remming van, G-eiwit-gekoppelde 
receptoren (GPCR). Daarnaast was beschreven dat het scaffold eiwit spinophilin cruciaal is 
voor de binding van RGS2 aan een GPCR en daarmee verantwoordelijk voor het 
inhiberende effect van RGS2. Echter, spinophilin heeft geen invloed op het effect van 
RGS2 ten aanzien van TRPV6 en sluit daarmee een mogelijke rol van een GPCR in de 
regulatie van TRPV6 door RGS2 uit. Daarentegen remt RGS2 de activiteit van TRPV6 
direct aan het celoppervlak, want RGS2 heeft geen effect op de plasmamembraanlokalisatie 
van het kanaal. Deze resultaten suggereren dat TRP kanalen rechtstreeks gereguleerd 
kunnen worden aan het celoppervlak.  
     Nipsnap1 is opgepikt met behulp van een andere identificatiemethode, namelijk via een 
zoektocht in internet eiwitdatabases en het gebruik van bioinformatica, zoals beschreven in 
Hoofdstuk 3. In de bestaande literatuur was geen functionele rol voor Nipsnap1 
beschreven, maar wel werd gesuggereerd dat dit eiwit een rol kan vervullen bij 
intracellulair transport. Uit onze experimenten blijkt dat Nipsnap1 zowel aan TRPV6 als 
aan het homologe TRPV5 kan binden, maar dat een fysiologisch relevante functie juist bij 
TRPV6 moet liggen. Nipsnap1 en TRPV5 komen namelijk niet samen tot expressie in de 
DCT en CNT. Nipsnap1 komt echter wel tot expressie in de twaalfvingerige darm en de 
 197
Chapter 9 
dikke darm, waar ook TRPV6 aanwezig is. Daarnaast heeft Nipsnap1 een veel groter 
remmend effect op de activiteit van TRPV6 dan op TRPV5. De toevoeging van 
recombinant Nipsnap1 eiwit in een cel met TRPV6 liet zien dat Nipsnap1 de activiteit van 
TRPV6 in een korte tijd inhibeert. Nipsnap1 had echter geen uitwerking op de 
plasmamembraanlokalisatie van TRPV6. Samengevat suggereren onze bevindingen dat 
Nipsnap1 de activiteit van TRPV6 direct aan het celoppervlak remt en dat Nipsnap1 geen 
rol heeft bij intracellulair transport. Bovendien beschrijft deze studie de eerste fysiologische 
functie van dit kanaal-geassocieerde eiwit.  
     Naast de functies van deze twee geassocieerde eiwitten die de activiteit van TRPV6 
reguleren aan het celoppervlak door binding aan het kanaal, kunnen andere moleculaire 
mechanismen mogelijk de plasmamembraanexpressie en dus activiteit van de 
calciumkanalen beïnvloeden. In Hoofdstukken 4 en 5 wordt beschreven op welke manier 
receptor-geactiveerde mechanismen de expressie en activiteit van TRPV5 reguleren. De 
experimenten in Hoofdstuk 4 laten zien dat de calcium-sensing receptor (CaR), die samen 
met TRPV5 tot expressie komt aan de luminale zijde van de DCT en CNT, een 
intracellulaire signaleringsroute aanzet die vervolgens via fosforylering van TRPV5 door 
een eiwitkinase (PKC) de activiteit van het kanaal verhoogt. In meer detail werd duidelijk 
dat een atypische vorm van PKC verantwoordelijk moest zijn voor dit effect en dat dit 
specifiek was voor TRPV5, omdat TRPV6 deze fosforylatiedomeinen niet bezit en ook 
geen reactie vertoonde op activatie van de CaR. Eerder werd aangetoond dat Tissue 
Kallikrein (TK) een soortgelijke GPCR activeerde en daarmee een intracellulaire 
signaleringsroute startte die de identieke PKC fosforylatiedomeinen in TRPV5 omvatte. De 
calciuminflux wordt door TK en PKC gestimuleerd, omdat deze het aantal kanalen aan het 
celoppervlak doen toenemen. Dit is een gevolg van een inhiberend effect van TK en PKC 
op de internalisatie van TRPV5 kanalen vanaf het celoppervlak. Ook voor de PTH type-1 
GPCR werd eenzelfde werkingsmechanisme aangetoond. Deze identieke fosforylatie-
mechanismen suggereren dat TRPV5 gestimuleerd wordt via een en hetzelfde PKC-
afhankelijke intracellulaire mechanisme, maar dat dit geïnitieerd kan worden door 
verschillende stimuli zoals de extracellulaire calciumconcentratie of hormonen. 
     In Hoofdstuk 5 is beschreven op welke wijze androgenen in mannelijke muizen het 
calciumverlies via de urine verhogen. Testosteron kan binden aan de androgeenreceptor die 
tot expressie komt in de nier, daar waar TRPV5 zich bevindt. Door het calciumverlies en de 
nierexpressie van TRPV5 en calbindine-D28K in mannelijke gecastreerde en controle 
muizen te vergelijken is duidelijk dat het verlies van androgenen (door castratie) de 
expressie van TRPV5 en calbindine-D28K doet toenemen. Omgekeerd neemt de expressie 
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van deze calciumtransporteurs weer af wanneer de gecastreerde dieren worden behandeld 
met testosteron. De castratie had geen effect op de concentratie van de calciotrope 
hormonen en estrogeen in het plasma tijdens het twee weken durende experiment. Het 
directe, remmende, effect van testosteron op transcellulair Ca2+ transport werd aangetoond 
door primaire cellen van CNT en verzamelbuizen (CCD) uit konijnen te behandelen met 
dihydrotestosteron (dat niet kan worden omgezet tot estrogeen). Hiermee werden de in vivo 
bevindingen bevestigd. Samengevat laat deze studie zien dat testosteron een direct 
remmend effect heeft op de expressie van de eiwitten die betrokken zijn bij actief 
calciumtransport in de nier. Daarnaast geven deze bevindingen een verklaring voor het sexe 
verschil in calciumverlies via de urine.  
     Om meer inzicht te verkrijgen in de moleculaire basis van de regulatie van de 
calciumkanalen aan het celoppervlak, zijn in vitro technieken ontwikkeld, zoals beschreven 
in Hoofdstukken 6 en 7. De heteromultimere assemblage en expressie van TRPV5 aan het 
celoppervlak werd bestudeerd door gebruik te maken van een eiwitexpressiesysteem dat 
afhankelijk is van Shield-1. De experimenten beschreven in Hoofdstuk 6 tonen aan dat de 
expressie van TRPV5 in de cel gereguleerd kan worden door Shield-1 na fusie van een 
gemuteerd FKBP12 (mtFKBP) eiwit aan TRPV5. mtFKBP-TRPV5 wordt door de cel 
afgebroken tenzij een dosis-afhankelijke hoeveelheid Shield-1 aanwezig is. Eerst is 
bewezen dat de kanaalkarakteristieken van mtFKBP-TRPV5 overeen komen met het 
wildtype TRPV5, waarna vervolgens de kanaalassemblage is bestudeerd. TRP kanalen 
bestaan uit vier losse subunits. Voor het bestuderen van de kanaalassemblage van TRPV5 
zijn mtFKBP-TRPV5 en wildtype TRPV5 subunits in een cel tot expressie gebracht in 
aanwezigheid van Shield-1. Vervolgens is het Shield-1 weggenomen en de hoeveelheid 
wildtype TRPV5 aan het celoppervlak bestudeerd door middel van een methode waarbij 
biotine wordt gebruikt. Deze experimenten tonen aan dat de hoeveelheid wildtype TRPV5 
afneemt door de afbraak van mtFKBP-TRPV5. Dit duidt niet alleen op de vorming van 
heteromultimere TRPV5 kanalen, maar geeft ook aan dat het niet nodig is om alle 
afzonderlijke subunits in dit eiwitcomplex te fuseren met mtFKBP voor de Shield-1-
afhankelijke expressie ervan.  
     Het tweede hulpmiddel dat werd ontwikkeld is een gepolariseerde niercellijn waarin 
fluorescent TRPV5 (GFP-TRPV5) stabiel tot expressie komt, zoals beschreven in 
Hoofdstuk 7. De kanaalkarakteristieken van GFP-TRPV5 komen overeen met het wildtype 
TRPV5. Vervolgens zijn de cellulaire lokalisatie en de activatie van GFP-TRPV5 
bestudeerd. GFP-TRPV5 toont een hoofdzakelijk intracellulair granulair patroon in deze 
cellijn. Echter, door het meten van de influx van radioactief-gelabeld calcium in de cellen is 
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aangetoond dat een significante hoeveelheid van het kanaal functioneel aan het 
celoppervlak aanwezig is. Deze calciuminflux is acht keer hoger aan de luminale zijde van 
de gepolariseerde GFP-TRPV5 cellen dan aan de basolaterale kant, en drie maal hoger ten 
opzichte van controle cellen. Vervolgens is de regulatie van (GFP-)TRPV5 in deze cellijn 
bestudeerd door het testen van verschillende TRPV5-activerende stoffen. In dit experiment 
verhoogden deze stoffen de activiteit van GFP-TRPV5, zonder daarbij invloed uit te 
oefenen op de influx van calcium in controlecellen. De resultaten van deze experimenten 
geven aan dat de gepolariseerde GFP-TRPV5 cellijn een goed model is om de regulatie van 
TRPV5 te bestuderen. 
     De bevindingen beschreven en bediscussieerd in dit proefschrift (Hoofdstukken 1-8) 
dragen bij aan onze kennis van de fysiologie en moleculaire grondslag van TRPV5 en 
TRPV6 regulatie aan het celoppervlak. Daarnaast zijn de CaR en de androgeenreceptor 
mogelijke farmacologische aangrijpingspunten die invloed kunnen uitoefenen op het 
dagelijkse behoud van de calciumbalans in het lichaam. Daarvoor dient echter ook gezocht 
te worden naar niercel-specifieke markers die ervoor zorgen dat de juiste receptoren 
worden bereikt. De celfysiologische uitdagingen in de toekomst zullen zich richten op het 
verder ophelderen van de exacte moleculaire mechanismen betrokken bij kanaal(in-
)activatie rechtstreeks aan het celoppervlak, waarbij een belangrijke rol zal zijn weggelegd 
voor het toepassen van geavanceerde (fluorescentie-)microscopie technieken. 
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LIST OF ABBREVIATIONS 
 
-/-  homozygous knock-out 
∆  deletion 
[Ca2+]e  extracellular Ca2+ concentration 
[Ca2+]i  intracellular Ca2+ concentration 
1,25(OH)2D3  1,25-dihydroxy-vitamin D3 
3H  tritium 
45Ca2+  radioactive ionized calcium isotope 
Å  angstrom 
ANOVA  analysis of variance 
AP-1   activator protein 1 
AQP2  aquaporin-2 
AR  α-adrenergic receptor, or androgen receptor 
ARE  androgen response element 
ATP  adenosine 5’-triphosphate 
AU  artificial units 
AVP  arginine vasopressin 
B2R  bradykinin 2 receptor 
BAPTA  1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid 
bp  basepairs 
BSA  bovine serum albumin 
BSPRY  B-box and SPRY-containing protein 
Ca2+  ionized calcium 
Caco-2  human colon cancer-derived cell line 
cAMP  adenosine 3’,5’-cyclic monophosphate 
CaR  calcium-sensing receptor 
CCD  cortical collecting duct 
cDNA  copy DNA 
Cl-  ionized chloride 
ClC  chloride channel 
CNT  connecting tubule 
Cr  creatinine 
CTRL  control 
DAG  diacylglycerol 
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DCT  distal convoluted tubule 
DHT  dihydrotestosterone 
DMEM  Dulbecco’s modified Eagle’s medium 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
DVF  divalent free 
EC50  half maximum effective concentration 
EDTA  ethylenediaminetetraacetate 
EGTA  ethylene glycol-bis(b-aminoethyl ether)-N,N,N’,N’-tetra acetic acid 
ENaC  epithelial Na+ channel 
ER  estrogen receptor 
FCS  fetal calf serum 
FGF23  fibroblast growth factor-23 
FKBP  FK506 (tacrolimus)-binding protein 
FRET  Förster resonance energy transfer 
GI  gastro-intestinal 
GFP  green-fluorescent protein 
GPCR  G-protein-coupled receptor 
GST  glutathione S-transferase 
GTP  guanosine triphosphate 
h  hour 
HA  hemagglutinin 
HEK293 human embryonic kidney 293 
HEPES  N-2-hydroxyethyl-piperazine-N’-2-ethanesulfonic acid 
HPRT  hypoxanthine-guanine phosphoribosyl transferase 
IBMX   3-isobutyl-1-methylxanthine 
IMCD  inner medullary collecting duct 
IOD  integrated optical density 
IP  inositol phosphate 
I/V  ion current-voltage profile 
K+  ionized potassium 
KHB  Krebs-Henseleit buffer 
KIR  inward rectifying potassium 
KOG  eukaryotic cluster of orthologous genes 
L-Phe  L-phenylalanine 
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MDCK  Madin-Darby canine kidney 
Mg2+  ionized magnesium 
min  minute 
mpkDCT murine renal DCT cell line 
mtFKBP mutant FKBP 
n  number 
Na+  ionized sodium 
NCC  Na+-Cl- cotransporter 
NCX1  Na+/Ca2+ exchanger-1 
Neo  neomycin 
NHE3  Na+/H+-exchanger 3 
NHERF  Na+/H+-exchanger regulating factor 
Nipsnap  4-nitrophenylphosphatase SNAP-25-like 
NMDG   N-methyl-D-glucamine 
NT  non-transfected 
ORX   orchidectomized 
Ostm  osteopetrosis-associated transmembrane protein 
OVX  ovariectomized 
p  probability 
Pi  inorganic phosphate 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
PCR  polymerase chain reaction 
PDZ  postsynaptic density-95/Discs large/zona occludens-1 
PGE2  prostaglandin E2
PKA  protein kinase A 
PKC  protein kinase C 
PLC  phospholipase C 
PMA  phorbol 12-myristate 13-acetate 
PMCA1b plasma membrane Ca2+-ATPase-1b 
PMSF  phenylmethylsulphonylfluoride 
PPIase  peptidyl-prolyl cis-trans isomerase 
PSS  physiological salt solution 
PTH  parathyroid hormone 
PTH1R  type 1 PTH receptor 
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RGS  regulator of G-protein signaling 
RNA  ribonucleic acid 
RT  reverse transcriptase 
RXR  retinoid X receptor 
s, sec  second 
SDS  sodium dodecyl sulphate 
SEM  standard error of the mean 
SGK1  glucocorticoid-inducible kinase-1 
SPL  spinophilin 
SUR  sulphonylurea receptor 
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TBS  tris-buffered saline 
TEER  transepithelial electrical resistance 
TIRF  total internal reflection fluorescence 
TK  tissue kallikrein 
TM   transmembrane 
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TRP  transient receptor potential 
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TRPM  TRP melastatin-subtype 
TRPML  TRP mucolipin-subtype 
TRPP  TRP polycystin-subtype 
TRPV  TRP vanilloid-subtype 
TSA  tyramide signal amplification 
v  volume 
VDR  vitamin D receptor 
VDRE  vitamin D-responsive element 
VSV  vesicular stomatitis virus 
w, wt  weight 
w/o  without  
WNK  with no lysine 
YFP  yellow-fluorescent protein 
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De eerste zin van dit hoofdstuk zou eigenlijk moeten bestaan uit een prijsvraag:  
Bedenk de mooiste variant op “Maintenance of the body Ca2+ balance is of vital importance 
for many physiological functions including intracellular signaling processes, neuronal 
excitability, muscle contraction and bone formation”… ☺ 
 
Na het schrijven van de wetenschappelijke hoofdstukken in dit proefschrift volgt de 
moeilijkste taak, het dankwoord, want dat is een hoofdstuk dat (veel/wel?) gelezen wordt. 
Daarentegen, mensen bedanken voor hun vriendschap, interesse en aandacht voor je werk 
en als persoon is geen vervelende taak, maar juist een leuke en zeker op z’n plaats als het 
promoveren betreft. Dit proefschrift was er nooit gekomen zonder de hulp van velen. 
 
René en Joost, beide geven jullie meer dan 100 % voor alles dat te maken heeft met de 
afdeling Fysiologie. Ik heb bewondering voor de eindeloze energie die jullie steeds weer 
ergens vandaan ‘toveren’ om de afdeling en de groep iontransport te leiden. De 
medewerkers van de afdeling vormen een hechte groep waar ik veel plezier mee heb 
beleefd en goede vriendschappen aan overgehouden. Joost, jij benaderde mij voor een AIO 
vacature en opende de deur naar het promoveren. Ik ken niemand die zo enthousiast kan 
zijn over het werk dat hij doet zoals jij. Het duurde dan ook niet lang om mij te overtuigen. 
René, al vanaf mijn eerste jaren bij Fysiologie heb je me steeds meer verantwoordelijk-
heden gegeven. Ik ben je dankbaar voor het vertrouwen dat je daarmee in me stelde. 
Snelheid is een kernwoord dat zeer goed bij jullie beide past. Wat het ook moge zijn, alles 
wordt meteen aangepakt; enerzijds is dat het snelle nakijkwerk waardoor schrijfwerk altijd 
lekker opschoot, anderzijds is dat het zoeken naar oplossingen voor praktische 
aangelegenheden op het lab. Als promotor en co-promotor hebben jullie mij veel geleerd 
over (nier-)fysiologie, het organiseren en uitvoeren van experimenten, en het steeds beter 
kunnen schrijven van artikelen. Jullie doelgerichtheid en immer positieve, maar kritische 
blik op wetenschappelijk onderzoek zijn voor mij een voorbeeld. De vele door jullie 
binnengehaalde beurzen en prijzen als docent en onderzoeker zijn daar het bewijs van en 
onderstreep ik van harte. 
 
Gang, together we started our Ph.D. student life. We shared a lot of up and downs that 
scientific research brings. I admire your never ending new ideas for experiments, 
enthusiasm, continuous smile, jokes, and your funny-but-catching research presentations. 
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You introduced real Chinese cooking to us (you are an excellent cook) and you were 
probably the best person to explain Dutch football to me ☺.  I’m sure you will be an 
excellent scientific researcher, which you already continued to be in the USA. Sylvie and I 
will never forget your phone call at our wedding. Thanks for being there and hopefully 
we’ll soon meet again at your promotion! 
 
Arjen, samen met Gang en mij begon ook jouw avontuur bij Fysiologie. Als snel bleek dat 
we steevast bij dezelfde afdelingen hadden gesolliciteerd voordat we bij elkaar uitkwamen. 
Onze gezamenlijke interesses werden daar op voorhand mee bevestigd. Als post-doc moest 
je een oogje in het zeil houden aan ‘onze kant van het lab’. Ik vraag me af of dat echt 
gelukt is, want in de wetenschap bestaan er volgens mij alleen maar eigenwijze mensen ☺. 
Je hebt me veel geleerd over moleculaire biologie en het AIO leven, en die kennis heb ik 
alweer kunnen overbrengen op anderen. Je was een leuke en betrokken collega en ik ben 
blij dat we elkaar ook na Fysiologie nog steeds zien. 
 
Stan, net als Joost zorgde je ervoor dat ik bij Fysiologie ging werken. Een goede keus 
omdat ik je daarna beter heb leren kennen. Ondanks dat je er nooit zelf de eer voor zult 
opstrijken ben je een geweldig voorbeeld als jonge wetenschapper. Je vermogen om 
moeilijke (cel)biologische kennis als heel eenvoudig te kunnen neerzetten is uniek. Jouw 
methode van ‘experimental setup’ heb ik hopelijk goed van je afgekeken, maar heeft er in 
ieder geval al voor gezorgd dat mijn manier van werken een stuk effectiever en beter is 
geworden. Ik heb met veel plezier met je samengewerkt en ben dankbaar voor het mooie 
resultaat met ‘ons Shield-verhaal’.  
 
Tim, jij was mijn vraagbaak toen ik bij Fysiologie begon. Ik heb je de oren van je hoofd 
gevraagd, maar dat heeft je nooit tegengehouden om daar veel tijd aan te besteden. Je 
werkmethode van ‘je kunt best vier dingen tegelijk doen, en eigenlijk nog wel meer als je 
andere mensen voor je laat werken’ heb ik nooit helemaal onder de knie gekregen. 
Waarschijnlijk was dat een aangeboren eigenschap, want Qing en Henrik lukt(e) dat ook 
prima ☺. Bedankt voor alles dat je me hebt geleerd en de publicaties die we samen op onze 
naam hebben staan! 
 
Catalin, je bent het beste voorbeeld van ‘goed onderzoek doe je nooit alleen’. Met jouw 
patch clamp expertise hebben we een aantal mooie artikelen bij elkaar gepipetteerd. Ik 
bewonder je doorzettingsvermogen om niet alleen te slagen in het promoveren, maar ook 
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aan te passen aan de Nederlandse cultuur, beter Nederlands te kunnen spreken dan ik, en 
dat allemaal tijdens het overwinnen van een zwaar ziektebed. Bedankt dat ik je paranimf 
mocht zijn. Ik volg nu je wetenschappelijke carrière! 
 
AnneMiete, net als bij Catalin was jouw immunohistochemie werk onmisbaar voor veel 
van ons onderzoek. Waarschijnlijk kom ik in de toekomst nog vaak bij je aankloppen als ik 
die techniek meer zelf ga uitvoeren. Naast het werk hebben we vele vakantieverhalen 
gedeeld en blijkt wel dat onze beider verlanglijst van bestemmingen eindeloos is… Erg 
leuk dat we nog steeds contact hebben en dat je Sylvie bijstaat als paranimf bij haar 
promotie. 
 
Niels, although you were from ‘the other group’ we soon got to know each other quite 
well. I enjoyed your staying in the Netherlands, the numerous talks about ‘a life in science’, 
and the biking and walking together with Sine and Ella. It is great that we still meet and 
that Dutch-Danish boundaries not seem to exist. Last times we came by train and car, so 
next time we’ll take the plane (or bike ☺). By the way, on the way back from Denmark we 
played that CD from NordstrØm endlessly, but still we don’t understand any of the lyrics ☺. 
 
Sjoerd, ‘limbo-er’, jij nam de post-doc taak van Arjen aan ‘onze kant van het lab’ over, 
maar als nieuweling zouden wij jóu wel even in de gaten houden ☺. Al snel ontstond er een 
hecht groepje samen met Theun, Henrik, Mark en Femke. Er was altijd wel iets grappigs 
met gene of dene uit te halen en we hebben heel wat afgelachen. Op wetenschappelijk 
gebied hebben we samen vele experimenten uitgevoerd, maar dat ene echte mooie resultaat 
bleef jammer genoeg altijd net buiten bereik. Ik weet dat Malden een te mooie plaats is om 
een huis te kopen, maar gelukkig wonen jullie net om de hoek voorbij dat zand-kuilen-
modder paadje in Molenhoek. Het is prachtig dat we elkaar nog vaak zien en ik vind het 
een eer dat je mijn paranimf wil zijn! 
 
Henrik, ‘You’ll never walk alone, because you have a car’. I admire (i.e. am jealous about) 
your enormous knowledge about (kidney) physiology. Like Tom N., you were there for 
many times to get my thoughts straight regarding our study with the ‘Taiwan connection’. I 
enjoy your “sarcasm” about science, the teasing of ‘Sloeber’, and your direct way of 
speaking (especially during research presentations; there will not be many people that use 
the words you do ☺).     
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Yu-Juei, your staying in the Netherlands was ‘short’, but long enough to get to know you 
better. I liked you - together with your wife - coming over to our house for a visit, and the 
continuous interest that you showed (and still show) in Sylvie’s and my do-abouts. 
Hopefully our collaborative study will result in a nice publication! 
 
Wouter, Kirsten, Rob, Qing, vooral jullie waren de gangmakers op de afdeling waardoor 
er altijd wel iets te beleven viel. De koffiepauzes en tochten naar de kantine waren vaak 
voorzien van sappige en spannende verhalen. Vooral daardoor voelde Fysiologie als een 
hechte familie. Bedankt voor de leuke tijd! 
 
Hanneke en Loren, ik wil jullie bedanken dat jullie het hebben aangedurfd om bij mij stage 
te komen lopen. Ik vond het erg leuk en leerzaam om jullie te begeleiden. Mijn 
eigenwijsheid zal het desondanks af en toe niet makkelijk hebben gemaakt. Jullie waren 
gezellige collega’s en hebben mooie resultaten geboekt. Hanneke, geweldig dat je (mede) 
door die stage de NCMLS student award en Unilever research prijs gewonnen hebt! Goed 
dat je toch aan het AIO-en begonnen bent. Binnenkort worden we weer collega’s. 
 
Twee hoofdstukken in dit proefschrift waren niet tot stand gekomen zonder succesvolle 
(inter-)nationale samenwerkingen. Dr. Daniela Riccardi, I would like to thank you and 
Lydia Searchfield for your great work on the calcium-sensing receptor immunohisto-
chemistry and the enthusiastic phone calls! Daarnaast ben ik prof. dr. Martijn Huynen en 
dr. Guénola Ricard dankbaar voor hun prachtige bioinformatica analyse die een belangrijke 
basis vormde voor ‘het Nipsnap1 verhaal’! 
 
En toen begon het post-doc leven. Een half jaar, zelfde afdeling, maar aan ‘de andere kant’ 
van het lab en nieuwe mensen dicht om je heen. Sandor, we hebben intensief samengewerkt 
om dat klot(ho)e verhaal de deur uit te krijgen. Ik hoop dat onze inspanningen resultaat 
zullen hebben. Bedankt voor de vele (non-)science gesprekken die we hebben gehad! Anil, 
especially during my post-doc time I got to know you much better. Out of the ‘patch cave’ 
we spent time together during diners, biking, etc. Let us make sure that we can keep that 
tradition alive! Titia, ik heb veel plezier beleefd met jou ‘aan de andere kant van de tafel’. 
Er was altijd wat te lachen. Tegen jouw positieve kijk op het leven kan mijn 
sarcasme/ironie niet op. Ook jouw multitasking zal ik nooit kunnen evenaren, maar ik weet 
zeker dat ieder die met je samenwerkt er extra energie door krijgt. Erg leuk dat jij en Jannes 
je eerste kindje verwachten. Een spannende tijd. De olvarit staat hier al klaar voor een 
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volgend etentje ☺. Kukiat, it was nice to ‘guide’ you through your start as Ph.D. student. 
Sometimes it was difficult due to our different backgrounds, but you were eager to learn 
and we got along really well. It was good to see that you, just like Sylvia, (seemingly) 
easily adapted to the Dutch live. I’m sure you both will do great in science. 
 
Naast al die mensen op de afdeling Fysiologie heb ik het geluk gehad dat vele van mijn 
vrienden in hetzelfde bootje stapten. Promotie lief en leed werd er veelvuldig gedeeld met 
Joep en Debby, Esther, Barbara en Joost, Kim en Louis, Chris en Marianne, Pascal en 
Gemma. Ik zal geen van jullie hoeven uit te leggen hoe de afgelopen jaren zijn geweest. 
Bedankt dat jullie er altijd waren en zijn! Louis, jij hebt dan de promotiedans ontsprongen, 
toch mag je straks op het matje komen. Ik vind het erg leuk dat je aan mijn zijde staat als 
paranimf! Harold en Pascal, wij kennen elkaar al sinds de HLO. Dat naar de universiteit 
gaan en AIO-en niet nodig is om veel publicaties op je naam te hebben heeft Harold wel 
bewezen! (Pascal, we pakken hem er nog wel een keer voor terug ☺.) Ik kan het niet laten 
om te vermelden dat ook dit proefschrift weer tot stand is gekomen met behulp van het 
belastinggeld van Tom ☺. Tom, het spijt me je te moeten zeggen dat ik nog steeds niet ga 
werken, maar weer als post-doc aan de slag ga. Onze vriendschap gaat al ver terug, die zal 
vast ook deze misstap weer overleven ☺. 
 
Ook mijn familie verdient een ereplaats in dit hoofdstuk. Mijn ‘ouwe’ wil ik bedanken 
voor hun eindeloze steun in de keuzes die ik gemaakt heb. Toch nog maar die extra studie, 
en dat extra jaartje erbij voor nog meer studievakken en studieverenigingsactiviteiten, geen 
probleem. Ik voel me gelukkig met de kansen die jullie mij hebben gegeven. Ik hoop dat 
mijn promotie bewijst dat het iets heeft opgeleverd. Na de promotie volgt een nieuwe stap. 
Zo ook voor jullie met de renovatie van het nieuwe huis. Beide kostten veel inspanning, 
maar de voldoening van de afronding is groot! Jan-Thijs, al vroeg kapte je met school, want 
waar is dat studeren nu eigenlijk voor nodig? Voor werken was je nooit te lui (en dat ben je 
nog steeds niet). Vaak ben ik jaloers geweest op je huisje-boompje-beestje, “wanneer zou 
mijn leven nu eens beginnen?”, daarbij vergetend wat ik allemaal wel al heb (gehad). Het is 
goed te zien dat je na al die jaren niet veranderd bent en nog steeds overloopt met ideeën 
die er misschien wel ooit van komen ☺. Anke, eerder dan ik nog verliet je de thuishaven 
om te gaan studeren. Ik was onzeker om te vertrekken, maar jij ging gewoon. Zo ‘flexibel’ 
als je met je studies was, zo ben je dat nu ook met je werk. Alles komt altijd op z’n pootjes 
terecht, zolang je houd van datgene dat je op dit moment doet!   
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Op het lab valt er veel meer te onderzoeken dan calciumkanaaltjes alleen. Soms moet je 
daar grenzen voor verleggen. Het valt te bezien of je dan over een hek moet klimmen of 
juist in het diepe springen – voor Helmond geldt beide (sorry, ik kon het niet laten ☺). 
Toch was dat de beste ontdekking van mijn leven. Sylvie, jij bent het bewijs dat een 
labrelatie wel stand houdt. Na wat experimenteerwerk en andere dingetjes (hoor ik nu 
iemand niezen? en, mijn Nederlands is slecht, maar jouw grammatica heb ik na vier jaar 
nog steeds niet doorgrond ☺) wisten wij zeker dat dit was ‘meant to be’. Hier staan we dan 
beide op dezelfde dag voor de afronding van ons promotie-onderzoek, maar ons huwelijk is 
boven alles het mooiste dat het AIO-en heeft opgeleverd! 
 
Naast het noemen bij naam wil ik hier iedereen bedanken die direct of indirect ervoor 
gezorgd heeft dat ik een onvergetelijke tijd tijdens het AIO-en heb gehad. Mocht je er 
desondanks achter komen dat ik vergeten ben je persoonlijk te noemen, vul dan je naam in 
op onderstaande stippellijn: 
 
…………………, bedankt!! 
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